0001717310FALSE2023FY00017173102023-01-012023-12-3100017173102023-06-30iso4217:USD00017173102024-03-15xbrli:shares00017173102023-10-012023-12-3100017173102023-12-3100017173102022-12-31iso4217:USDxbrli:shares00017173102022-01-012022-12-3100017173102021-01-012021-12-310001717310us-gaap:CommonStockMember2020-12-310001717310us-gaap:AdditionalPaidInCapitalMember2020-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2020-12-310001717310vll9:DistributableIncomeLossMember2020-12-3100017173102020-12-310001717310vll9:DistributableIncomeLossMember2021-01-012021-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2021-01-012021-12-310001717310us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001717310us-gaap:CommonStockMember2021-12-310001717310us-gaap:AdditionalPaidInCapitalMember2021-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2021-12-310001717310vll9:DistributableIncomeLossMember2021-12-3100017173102021-12-310001717310vll9:DistributableIncomeLossMember2022-01-012022-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2022-01-012022-12-310001717310us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001717310us-gaap:CommonStockMember2022-12-310001717310us-gaap:AdditionalPaidInCapitalMember2022-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2022-12-310001717310vll9:DistributableIncomeLossMember2022-12-310001717310vll9:DistributableIncomeLossMember2023-01-012023-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2023-01-012023-12-310001717310us-gaap:CommonStockMember2023-12-310001717310us-gaap:AdditionalPaidInCapitalMember2023-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2023-12-310001717310vll9:DistributableIncomeLossMember2023-12-310001717310Calysta, Inc., Senior Secured2023-12-31xbrli:pure0001717310Genomic Prediction, Inc., Senior Secured2023-12-310001717310GLO Pharma, Inc., Senior Secured 12023-12-310001717310GLO Pharma, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsBiotechnologyMembervll9:GLOPharmaIncMember2023-12-310001717310Ukko Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310Canary Connect, Inc., Senior Secured 12023-12-310001717310Canary Connect, Inc., Senior Secured 22023-12-310001717310Canary Connect, Inc., Senior Secured 32023-12-310001717310vll9:CanaryConnectIncMembervll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310Proto, Inc., Senior Secured 12023-12-310001717310Proto, Inc., Senior Secured 22023-12-310001717310vll9:ProtoIncMembervll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310vll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310Diamanti, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMember2023-12-31000171731010club Pte Ltd., Senior Secured2023-12-310001717310Ainsly, Inc., Senior Secured 12023-12-310001717310Ainsly, Inc., Senior Secured 22023-12-310001717310vll9:AinslyIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310D2C Store, Inc., Senior Secured2023-12-310001717310Good Counsel, LLC, Senior Secured2023-12-310001717310iZENEtech, Inc., Senior Secured2023-12-310001717310Kings Mountain I LLC, Senior Secured2023-12-310001717310Miami Labs, Inc., Senior Secured2023-12-310001717310OneLocal, Inc., Senior Secured2023-12-310001717310Osix Corporation, Senior Secured2023-12-310001717310Pixalate, Inc., Senior Secured2023-12-310001717310Quantcast Corp., Senior Secured2023-12-310001717310RenoFi, Inc., Senior Secured 12023-12-310001717310RenoFi, Inc., Senior Secured 22023-12-310001717310vll9:RenoFiIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310Residently USA, LLC, Senior Secured2023-12-310001717310RetailerX, Inc., Senior Secured 2023-12-310001717310Serface Care, Inc., Senior Secured2023-12-310001717310Stay Alfred, Inc., Senior Secured2023-12-310001717310Usual Beverage Co., Senior Secured2023-12-310001717310Verishop, Inc., Senior Secured2023-12-310001717310Vinvesto, Inc., Senior Secured 12023-12-310001717310Vinvesto, Inc., Senior Secured 22023-12-310001717310vll9:VinvestoIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310vll9:LoanInvestmentsInternetMember2023-12-310001717310Anutra Medical, Inc., Senior Secured2023-12-310001717310CytoVale, Inc., Senior Secured2023-12-310001717310Medrobotics Corporation, Inc., Senior Secured2023-12-310001717310Norbert Health, Inc., Senior Secured2023-12-310001717310Siren Care, Inc., Senior Secured 12023-12-310001717310vll9:LoanInvestmentsMedicalDevicesMember2023-12-310001717310Elysium Health, Inc., Senior Secured2023-12-310001717310GoForward, Inc., Senior Secured 12023-12-310001717310Grayce, Inc., Senior Secured 12023-12-310001717310Grayce, Inc., Senior Secured 22023-12-310001717310Grayce, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:GrayceIncMember2023-12-310001717310Hello Heart Inc., Senior Secured 22023-12-310001717310Hello Heart Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:HelloHeartIncMember2023-12-310001717310Honeybee Health, Inc., Senior Secured2023-12-310001717310Julie Products Inc., Senior Secured 12023-12-310001717310Julie Products Inc., Senior Secured 22023-12-310001717310Julie Products Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:JulieProductsIncMember2023-12-310001717310KBS, Inc., Senior Secured2023-12-310001717310Minded, Inc., Senior Secured 12023-12-310001717310Open Inc., Senior Secured 12023-12-310001717310Open Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:OpenIncMember2023-12-310001717310Oula Health, Inc., Senior Secured 12023-12-310001717310Oula Health, Inc., Senior Secured 22023-12-310001717310vll9:OulaHealthIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310PrecisionOS Technology Inc., Senior Secured2023-12-310001717310Therapydia, Inc., Senior Secured2023-12-310001717310Tia, Inc., Senior Secured 12023-12-310001717310Tia, Inc., Senior Secured 22023-12-310001717310vll9:TiaIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310Vessel Health, Inc., Senior Secured2023-12-310001717310Yes Health, Inc., Senior Secured2023-12-310001717310Yuva Biosciences, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMember2023-12-3100017173108i Corporation, Senior Secured2023-12-310001717310Aclima, Inc., Senior Secured2023-12-310001717310Airspeed, Inc., Senior Secured 12023-12-310001717310Airspeed, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:AirspeedIncMember2023-12-310001717310Azumo, Inc., Senior Secured2023-12-310001717310Bankroll Club, LLC, Senior Secured 12023-12-310001717310Beautiful Beanfields, Inc., Senior Secured2023-12-310001717310BloomTech Inc., Senior Secured2023-12-310001717310Brave Care Technologies, Inc., Senior Secured2023-12-310001717310Bryte, Inc., Senior Secured2023-12-310001717310Candy Club Holdings, Inc., Senior Secured2023-12-310001717310Ceres Imaging, Inc., Senior Secured 12023-12-310001717310Ceres Imaging, Inc., Senior Secured 22023-12-310001717310vll9:CeresImagingIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Content Adjacent, Inc., Senior Secured2023-12-310001717310Copia Global Inc., Senior Secured 12023-12-310001717310CornerUp, Inc., Senior Secured 12023-12-310001717310CornerUp, Inc., Senior Secured 22023-12-310001717310vll9:CornerUpIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Creoate Limited, Senior Secured 12023-12-310001717310Creoate Limited, Senior Secured 22023-12-310001717310Creoate Limited, Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:CreoateLimitedMember2023-12-310001717310Daybase, Inc., Senior Secured2023-12-310001717310EasyKnock, Inc., Senior Secured 12023-12-310001717310EasyKnock, Inc., Senior Secured 22023-12-310001717310EasyKnock, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:EasyKnockIncMember2023-12-310001717310Eguana Technologies, Inc., Senior Secured 12023-12-310001717310Eguana Technologies, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:EguanaTechnologiesIncMember2023-12-310001717310Fanimal, Inc., Senior Secured 12023-12-310001717310Fanimal, Inc., Senior Secured 22023-12-310001717310Fanimal, Inc., Senior Secured 32023-12-310001717310Fanimal, Inc., Senior Secured 42023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:FanimalIncMember2023-12-310001717310Hadrian Automation, Inc., Senior Secured2023-12-310001717310Heading Health Inc., Senior Secured 12023-12-310001717310Higher Ground Education, Inc., Senior Secured 12023-12-310001717310Higher Ground Education, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:HigherGroundEducationIncMember2023-12-310001717310Hint, Inc., Senior Secured 12023-12-310001717310Holo, Inc., Senior Secured 12023-12-310001717310Holo, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:HoloIncMember2023-12-310001717310Hyphen Technologies, Inc., Senior Secured 12023-12-310001717310Hyphen Technologies, Inc., Senior Secured 22023-12-310001717310vll9:HyphenTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Intuition Robotics, Inc., Senior Secured2023-12-310001717310Invert Robotics Group, Ltd., Senior Secured2023-12-310001717310Joy Memories, Inc, Senior Secured2023-12-310001717310Kinoo, Inc., Senior Secured2023-12-310001717310Lacuna Technologies, Inc., Senior Secured 12023-12-310001717310LendTable Inc., Senior Secured 12023-12-310001717310LendTable Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:LendTableIncMember2023-12-310001717310Literati, Inc., Senior Secured 12023-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 12023-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:LogistechSolutionsPteLtdMember2023-12-310001717310Mavenform, Inc., Senior Secured 12023-12-310001717310Mavenform, Inc., Senior Secured 22023-12-310001717310Mavenform, Inc., Senior Secured 32023-12-310001717310Mavenform, Inc., Senior Secured 42023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:MavenformIncMember2023-12-310001717310Merlin Labs, Inc., Senior Secured2023-12-310001717310MinoMonsters, Inc., Senior Secured2023-12-310001717310Momentus, Inc., Senior Secured2023-12-310001717310Natomas Labs, Inc., Senior Secured2023-12-310001717310Noteleaf, Inc., Senior Secured2023-12-310001717310Ocho Holdings Co., Senior Secured 12023-12-310001717310OnePointOne, Inc., Senior Secured 12023-12-310001717310OnePointOne, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:OnePointOneIncMember2023-12-310001717310Phase Four, Inc., Senior Secured 12023-12-310001717310Phase Four, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PhaseFourIncMember2023-12-310001717310Plant Prefab, Inc., Senior Secured 12023-12-310001717310Plant Prefab, Inc., Senior Secured 22023-12-310001717310Plant Prefab, Inc., Senior Secured 32023-12-310001717310vll9:PlantPrefabIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310PlantBaby, inc., Senior Secured 12023-12-310001717310PlantBaby, inc., Senior Secured 22023-12-310001717310PlantBaby, inc., Senior Secured 32023-12-310001717310PlantBaby, inc., Senior Secured 42023-12-310001717310PlantBaby, inc., Senior Secured 52023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PlantBabyIncMember2023-12-310001717310Platform Science, Inc., Senior Secured 12023-12-310001717310Platform Science, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PlatformScienceIncMember2023-12-310001717310Privoro Holdings, Inc., Senior Secured2023-12-310001717310Reali Inc., Senior Secured2023-12-310001717310Rise Gardens, Inc., Senior Secured 12023-12-310001717310Rise Gardens, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:RiseGardensIncMember2023-12-310001717310Romaine Empire, Inc., Senior Secured 32023-12-310001717310Setex Technologies, Inc., Senior Secured2023-12-310001717310SISU Aesthetics Clinic, Inc., Senior Secured 12023-12-310001717310SISU Aesthetics Clinic, Inc., Senior Secured 22023-12-310001717310vll9:SISUAestheticsClinicIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310SMS OPCO LLC, Senior Secured2023-12-310001717310Supplant, Inc., Senior Secured 12023-12-310001717310Supplant, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:SupplantIncMember2023-12-310001717310Sustainable Living Partners, LLC, Senior Secured2023-12-310001717310The Farm Project, PBC., Senior Secured2023-12-310001717310The Safe and Fair Food Company LLC, Senior Secured2023-12-310001717310TheSquareFoot, Inc., Senior Secured2023-12-310001717310Titan Health & Security Technologies, Inc., Senior Secured2023-12-310001717310TLNT Inc., Senior Secured 12023-12-310001717310TLNT Inc., Senior Secured 22023-12-310001717310TLNT Inc., Senior Secured 32023-12-310001717310TLNT Inc., Senior Secured 42023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:TLNTIncMember2023-12-310001717310Umbra Lab, Inc., Senior Secured 12023-12-310001717310Umbra Lab, Inc., Senior Secured 22023-12-310001717310Umbra Lab, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:UmbraLabIncMember2023-12-310001717310Velo Holdings Limited, Senior Secured2023-12-310001717310Virtuix Holdings, Inc., Senior Secured2023-12-310001717310Wellth, Inc., Senior Secured 12023-12-310001717310Wellth, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:WellthIncMember2023-12-310001717310Wheels Labs, Inc., Senior Secured2023-12-310001717310World Wrapps II, Inc., Senior Secured 12023-12-310001717310World Wrapps II, Inc., Senior Secured 22023-12-310001717310World Wrapps II, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:WorldWrappsIIIncMember2023-12-310001717310Zeno Technologies, Inc., Senior Secured 12023-12-310001717310Zeno Technologies, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:ZenoTechnologiesIncMember2023-12-310001717310Zimeno Inc., Senior Secured 12023-12-310001717310Zimeno Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:ZimenoIncMember2023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Axiado Corporation, Senior Secured 12023-12-310001717310Axiado Corporation, Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSecurityMembervll9:AxiadoCorporationMember2023-12-310001717310Lassen Peak, Inc., Senior Secured2023-12-310001717310Popily, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsSecurityMember2023-12-310001717310Abacum Inc., Senior Secured2023-12-310001717310Afero, Inc., Senior Secured2023-12-310001717310BackboneAI Inc., Senior Secured2023-12-310001717310Bizly, Inc., Senior Secured2023-12-310001717310BlueCart, Inc., Senior Secured 12023-12-310001717310BlueCart, Inc., Senior Secured 22023-12-310001717310vll9:BlueCartIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Canopy Technology Corp., Senior Secured 12023-12-310001717310Canopy Technology Corp., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:CanopyTechnologyCorpMember2023-12-310001717310Chowbus, Inc., Senior Secured2023-12-310001717310Common Sun, Inc, Senior Secured 12023-12-310001717310Common Sun, Inc, Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:CommonSunIncMember2023-12-310001717310Eskalera, Inc., Senior Secured2023-12-310001717310Form Remodel, Inc., Senior Secured 12023-12-310001717310Form Remodel, Inc., Senior Secured 22023-12-310001717310Form Remodel, Inc., Senior Secured 32023-12-310001717310Form Remodel, Inc., Senior Secured 42023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:FormRemodelIncMember2023-12-310001717310FutureProof Technologies, Inc., Senior Secured2023-12-310001717310Grokker, Inc., Senior Secured 12023-12-310001717310Grokker, Inc., Senior Secured 22023-12-310001717310vll9:GrokkerIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310HaystacksAI, Inc., Senior Secured 12023-12-310001717310HaystacksAI, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:HaystacksAIIncMember2023-12-310001717310Hoken Holdings Inc., Senior Secured2023-12-310001717310Journey Builders, Inc., Senior Secured 12023-12-310001717310Ketch Kloud, Inc., Senior Secured2023-12-310001717310Ocurate, Inc., Senior Secured 12023-12-310001717310Ocurate, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:OcurateIncMember2023-12-310001717310Overalls, Inc., Senior Secured 12023-12-310001717310Overalls, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:OverallsIncMember2023-12-310001717310Parkoursc, Inc., Senior Secured 12023-12-310001717310Ratio Technologies, Inc., Senior Secured 12023-12-310001717310Ratio Technologies, Inc., Senior Secured 22023-12-310001717310Ratio Technologies, Inc., Senior Secured 32023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:RatioTechnologiesIncMember2023-12-310001717310Safe Securities Inc., Senior Secured 12023-12-310001717310Safe Securities Inc., Senior Secured 22023-12-310001717310vll9:SafeSecuritiesIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310SF Insuretech, Inc., Senior Secured 12023-12-310001717310SF Insuretech, Inc., Senior Secured 22023-12-310001717310SF Insuretech, Inc., Senior Secured 32023-12-310001717310SF Insuretech, Inc., Senior Secured 42023-12-310001717310vll9:SFInsuretechIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Swiftly Systems, Inc., Senior Secured 12023-12-310001717310Swiftly Systems, Inc., Senior Secured 22023-12-310001717310vll9:SwiftlySystemsIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Terragon, Inc., Senior Secured2023-12-310001717310Traction Apps, Inc., Senior Secured2023-12-310001717310Truthset, Inc., Senior Secured2023-12-310001717310UCM Digital Health, Inc., Senior Secured2023-12-310001717310Vesta Housing, Inc., Senior Secured 12023-12-310001717310Vesta Housing, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:VestaHousingIncMember2023-12-310001717310WorkRails, Inc., Senior Secured2023-12-310001717310Workspot, Inc., Senior Secured 12023-12-310001717310vll9:LoanInvestmentsSoftwareMember2023-12-310001717310iLearningEngines Inc., Senior Secured 12023-12-310001717310iLearningEngines Inc., Senior Secured 22023-12-310001717310iLearningEngines Inc., Senior Secured 32023-12-310001717310iLearningEngines Inc., Senior Secured 42023-12-310001717310iLearningEngines Inc., Senior Secured 52023-12-310001717310iLearningEngines Inc., Senior Secured 62023-12-310001717310vll9:LoanInvestmentsTechnologyServicesMembervll9:ILearningEnginesIncMember2023-12-310001717310Klar Holdings Limited, Senior Secured 12023-12-310001717310Klar Holdings Limited, Senior Secured 32023-12-310001717310Klar Holdings Limited, Senior Secured 42023-12-310001717310vll9:LoanInvestmentsTechnologyServicesMembervll9:KlarHoldingsLimitedMember2023-12-310001717310Loansnap Holdings Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310AirVine Scientific, Inc., Senior Secured 12023-12-310001717310AirVine Scientific, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsWirelessMembervll9:AirVineScientificIncMember2023-12-310001717310Juvo Mobile, Inc., Senior Secured2023-12-310001717310Juvo Mobile, Inc., Senior Secured 22023-12-310001717310vll9:LoanInvestmentsWirelessMembervll9:JuvoMobileIncMember2023-12-310001717310MeshPlusPlus, Inc., Senior Secured 12023-12-310001717310MeshPlusPlus, Inc., Senior Secured 22023-12-310001717310vll9:MeshPlusPlusIncMembervll9:LoanInvestmentsWirelessMember2023-12-310001717310vll9:LoanInvestmentsWirelessMember2023-12-310001717310First American Government Obligations Fund2023-12-310001717310Calysta, Inc., Senior Secured2022-12-310001717310Driver Bioengineering, Inc., Senior Secured 12022-12-310001717310Driver Bioengineering, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsBiotechnologyMembervll9:DriverBioengineeringIncMember2022-12-310001717310Genomic Prediction, Inc., Senior Secured2022-12-310001717310GLO Pharma, Inc., Senior Secured 12022-12-310001717310GLO Pharma, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsBiotechnologyMembervll9:GLOPharmaIncMember2022-12-310001717310Quartzy, Inc., Senior Secured 12022-12-310001717310Quartzy, Inc., Senior Secured 22022-12-310001717310Quartzy, Inc., Senior Secured 32022-12-310001717310Quartzy, Inc., Senior Secured 42022-12-310001717310Quartzy, Inc., Senior Secured 52022-12-310001717310Quartzy, Inc., Senior Secured 62022-12-310001717310Quartzy, Inc., Senior Secured 72022-12-310001717310vll9:LoanInvestmentsBiotechnologyMembervll9:QuartzyIncMember2022-12-310001717310Ukko Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsBiotechnologyMember2022-12-310001717310Canary Connect, Inc., Senior Secured 12022-12-310001717310Canary Connect, Inc., Senior Secured 22022-12-310001717310Canary Connect, Inc., Senior Secured 32022-12-310001717310Canary Connect, Inc., Senior Secured 42022-12-310001717310vll9:CanaryConnectIncMembervll9:LoanInvestmentsComputersAndStorageMember2022-12-310001717310Proto, Inc., Senior Secured 12022-12-310001717310Proto, Inc., Senior Secured 22022-12-310001717310vll9:ProtoIncMembervll9:LoanInvestmentsComputersAndStorageMember2022-12-310001717310vll9:LoanInvestmentsComputersAndStorageMember2022-12-310001717310Diamanti, Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMember2022-12-31000171731010club Pte Ltd., Senior Secured 12022-12-31000171731010club Pte Ltd., Senior Secured 22022-12-310001717310vll9:A10clubPteLtdMembervll9:LoanInvestmentsInternetMember2022-12-310001717310Ainsly, Inc., Senior Secured 12022-12-310001717310Ainsly, Inc., Senior Secured 22022-12-310001717310Ainsly, Inc., Senior Secured 32022-12-310001717310vll9:AinslyIncMembervll9:LoanInvestmentsInternetMember2022-12-310001717310D2C Store, Inc., Senior Secured2022-12-310001717310Good Counsel, LLC, Senior Secured2022-12-310001717310iZENEtech, Inc., Senior Secured2022-12-310001717310Kings Mountain I LLC, Senior Secured2022-12-310001717310Mantra Health, Inc., Senior Secured2022-12-310001717310Merchbar, Inc., Senior Secured2022-12-310001717310Miami Labs, Inc., Senior Secured2022-12-310001717310OneLocal, Inc., Senior Secured 12022-12-310001717310OneLocal, Inc., Senior Secured 22022-12-310001717310OneLocal, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsInternetMembervll9:OneLocalIncMember2022-12-310001717310Osix Corporation, Senior Secured2022-12-310001717310Pixalate, Inc., Senior Secured2022-12-310001717310Quantcast Corp., Senior Secured2022-12-310001717310RenoFi, Inc., Senior Secured 12022-12-310001717310RenoFi, Inc., Senior Secured 22022-12-310001717310RenoFi, Inc., Senior Secured 32022-12-310001717310RenoFi, Inc., Senior Secured 42022-12-310001717310RenoFi, Inc., Senior Secured 52022-12-310001717310vll9:RenoFiIncMembervll9:LoanInvestmentsInternetMember2022-12-310001717310Residently USA, LLC, Senior Secured2022-12-310001717310RetailerX, Inc., Senior Secured 12022-12-310001717310RetailerX, Inc., Senior Secured 22022-12-310001717310RetailerX, Inc., Senior Secured 32022-12-310001717310RetailerX, Inc., Senior Secured 42022-12-310001717310RetailerX, Inc., Senior Secured 52022-12-310001717310vll9:RetailerXIncMembervll9:LoanInvestmentsInternetMember2022-12-310001717310Serface Care, Inc., Senior Secured2022-12-310001717310Starface World, Inc., Senior Secured 12022-12-310001717310Starface World, Inc., Senior Secured 22022-12-310001717310Starface World, Inc., Senior Secured 32022-12-310001717310Starface World, Inc., Senior Secured 42022-12-310001717310Starface World, Inc., Senior Secured 52022-12-310001717310vll9:StarfaceWorldIncMembervll9:LoanInvestmentsInternetMember2022-12-310001717310Stay Alfred, Inc., Senior Secured2022-12-310001717310Usual Beverage Co., Senior Secured2022-12-310001717310Verishop, Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsInternetMember2022-12-3100017173103D Bio Holdings, Inc., Senior Secured2022-12-310001717310Ablacon, Inc., Senior Secured 12022-12-310001717310Ablacon, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsMedicalDevicesMembervll9:AblaconIncMember2022-12-310001717310Anutra Medical, Inc., Senior Secured2022-12-310001717310CytoVale, Inc., Senior Secured2022-12-310001717310Medrobotics Corporation, Inc., Senior Secured2022-12-310001717310Norbert Health, Inc., Senior Secured2022-12-310001717310Serpex Medical Inc., Senior Secured2022-12-310001717310Siren Care, Inc., Senior Secured 12022-12-310001717310Siren Care, Inc., Senior Secured 22022-12-310001717310vll9:SirenCareIncMembervll9:LoanInvestmentsMedicalDevicesMember2022-12-310001717310vll9:LoanInvestmentsMedicalDevicesMember2022-12-310001717310Alchera Incorporated, Senior Secured 12022-12-310001717310Alchera Incorporated, Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:AlcheraIncorporatedMember2022-12-310001717310Elysium Health, Inc., Senior Secured2022-12-310001717310GoForward, Inc., Senior Secured 12022-12-310001717310GoForward, Inc., Senior Secured 22022-12-310001717310vll9:GoForwardIncMembervll9:LoanInvestmentsOtherHealthcareMember2022-12-310001717310Grayce, Inc., Senior Secured 12022-12-310001717310Grayce, Inc., Senior Secured 22022-12-310001717310Grayce, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:GrayceIncMember2022-12-310001717310Hello Heart Inc., Senior Secured 12022-12-310001717310Hello Heart Inc., Senior Secured 22022-12-310001717310Hello Heart Inc., Senior Secured 32022-12-310001717310Hello Heart Inc., Senior Secured 42022-12-310001717310Hello Heart Inc., Senior Secured 52022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:HelloHeartIncMember2022-12-310001717310Honeybee Health, Inc., Senior Secured2022-12-310001717310HumanAPI, Inc., Senior Secured 12022-12-310001717310HumanAPI, Inc., Senior Secured 22022-12-310001717310HumanAPI, Inc., Senior Secured 32022-12-310001717310HumanAPI, Inc., Senior Secured 42022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:HumanAPIIncMember2022-12-310001717310Julie Products Inc., Senior Secured2022-12-310001717310KBS, Inc., Senior Secured2022-12-310001717310Minded, Inc., Senior Secured 12022-12-310001717310Minded, Inc., Senior Secured 22022-12-310001717310vll9:MindedIncMembervll9:LoanInvestmentsOtherHealthcareMember2022-12-310001717310Open Inc., Senior Secured2022-12-310001717310Oula Health, Inc., Senior Secured 12022-12-310001717310Oula Health, Inc., Senior Secured 22022-12-310001717310vll9:OulaHealthIncMembervll9:LoanInvestmentsOtherHealthcareMember2022-12-310001717310PrecisionOS Technology Inc., Senior Secured2022-12-310001717310Therapydia, Inc., Senior Secured 12022-12-310001717310Therapydia, Inc., Senior Secured 22022-12-310001717310Therapydia, Inc., Senior Secured 32022-12-310001717310Therapydia, Inc., Senior Secured 42022-12-310001717310Therapydia, Inc., Senior Secured 52022-12-310001717310Therapydia, Inc., Senior Secured 62022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMembervll9:TherapydiaIncMember2022-12-310001717310Tia, Inc., Senior Secured 12022-12-310001717310Tia, Inc., Senior Secured 22022-12-310001717310vll9:TiaIncMembervll9:LoanInvestmentsOtherHealthcareMember2022-12-310001717310Vessel Health, Inc., Senior Secured2022-12-310001717310Yes Health, Inc., Senior Secured2022-12-310001717310Yuva Biosciences, Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsOtherHealthcareMember2022-12-3100017173108i Corporation, Senior Secured2022-12-310001717310Aclima, Inc., Senior Secured2022-12-310001717310Airspeed, Inc., Senior Secured2022-12-310001717310Antitoxin Technologies Inc., Senior Secured2022-12-310001717310ATeam Army, Inc., Senior Secured2022-12-310001717310Azumo, Inc., Senior Secured2022-12-310001717310Bankroll Club, LLC, Senior Secured 12022-12-310001717310Bankroll Club, LLC, Senior Secured 22022-12-310001717310Bankroll Club, LLC, Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:BankrollClubLLCMember2022-12-310001717310Beautiful Beanfields, Inc., Senior Secured2022-12-310001717310BloomTech Inc., Senior Secured 12022-12-310001717310BloomTech Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:BloomTechIncMember2022-12-310001717310Brave Care Technologies, Inc., Senior Secured2022-12-310001717310Brightside Benefit, Inc., Senior Secured2022-12-310001717310Bryte, Inc., Senior Secured2022-12-310001717310BW Industries, Inc., Senior Secured 12022-12-310001717310BW Industries, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:BWIndustriesIncMember2022-12-310001717310Candy Club Holdings, Inc., Senior Secured 12022-12-310001717310Candy Club Holdings, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:CandyClubHoldingsIncMember2022-12-310001717310Ceres Imaging, Inc., Senior Secured 12022-12-310001717310Ceres Imaging, Inc., Senior Secured 22022-12-310001717310vll9:CeresImagingIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Content Adjacent, Inc., Senior Secured 12022-12-310001717310Content Adjacent, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:ContentAdjacentIncMember2022-12-310001717310Copia Global Inc., Senior Secured 12022-12-310001717310Copia Global Inc., Senior Secured 22022-12-310001717310vll9:CopiaGlobalIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310CornerUp, Inc., Senior Secured 12022-12-310001717310CornerUp, Inc., Senior Secured 22022-12-310001717310vll9:CornerUpIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Creoate Limited, Senior Secured 12022-12-310001717310Creoate Limited, Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:CreoateLimitedMember2022-12-310001717310Daybase, Inc., Senior Secured2022-12-310001717310EasyKnock, Inc., Senior Secured 12022-12-310001717310EasyKnock, Inc., Senior Secured 22022-12-310001717310EasyKnock, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:EasyKnockIncMember2022-12-310001717310Eguana Technologies, Inc., Senior Secured 12022-12-310001717310Eguana Technologies, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:EguanaTechnologiesIncMember2022-12-310001717310Fakespot, Inc., Senior Secured 12022-12-310001717310Fakespot, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:FakespotIncMember2022-12-310001717310Fanimal, Inc., Senior Secured 12022-12-310001717310Fanimal, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:FanimalIncMember2022-12-310001717310Fitplan, Inc., Senior Secured2022-12-310001717310Flo Water, Inc., Senior Secured2022-12-310001717310Hadrian Automation, Inc., Senior Secured2022-12-310001717310Heading Health Inc., Senior Secured 12022-12-310001717310Heading Health Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:HeadingHealthIncMember2022-12-310001717310Higher Ground Education, Inc., Senior Secured 12022-12-310001717310Higher Ground Education, Inc., Senior Secured 22022-12-310001717310Higher Ground Education, Inc., Senior Secured 32022-12-310001717310Higher Ground Education, Inc., Senior Secured 42022-12-310001717310Higher Ground Education, Inc., Senior Secured 52022-12-310001717310Higher Ground Education, Inc., Senior Secured 62022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:HigherGroundEducationIncMember2022-12-310001717310Hint, Inc., Senior Secured 12022-12-310001717310Hint, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:HintIncMember2022-12-310001717310Holo, Inc., Senior Secured2022-12-310001717310Hyphen Technologies, Inc., Senior Secured 12022-12-310001717310Hyphen Technologies, Inc., Senior Secured 22022-12-310001717310vll9:HyphenTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Intergalactic Foods Corporation, Senior Secured2022-12-310001717310Intuition Robotics, Inc., Senior Secured2022-12-310001717310Invert Robotics Group, Ltd., Senior Secured2022-12-310001717310Jiko Group, Inc., Senior Secured2022-12-310001717310Joy Memories, Inc, Senior Secured2022-12-310001717310Kinoo, Inc., Senior Secured2022-12-310001717310Lacuna Technologies, Inc., Senior Secured 12022-12-310001717310Lacuna Technologies, Inc., Senior Secured 22022-12-310001717310vll9:LacunaTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310LendTable Inc., Senior Secured2022-12-310001717310Level Home, Inc., Senior Secured 12022-12-310001717310Level Home, Inc., Senior Secured 22022-12-310001717310vll9:LevelHomeIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Literati, Inc., Senior Secured 12022-12-310001717310Literati, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:LiteratiIncMember2022-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured2022-12-310001717310MASC Inc., Senior Secured2022-12-310001717310Mavenform, Inc., Senior Secured 12022-12-310001717310Mavenform, Inc., Senior Secured 22022-12-310001717310Mavenform, Inc., Senior Secured 32022-12-310001717310Mavenform, Inc., Senior Secured 42022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:MavenformIncMember2022-12-310001717310Merlin Labs, Inc., Senior Secured 12022-12-310001717310Merlin Labs, Inc., Senior Secured 22022-12-310001717310vll9:MerlinLabsIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310MinoMonsters, Inc., Senior Secured2022-12-310001717310Momentus, Inc., Senior Secured2022-12-310001717310Natomas Labs, Inc., Senior Secured2022-12-310001717310NewGlobe Education, Inc., Senior Secured2022-12-310001717310Noteleaf, Inc., Senior Secured2022-12-310001717310Nue Life Health, Inc., Senior Secured2022-12-310001717310Ocho Holdings Co., Senior Secured 12022-12-310001717310Ocho Holdings Co., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:OchoHoldingsCoMember2022-12-310001717310OnePointOne, Inc., Senior Secured 12022-12-310001717310OnePointOne, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:OnePointOneIncMember2022-12-310001717310Opya, Inc., Senior Secured2022-12-310001717310Percepto, Inc., Senior Secured2022-12-310001717310Phase Four, Inc., Senior Secured 12022-12-310001717310Phase Four, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PhaseFourIncMember2022-12-310001717310Plant Prefab, Inc., Senior Secured 12022-12-310001717310Plant Prefab, Inc., Senior Secured 22022-12-310001717310Plant Prefab, Inc., Senior Secured 32022-12-310001717310vll9:PlantPrefabIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310PlantBaby, inc., Senior Secured 12022-12-310001717310PlantBaby, inc., Senior Secured 22022-12-310001717310PlantBaby, inc., Senior Secured 32022-12-310001717310PlantBaby, inc., Senior Secured 42022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PlantBabyIncMember2022-12-310001717310Platform Science, Inc., Senior Secured 12022-12-310001717310Platform Science, Inc., Senior Secured 22022-12-310001717310Platform Science, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:PlatformScienceIncMember2022-12-310001717310Privoro Holdings, Inc., Senior Secured2022-12-310001717310Reali Inc., Senior Secured2022-12-310001717310Rise Gardens, Inc., Senior Secured2022-12-310001717310Romaine Empire, Inc., Senior Secured 12022-12-310001717310Romaine Empire, Inc., Senior Secured 22022-12-310001717310Romaine Empire, Inc., Senior Secured 32022-12-310001717310vll9:RomaineEmpireIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Saltbox, Inc., Senior Secured2022-12-310001717310Setex Technologies, Inc., Senior Secured2022-12-310001717310SISU Aesthetics Clinic, Inc., Senior Secured2022-12-310001717310SMS OPCO LLC, Senior Secured2022-12-310001717310Supplant, Inc., Senior Secured2022-12-310001717310Sustainable Living Partners, LLC, Senior Secured 12022-12-310001717310Sustainable Living Partners, LLC, Senior Secured 22022-12-310001717310Sustainable Living Partners, LLC, Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:SustainableLivingPartnersLLCMember2022-12-310001717310The Farm Project, PBC., Senior Secured2022-12-310001717310The Safe and Fair Food Company LLC, Senior Secured2022-12-310001717310TheSquareFoot, Inc., Senior Secured 12022-12-310001717310TheSquareFoot, Inc., Senior Secured 22022-12-310001717310vll9:TheSquareFootIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Titan Health & Security Technologies, Inc., Senior Secured2022-12-310001717310TLNT Inc., Senior Secured 12022-12-310001717310TLNT Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:TLNTIncMember2022-12-310001717310TomoCredit, Inc., Senior Secured 12022-12-310001717310TomoCredit, Inc., Senior Secured 22022-12-310001717310vll9:TomoCreditIncMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Umbra Lab, Inc., Senior Secured 12022-12-310001717310Umbra Lab, Inc., Senior Secured 22022-12-310001717310Umbra Lab, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:UmbraLabIncMember2022-12-310001717310Veev Group, Inc., Senior Secured 12022-12-310001717310Veev Group, Inc., Senior Secured 22022-12-310001717310Veev Group, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:VeevGroupIncMember2022-12-310001717310Velo Holdings Limited, Senior Secured2022-12-310001717310Virtuix Holdings, Inc., Senior Secured2022-12-310001717310Wellth, Inc., Senior Secured 12022-12-310001717310Wellth, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:WellthIncMember2022-12-310001717310Wheels Labs, Inc., Senior Secured2022-12-310001717310World Wrapps II, Inc., Senior Secured 12022-12-310001717310World Wrapps II, Inc., Senior Secured 22022-12-310001717310World Wrapps II, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:WorldWrappsIIIncMember2022-12-310001717310Zeno Technologies, Inc., Senior Secured 12022-12-310001717310Zeno Technologies, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMembervll9:ZenoTechnologiesIncMember2022-12-310001717310Zimeno Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310Axiado Corporation, Senior Secured 12022-12-310001717310Axiado Corporation, Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSecurityMembervll9:AxiadoCorporationMember2022-12-310001717310Lassen Peak, Inc., Senior Secured2022-12-310001717310Popily, Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsSecurityMember2022-12-310001717310Afero, Inc., Senior Secured2022-12-310001717310Amino, Inc., Senior Secured 12022-12-310001717310Amino, Inc., Senior Secured 22022-12-310001717310Amino, Inc., Senior Secured 32022-12-310001717310Amino, Inc., Senior Secured 42022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:AminoIncMember2022-12-310001717310BackboneAI Inc., Senior Secured 12022-12-310001717310BackboneAI Inc., Senior Secured 22022-12-310001717310BackboneAI Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:BackboneAIIncMember2022-12-310001717310Big Run Studios, Inc., Senior Secured 12022-12-310001717310Big Run Studios, Inc., Senior Secured 22022-12-310001717310vll9:BigRunStudiosIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310Bizly, Inc., Senior Secured 12022-12-310001717310Bizly, Inc., Senior Secured 22022-12-310001717310Bizly, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:BizlyIncMember2022-12-310001717310BlueCart, Inc., Senior Secured2022-12-310001717310Canopy Technology Corp., Senior Secured2022-12-310001717310Chowbus, Inc., Senior Secured2022-12-310001717310Clarified Inc., Senior Secured2022-12-310001717310Common Sun, Inc, Senior Secured 12022-12-310001717310Common Sun, Inc, Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:CommonSunIncMember2022-12-310001717310Eskalera, Inc., Senior Secured 12022-12-310001717310Eskalera, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:EskaleraIncMember2022-12-310001717310Form Remodel, Inc., Senior Secured 12022-12-310001717310Form Remodel, Inc., Senior Secured 22022-12-310001717310Form Remodel, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:FormRemodelIncMember2022-12-310001717310FutureProof Technologies, Inc., Senior Secured2022-12-310001717310Grokker, Inc., Senior Secured 12022-12-310001717310Grokker, Inc., Senior Secured 22022-12-310001717310vll9:GrokkerIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310HaystacksAI, Inc., Senior Secured 12022-12-310001717310HaystacksAI, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:HaystacksAIIncMember2022-12-310001717310Hoken Holdings Inc., Senior Secured2022-12-310001717310ICX Media, Inc., Senior Secured2022-12-310001717310Journey Builders, Inc., Senior Secured 12022-12-310001717310Journey Builders, Inc., Senior Secured 22022-12-310001717310vll9:JourneyBuildersIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310Ketch Kloud, Inc., Senior Secured2022-12-310001717310Medable, Inc., Senior Secured 12022-12-310001717310Medable, Inc., Senior Secured 22022-12-310001717310vll9:MedableIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310Ocurate, Inc., Senior Secured 12022-12-310001717310Ocurate, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:OcurateIncMember2022-12-310001717310Overalls, Inc., Senior Secured2022-12-310001717310Parkoursc, Inc., Senior Secured 12022-12-310001717310Parkoursc, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:ParkourscIncMember2022-12-310001717310Ratio Technologies, Inc., Senior Secured 12022-12-310001717310Ratio Technologies, Inc., Senior Secured 22022-12-310001717310Ratio Technologies, Inc., Senior Secured 32022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:RatioTechnologiesIncMember2022-12-310001717310Safe Securities Inc., Senior Secured 12022-12-310001717310Safe Securities Inc., Senior Secured 22022-12-310001717310Safe Securities Inc., Senior Secured 32022-12-310001717310vll9:SafeSecuritiesIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310SF Insuretech, Inc., Senior Secured2022-12-310001717310Sonatus, Inc, Senior Secured2022-12-310001717310StayTuned Digital, Inc., Senior Secured 12022-12-310001717310StayTuned Digital, Inc., Senior Secured 22022-12-310001717310StayTuned Digital, Inc., Senior Secured 32022-12-310001717310StayTuned Digital, Inc., Senior Secured 42022-12-310001717310StayTuned Digital, Inc., Senior Secured 52022-12-310001717310StayTuned Digital, Inc., Senior Secured 62022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:StayTunedDigitalIncMember2022-12-310001717310Swiftly Systems, Inc., Senior Secured 12022-12-310001717310Swiftly Systems, Inc., Senior Secured 22022-12-310001717310vll9:SwiftlySystemsIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310Terragon, Inc., Senior Secured2022-12-310001717310Traction Apps, Inc., Senior Secured2022-12-310001717310Truthset, Inc., Senior Secured2022-12-310001717310UCM Digital Health, Inc., Senior Secured 12022-12-310001717310UCM Digital Health, Inc., Senior Secured 22022-12-310001717310vll9:UCMDigitalHealthIncMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310Vesta Housing, Inc., Senior Secured 12022-12-310001717310Vesta Housing, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:VestaHousingIncMember2022-12-310001717310WorkRails, Inc., Senior Secured2022-12-310001717310Workspot, Inc., Senior Secured 12022-12-310001717310Workspot, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsSoftwareMembervll9:WorkspotIncMember2022-12-310001717310vll9:LoanInvestmentsSoftwareMember2022-12-310001717310iLearningEngines Inc., Senior Secured 12022-12-310001717310iLearningEngines Inc., Senior Secured 22022-12-310001717310iLearningEngines Inc., Senior Secured 32022-12-310001717310iLearningEngines Inc., Senior Secured 42022-12-310001717310iLearningEngines Inc., Senior Secured 52022-12-310001717310vll9:LoanInvestmentsTechnologyServicesMembervll9:ILearningEnginesIncMember2022-12-310001717310Klar Holdings Limited, Senior Secured 12022-12-310001717310Klar Holdings Limited, Senior Secured 22022-12-310001717310Klar Holdings Limited, Senior Secured 32022-12-310001717310Klar Holdings Limited, Senior Secured 42022-12-310001717310vll9:LoanInvestmentsTechnologyServicesMembervll9:KlarHoldingsLimitedMember2022-12-310001717310Loansnap Holdings Inc., Senior Secured 12022-12-310001717310Loansnap Holdings Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsTechnologyServicesMembervll9:LoansnapHoldingsIncMember2022-12-310001717310Zanbato, Inc., Senior Secured2022-12-310001717310vll9:LoanInvestmentsTechnologyServicesMember2022-12-310001717310AirVine Scientific, Inc., Senior Secured 12022-12-310001717310AirVine Scientific, Inc., Senior Secured 22022-12-310001717310vll9:LoanInvestmentsWirelessMembervll9:AirVineScientificIncMember2022-12-310001717310Juvo Mobile, Inc., Senior Secured2022-12-310001717310MeshPlusPlus, Inc., Senior Secured 12022-12-310001717310MeshPlusPlus, Inc., Senior Secured 22022-12-310001717310vll9:MeshPlusPlusIncMembervll9:LoanInvestmentsWirelessMember2022-12-310001717310vll9:LoanInvestmentsWirelessMember2022-12-310001717310First American Government Obligations2022-12-310001717310vll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMember2023-12-310001717310srt:MinimumMembervll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMember2023-12-310001717310vll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMember2023-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMember2023-12-310001717310srt:MinimumMembervll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMember2023-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMember2023-12-310001717310vll9:InterestRateCollarMember2023-12-310001717310vll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMembervll9:InterestRateCollarCapRate086FloorRate035Maturity3182024Member2022-12-310001717310srt:MinimumMembervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:InterestRateCollarCapRate086FloorRate035Maturity3182024Member2022-12-310001717310vll9:ZionsBancorporationNAMembervll9:InterestRateCollarCapRate086FloorRate035Maturity3182024Member2022-12-310001717310vll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMember2022-12-310001717310srt:MinimumMembervll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMember2022-12-310001717310vll9:InterestRateCollarCapRate136FloorRate042Maturity6302025Membervll9:ZionsBancorporationNAMember2022-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMember2022-12-310001717310srt:MinimumMembervll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembervll9:SecuredOvernightFinancingRateSOFRMember2022-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMember2022-12-310001717310vll9:InterestRateCollarMember2022-12-310001717310vll9:VentureLendingLeasingIXLLCMembervll9:VentureLendingLeasingIXIncMember2023-01-012023-12-310001717310vll9:VentureLendingLeasingIXLLCMember2017-06-012017-06-300001717310vll9:VentureLendingLeasingIXLLCMember2017-06-30vll9:bank_accountvll9:financial_institution0001717310vll9:FirstAmericanGovernmentObligationsFundMember2023-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2023-01-012023-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2022-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2022-01-012022-12-310001717310vll9:PerformingLoansMembersrt:WeightedAverageMember2023-01-012023-12-310001717310vll9:PerformingLoansMembersrt:WeightedAverageMember2022-01-012022-12-310001717310srt:WeightedAverageMember2023-01-012023-12-310001717310srt:WeightedAverageMember2022-01-012022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsEnterpriseNetworkingMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembersrt:MaximumMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsInternetMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsInternetMembersrt:MaximumMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMembersrt:MaximumMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationAssetRecoveryMembersrt:MaximumMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMembersrt:MaximumMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSecurityMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSecurityMembervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSoftwareMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembersrt:MaximumMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsTechnologyServicesMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembersrt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2023-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Member2023-12-31vll9:loan0001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsComputersAndStorageMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsEnterpriseNetworkingMembervll9:ValuationAssetRecoveryMember2022-12-310001717310srt:MinimumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2022-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembersrt:MaximumMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsInternetMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsInternetMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsInternetMembersrt:MaximumMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsMedicalDevicesMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMembersrt:MaximumMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationAssetRecoveryMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:LoanInvestmentsOtherHealthcareMembervll9:ValuationAssetRecoveryMembersrt:MaximumMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsOtherTechnologyMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMembersrt:MaximumMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSecurityMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSecurityMembervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsSoftwareMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310srt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembersrt:MaximumMembervll9:LoanInvestmentsSoftwareMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsTechnologyServicesMembervll9:ValuationHypotheticalMarketAnalysisAndAssetRecoveryMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsTechnologyServicesMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:ValuationHypotheticalMarketAnalysisMembervll9:LoanInvestmentsTechnologyServicesMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsTechnologyServicesMember2022-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMembersrt:MaximumMember2022-12-310001717310vll9:MeasurementInputHypotheticalMarketCouponRateMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMembervll9:LoanInvestmentsWirelessMembervll9:ValuationHypotheticalMarketAnalysisMember2022-12-310001717310us-gaap:FairValueInputsLevel3Member2022-12-310001717310us-gaap:FairValueInputsLevel1Member2023-12-310001717310us-gaap:FairValueInputsLevel2Member2023-12-310001717310us-gaap:FairValueInputsLevel1Member2022-12-310001717310us-gaap:FairValueInputsLevel2Member2022-12-310001717310us-gaap:LoansMember2022-12-310001717310us-gaap:WarrantMember2022-12-310001717310us-gaap:CommonStockMember2022-12-310001717310us-gaap:LoansMember2023-01-012023-12-310001717310us-gaap:WarrantMember2023-01-012023-12-310001717310us-gaap:CommonStockMember2023-01-012023-12-310001717310vll9:DebtAndEquitySecuritiesRealizedGainLossMemberus-gaap:LoansMember2023-01-012023-12-310001717310us-gaap:LoansMembervll9:DebtAndEquitySecuritiesUnrealizedGainLossMember2023-01-012023-12-310001717310us-gaap:LoansMember2023-12-310001717310us-gaap:WarrantMember2023-12-310001717310us-gaap:CommonStockMember2023-12-310001717310us-gaap:LoansMember2021-12-310001717310us-gaap:WarrantMember2021-12-310001717310us-gaap:CommonStockMember2021-12-310001717310us-gaap:OtherAssetsMember2021-12-310001717310us-gaap:LoansMember2022-01-012022-12-310001717310us-gaap:WarrantMember2022-01-012022-12-310001717310us-gaap:CommonStockMember2022-01-012022-12-310001717310us-gaap:OtherAssetsMember2022-01-012022-12-310001717310vll9:DebtAndEquitySecuritiesRealizedGainLossMemberus-gaap:LoansMember2022-01-012022-12-310001717310us-gaap:LoansMembervll9:DebtAndEquitySecuritiesUnrealizedGainLossMember2022-01-012022-12-310001717310us-gaap:OtherAssetsMember2022-12-310001717310vll9:CashDividendDistributionMember2023-01-012023-12-310001717310vll9:CashDividendDistributionMember2022-01-012022-12-310001717310vll9:CashDividendDistributionMember2021-01-012021-12-310001717310vll9:EquityDividendDistributionMember2023-01-012023-12-310001717310vll9:EquityDividendDistributionMember2022-01-012022-12-310001717310vll9:EquityDividendDistributionMember2021-01-012021-12-310001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-05-170001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-10-260001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-12-310001717310us-gaap:LineOfCreditMembervll9:ReferenceRateMembervll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:ReferenceRateMembervll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310srt:MinimumMemberus-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310srt:MinimumMemberus-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310srt:MinimumMemberus-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310srt:MinimumMemberus-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-12-310001717310us-gaap:LineOfCreditMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMembervll9:DailySimpleSecuredOvernightFinancingRateSOFRRateMember2023-12-310001717310us-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001717310us-gaap:LineOfCreditMembervll9:SecuredOvernightFinancingRateSOFRMembervll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-01-012022-12-310001717310vll9:ManagementFeePeriodOneMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodTwoMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodThreeMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodFourMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodFiveMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodSixMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodSevenMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodEightMember2023-01-012023-12-310001717310vll9:ManagementFeePeriodNineMember2023-01-012023-12-3100017173102023-01-012023-06-3000017173102023-07-012023-12-3100017173102022-01-012022-06-3000017173102022-07-012022-12-310001717310vll9:FundMember2023-12-310001717310vll9:FundVIIIMember2023-12-310001717310vll9:FundXMember2023-12-310001717310vll9:InterestRateCollarTerminatedMember2023-12-310001717310vll9:InterestRateCollarTerminatedMember2022-12-310001717310vll9:InterestRateCollarTerminatedMember2023-01-012023-12-310001717310vll9:InterestRateCollarTerminatedMember2022-01-012022-12-310001717310vll9:InterestRateCollarMember2023-01-012023-12-310001717310vll9:InterestRateCollarMember2022-01-012022-12-310001717310vll9:InterestRateCollarMember2021-01-012021-12-310001717310vll9:InterestRateSwapAndFloorMember2023-01-012023-12-310001717310vll9:InterestRateSwapAndFloorMember2022-01-012022-12-310001717310vll9:InterestRateSwapAndFloorMember2021-01-012021-12-310001717310us-gaap:AssetsMemberus-gaap:LoansMember2023-12-310001717310us-gaap:AssetsMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2023-12-310001717310us-gaap:AssetsMember2023-12-310001717310us-gaap:DerivativeFinancialInstrumentsAssetsMember2022-12-310001717310us-gaap:LiabilityMember2023-12-310001717310us-gaap:LiabilityMember2022-12-310001717310Abacum Inc., Software2022-12-310001717310Airspeed, Inc., Other Technology2022-12-310001717310Azumo, Inc., Other Technology2022-12-310001717310Bankroll Club, LLC, Other Technology2022-12-310001717310BlueCart, Inc., Software2022-12-310001717310Bryte, Inc., Other Technology2022-12-310001717310Canopy Technology Corp., Software2022-12-310001717310CornerUp, Inc., Other Technology2022-12-310001717310Creoate Limited, Other Technology2022-12-310001717310EasyKnock, Inc., Other Technology2022-12-310001717310Fanimal, Inc., Other Technology2022-12-310001717310Form Remodel, Inc., Software2022-12-310001717310FutureProof Technologies, Inc., Software2022-12-310001717310Grayce, Inc., Other Healthcare2022-12-310001717310Heading Health Inc., Other Technology2022-12-310001717310Hoken Holdings Inc., Software2022-12-310001717310Holo, Inc., Other Technology2022-12-310001717310iLearningEngines Inc., Technology Services2022-12-310001717310Julie Products Inc., Other Healthcare2022-12-310001717310Juvo Mobile, Inc., Wireless2022-12-310001717310KBS, Inc., Other Healthcare2022-12-310001717310LendTable Inc., Other Technology2022-12-310001717310Literati, Inc., Other Technology2022-12-310001717310Logistech Solutions Pte. Ltd., Other Technology2022-12-310001717310Miami Labs, Inc., Internet2022-12-310001717310Nue Life Health, Inc., Other Technology2022-12-310001717310Open Inc., Other Healthcare2022-12-310001717310Overalls, Inc., Software2022-12-310001717310Plant Prefab, Inc., Other Technology2022-12-310001717310PlantBaby, inc., Other Technology2022-12-310001717310Platform Science, Inc., Other Technology2022-12-310001717310Rise Gardens, Inc., Other Technology2022-12-310001717310Romaine Empire, Inc., Other Technology2022-12-310001717310SISU Aesthetics Clinic, Inc., Other Technology2022-12-310001717310Snoqualmie, Inc., Other Healthcare2022-12-310001717310Supplant, Inc., Other Technology2022-12-310001717310TheSquareFoot, Inc., Other Technology2022-12-310001717310TLNT Inc., Other Technology2022-12-310001717310Ukko Inc., Biotechnology2022-12-310001717310Vinvesto, Inc., Internet2022-12-310001717310Virtuix Holdings, Inc., Other Technology2022-12-310001717310Yuva Biosciences, Inc., Other Healthcare2022-12-310001717310Zimeno Inc., Other Technology2022-12-3100017173102020-01-012020-12-3100017173102019-01-012019-12-3100017173102019-12-3100017173102018-12-31

0001717310FALSE2024FYoneoneoneoneiso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:purevll9:bank_accountvll9:financial_institutionvll9:segmentvll9:loan00017173102024-01-012024-12-3100017173102024-06-3000017173102025-03-1700017173102024-10-012024-12-3100017173102024-12-3100017173102023-12-3100017173102023-01-012023-12-3100017173102022-01-012022-12-310001717310us-gaap:CommonStockMember2021-12-310001717310us-gaap:AdditionalPaidInCapitalMember2021-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2021-12-310001717310vll9:DistributableIncomeLossMember2021-12-3100017173102021-12-310001717310vll9:DistributableIncomeLossMember2022-01-012022-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2022-01-012022-12-310001717310us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001717310us-gaap:CommonStockMember2022-12-310001717310us-gaap:AdditionalPaidInCapitalMember2022-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2022-12-310001717310vll9:DistributableIncomeLossMember2022-12-3100017173102022-12-310001717310vll9:DistributableIncomeLossMember2023-01-012023-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2023-01-012023-12-310001717310us-gaap:CommonStockMember2023-12-310001717310us-gaap:AdditionalPaidInCapitalMember2023-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2023-12-310001717310vll9:DistributableIncomeLossMember2023-12-310001717310vll9:DistributableIncomeLossMember2024-01-012024-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2024-01-012024-12-310001717310us-gaap:CommonStockMember2024-12-310001717310us-gaap:AdditionalPaidInCapitalMember2024-12-310001717310vll9:CumulativeReturnOfCapitalDistributionsMember2024-12-310001717310vll9:DistributableIncomeLossMember2024-12-310001717310Calysta, Inc., Senior Secured2024-12-310001717310Genomic Prediction, Inc., Senior Secured2024-12-310001717310Ukko Inc., Senior Secured2024-12-310001717310vll9:LoanInvestmentsBiotechnologyMember2024-12-310001717310Canary Connect, Inc., Senior Secured 2024-12-310001717310Proto, Inc., Senior Secured 12024-12-310001717310Proto, Inc., Senior Secured 22024-12-310001717310vll9:ProtoIncMembervll9:LoanInvestmentsComputersAndStorageMember2024-12-310001717310vll9:LoanInvestmentsComputersAndStorageMember2024-12-310001717310Diamanti, Inc., Senior Secured2024-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMember2024-12-31000171731010club Pte Ltd., Senior Secured 2024-12-310001717310D2C Store, Inc., Senior Secured2024-12-310001717310Good Counsel, Inc., Senior Secured2024-12-310001717310iZENEtech, Inc., Senior Secured2024-12-310001717310Miami Labs, Inc., Senior Secured2024-12-310001717310OneLocal, Inc., Senior Secured 2024-12-310001717310Quantcast Corp., Senior Secured2024-12-310001717310Residently USA, LLC, Senior Secured2024-12-310001717310RetailerX, Inc., Senior Secured 2024-12-310001717310Serface Care, Inc., Senior Secured2024-12-310001717310Stay Alfred, Inc., Senior Secured2024-12-310001717310Vinvesto, Inc., Senior Secured 12024-12-310001717310Vinvesto, Inc., Senior Secured 22024-12-310001717310vll9:VinvestoIncMembervll9:LoanInvestmentsInternetMember2024-12-310001717310vll9:LoanInvestmentsInternetMember2024-12-310001717310Anutra Medical, Inc., Senior Secured2024-12-310001717310Medrobotics Corporation, Inc., Senior Secured2024-12-310001717310Siren Care, Inc., Senior Secured 2024-12-310001717310vll9:LoanInvestmentsMedicalDevicesMember2024-12-310001717310Elysium Health, Inc., Senior Secured2024-12-310001717310GoForward, Inc., Senior Secured2024-12-310001717310Hello Heart Inc., Senior Secured 2024-12-310001717310Honeybee Health, Inc., Senior Secured2024-12-310001717310Julie Products Inc., Senior Secured 12024-12-310001717310Julie Products Inc., Senior Secured 22024-12-310001717310Julie Products Inc., Senior Secured 32024-12-310001717310vll9:JulieProductsIncMembervll9:LoanInvestmentsOtherHealthcareMember2024-12-310001717310KBS, Inc., Senior Secured2024-12-310001717310Open Inc., Senior Secured 12024-12-310001717310Open Inc., Senior Secured 22024-12-310001717310vll9:OpenIncMembervll9:LoanInvestmentsOtherHealthcareMember2024-12-310001717310PrecisionOS Technology Inc., Senior Secured2024-12-310001717310Therapydia, Inc., Senior Secured 2024-12-310001717310Vessel Health, Inc., Senior Secured2024-12-310001717310Yuva Biosciences, Inc., Senior Secured2024-12-310001717310vll9:LoanInvestmentsOtherHealthcareMember2024-12-310001717310Azumo, Inc., Senior Secured2024-12-310001717310Bankroll Club, LLC, Senior Secured 2024-12-310001717310Beautiful Beanfields, Inc., Senior Secured2024-12-310001717310BloomTech Inc., Senior Secured 2024-12-310001717310Brave Care Technologies, Inc., Senior Secured2024-12-310001717310Bryte, Inc., Senior Secured2024-12-310001717310Candy Club Holdings, Inc., Senior Secured 2024-12-310001717310Ceres Imaging, Inc., Senior Secured 2024-12-310001717310Coffee.ai Inc., Senior Secured 2024-12-310001717310Content Adjacent, Inc., Senior Secured 2024-12-310001717310CornerUp, Inc., Senior Secured 2024-12-310001717310Creoate Limited, Senior Secured 12024-12-310001717310Creoate Limited, Senior Secured 22024-12-310001717310Creoate Limited, Senior Secured 32024-12-310001717310vll9:CreoateLimitedMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Digital. Thing(s), Inc., Senior Secured2024-12-310001717310Eguana Technologies, Inc., Senior Secured 2024-12-310001717310Fanimal, Inc., Senior Secured 2024-12-310001717310Heading Health Inc., Senior Secured 2024-12-310001717310Higher Ground Education, Inc., Senior Secured 12024-12-310001717310Higher Ground Education, Inc., Senior Secured 22024-12-310001717310vll9:HigherGroundEducationIncMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Hint, Inc., Senior Secured 2024-12-310001717310Holo, Inc., Senior Secured2024-12-310001717310Hyphen Technologies, Inc., Senior Secured2024-12-310001717310Intuition Robotics, Inc., Senior Secured2024-12-310001717310Invert Robotics Group, Ltd., Senior Secured2024-12-310001717310Joy Memories, Inc, Senior Secured2024-12-310001717310Kibeam Learning, Inc., Senior Secured2024-12-310001717310LendTable Inc., Senior Secured2024-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 12024-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 22024-12-310001717310vll9:LogistechSolutionsPteLtdMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Mavenform, Inc., Senior Secured2024-12-310001717310Merlin Labs, Inc., Senior Secured 2024-12-310001717310Noteleaf, Inc., Senior Secured2024-12-310001717310Ocho Holdings Co., Senior Secured2024-12-310001717310Plant Prefab, Inc., Senior Secured 2024-12-310001717310PlantBaby, inc., Senior Secured 12024-12-310001717310PlantBaby, inc., Senior Secured 22024-12-310001717310PlantBaby, inc., Senior Secured 32024-12-310001717310PlantBaby, inc., Senior Secured 42024-12-310001717310PlantBaby, inc., Senior Secured 52024-12-310001717310vll9:PlantBabyIncMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Platform Science, Inc., Senior Secured 12024-12-310001717310Platform Science, Inc., Senior Secured 22024-12-310001717310vll9:PlatformScienceIncMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Reali Inc., Senior Secured2024-12-310001717310Rise Gardens, Inc., Senior Secured2024-12-310001717310Romaine Empire, Inc., Senior Secured 2024-12-310001717310SMS OPCO LLC, Senior Secured2024-12-310001717310Supplant, Inc., Senior Secured 12024-12-310001717310Supplant, Inc., Senior Secured 22024-12-310001717310vll9:SupplantIncMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Sustainable Living Partners, LLC, Senior Secured 2024-12-310001717310The Farm Project, PBC., Senior Secured2024-12-310001717310TheSquareFoot, Inc., Senior Secured 2024-12-310001717310Titan Health & Security Technologies, Inc., Senior Secured2024-12-310001717310Umbra Lab, Inc., Senior Secured 2024-12-310001717310Velo Holdings Limited, Senior Secured2024-12-310001717310Virtuix Holdings, Inc., Senior Secured2024-12-310001717310Wheels Labs, Inc., Senior Secured2024-12-310001717310Zeno Technologies, Inc., Senior Secured 2024-12-310001717310Zimeno Inc., Senior Secured 12024-12-310001717310Zimeno Inc., Senior Secured 22024-12-310001717310vll9:ZimenoIncMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310vll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310Axiado Corporation, Senior Secured 12024-12-310001717310Axiado Corporation, Senior Secured 22024-12-310001717310vll9:AxiadoCorporationMembervll9:LoanInvestmentsSecurityMember2024-12-310001717310Popily, Inc., Senior Secured2024-12-310001717310vll9:LoanInvestmentsSecurityMember2024-12-310001717310Abacum Inc., Senior Secured2024-12-310001717310Bizly, Inc., Senior Secured 2024-12-310001717310BlueCart, Inc., Senior Secured2024-12-310001717310Canopy Technology Corp., Senior Secured 12024-12-310001717310Canopy Technology Corp., Senior Secured 22024-12-310001717310vll9:CanopyTechnologyCorpMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310Chowbus, Inc., Senior Secured2024-12-310001717310Common Sun, Inc, Senior Secured 12024-12-310001717310Common Sun, Inc, Senior Secured 22024-12-310001717310vll9:CommonSunIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310Eskalera, Inc., Senior Secured 2024-12-310001717310Form Remodel, Inc., Senior Secured 12024-12-310001717310Form Remodel, Inc., Senior Secured 22024-12-310001717310Form Remodel, Inc., Senior Secured 32024-12-310001717310Form Remodel, Inc., Senior Secured 42024-12-310001717310vll9:FormRemodelIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310FutureProof Technologies, Inc., Senior Secured2024-12-310001717310Grokker, Inc., Senior Secured 12024-12-310001717310Grokker, Inc., Senior Secured 22024-12-310001717310vll9:GrokkerIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310HaystacksAI, Inc., Senior Secured 2024-12-310001717310Hoken Holdings Inc., Senior Secured2024-12-310001717310Ketch Kloud, Inc., Senior Secured2024-12-310001717310Ratio Technologies, Inc., Senior Secured 12024-12-310001717310Ratio Technologies, Inc., Senior Secured 22024-12-310001717310Ratio Technologies, Inc., Senior Secured 32024-12-310001717310vll9:RatioTechnologiesIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310Safe Securities Inc., Senior Secured 12024-12-310001717310Safe Securities Inc., Senior Secured 22024-12-310001717310vll9:SafeSecuritiesIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310SF Insuretech, Inc., Senior Secured 12024-12-310001717310SF Insuretech, Inc., Senior Secured 22024-12-310001717310SF Insuretech, Inc., Senior Secured 32024-12-310001717310vll9:SFInsuretechIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310Swiftly Systems, Inc., Senior Secured2024-12-310001717310Terragon, Inc., Senior Secured2024-12-310001717310Traction Apps, Inc., Senior Secured2024-12-310001717310UCM Digital Health, Inc., Senior Secured 2024-12-310001717310Vesta Housing, Inc., Senior Secured 12024-12-310001717310Vesta Housing, Inc., Senior Secured 22024-12-310001717310vll9:VestaHousingIncMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310vll9:LoanInvestmentsSoftwareMember2024-12-310001717310Klar Holdings Limited, Senior Secured2024-12-310001717310Loansnap Holdings Inc., Senior Secured 2024-12-310001717310vll9:LoanInvestmentsTechnologyServicesMember2024-12-310001717310Juvo Mobile, Inc., Senior Secured 12024-12-310001717310Juvo Mobile, Inc., Senior Secured 22024-12-310001717310vll9:JuvoMobileIncMembervll9:LoanInvestmentsWirelessMember2024-12-310001717310vll9:LoanInvestmentsWirelessMember2024-12-310001717310First American Government Obligations Fund2024-12-310001717310Calysta, Inc., Senior Secured2023-12-310001717310Genomic Prediction, Inc., Senior Secured2023-12-310001717310GLO Pharma, Inc., Senior Secured 12023-12-310001717310GLO Pharma, Inc., Senior Secured 22023-12-310001717310vll9:GLOPharmaIncMembervll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310Ukko Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310Canary Connect, Inc., Senior Secured 12023-12-310001717310Canary Connect, Inc., Senior Secured 22023-12-310001717310Canary Connect, Inc., Senior Secured 32023-12-310001717310vll9:CanaryConnectIncMembervll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310Proto, Inc., Senior Secured 12023-12-310001717310Proto, Inc., Senior Secured 22023-12-310001717310vll9:ProtoIncMembervll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310vll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310Diamanti, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsEnterpriseNetworkingMember2023-12-31000171731010club Pte Ltd., Senior Secured2023-12-310001717310Ainsly, Inc., Senior Secured 12023-12-310001717310Ainsly, Inc., Senior Secured 22023-12-310001717310vll9:AinslyIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310D2C Store, Inc., Senior Secured2023-12-310001717310Good Counsel, LLC, Senior Secured2023-12-310001717310iZENEtech, Inc., Senior Secured2023-12-310001717310Kings Mountain I LLC, Senior Secured2023-12-310001717310Miami Labs, Inc., Senior Secured2023-12-310001717310OneLocal, Inc., Senior Secured2023-12-310001717310Osix Corporation, Senior Secured2023-12-310001717310Pixalate, Inc., Senior Secured2023-12-310001717310Quantcast Corp., Senior Secured2023-12-310001717310RenoFi, Inc., Senior Secured 12023-12-310001717310RenoFi, Inc., Senior Secured 22023-12-310001717310vll9:RenoFiIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310Residently USA, LLC, Senior Secured2023-12-310001717310RetailerX, Inc., Senior Secured 2023-12-310001717310Serface Care, Inc., Senior Secured2023-12-310001717310Stay Alfred, Inc., Senior Secured2023-12-310001717310Usual Beverage Co., Senior Secured2023-12-310001717310Verishop, Inc., Senior Secured2023-12-310001717310Vinvesto, Inc., Senior Secured 12023-12-310001717310Vinvesto, Inc., Senior Secured 22023-12-310001717310vll9:VinvestoIncMembervll9:LoanInvestmentsInternetMember2023-12-310001717310vll9:LoanInvestmentsInternetMember2023-12-310001717310Anutra Medical, Inc., Senior Secured2023-12-310001717310CytoVale, Inc., Senior Secured2023-12-310001717310Medrobotics Corporation, Inc., Senior Secured2023-12-310001717310Norbert Health, Inc., Senior Secured2023-12-310001717310Siren Care, Inc., Senior Secured 2023-12-310001717310vll9:LoanInvestmentsMedicalDevicesMember2023-12-310001717310Elysium Health, Inc., Senior Secured2023-12-310001717310GoForward, Inc., Senior Secured 2023-12-310001717310Grayce, Inc., Senior Secured 12023-12-310001717310Grayce, Inc., Senior Secured 22023-12-310001717310Grayce, Inc., Senior Secured 32023-12-310001717310vll9:GrayceIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310Hello Heart Inc., Senior Secured 12023-12-310001717310Hello Heart Inc., Senior Secured 22023-12-310001717310vll9:HelloHeartIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310Honeybee Health, Inc., Senior Secured2023-12-310001717310Julie Products Inc., Senior Secured 12023-12-310001717310Julie Products Inc., Senior Secured 22023-12-310001717310Julie Products Inc., Senior Secured 32023-12-310001717310vll9:JulieProductsIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310KBS, Inc., Senior Secured2023-12-310001717310Minded, Inc., Senior Secured 2023-12-310001717310Open Inc., Senior Secured 12023-12-310001717310Open Inc., Senior Secured 22023-12-310001717310vll9:OpenIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310Oula Health, Inc., Senior Secured 12023-12-310001717310Oula Health, Inc., Senior Secured 22023-12-310001717310vll9:OulaHealthIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310PrecisionOS Technology Inc., Senior Secured2023-12-310001717310Therapydia, Inc., Senior Secured2023-12-310001717310Tia, Inc., Senior Secured 12023-12-310001717310Tia, Inc., Senior Secured 22023-12-310001717310vll9:TiaIncMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310Vessel Health, Inc., Senior Secured2023-12-310001717310Yes Health, Inc., Senior Secured2023-12-310001717310Yuva Biosciences, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsOtherHealthcareMember2023-12-3100017173108i Corporation, Senior Secured2023-12-310001717310Aclima, Inc., Senior Secured2023-12-310001717310Airspeed, Inc., Senior Secured 12023-12-310001717310Airspeed, Inc., Senior Secured 22023-12-310001717310vll9:AirspeedIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Azumo, Inc., Senior Secured2023-12-310001717310Bankroll Club, LLC, Senior Secured 2023-12-310001717310Beautiful Beanfields, Inc., Senior Secured2023-12-310001717310BloomTech Inc., Senior Secured2023-12-310001717310Brave Care Technologies, Inc., Senior Secured2023-12-310001717310Bryte, Inc., Senior Secured2023-12-310001717310Candy Club Holdings, Inc., Senior Secured2023-12-310001717310Ceres Imaging, Inc., Senior Secured 12023-12-310001717310Ceres Imaging, Inc., Senior Secured 22023-12-310001717310vll9:CeresImagingIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Content Adjacent, Inc., Senior Secured2023-12-310001717310Copia Global Inc., Senior Secured 2023-12-310001717310CornerUp, Inc., Senior Secured 12023-12-310001717310CornerUp, Inc., Senior Secured 22023-12-310001717310vll9:CornerUpIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Creoate Limited, Senior Secured 12023-12-310001717310Creoate Limited, Senior Secured 22023-12-310001717310Creoate Limited, Senior Secured 32023-12-310001717310vll9:CreoateLimitedMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Daybase, Inc., Senior Secured2023-12-310001717310EasyKnock, Inc., Senior Secured 12023-12-310001717310EasyKnock, Inc., Senior Secured 22023-12-310001717310EasyKnock, Inc., Senior Secured 32023-12-310001717310vll9:EasyKnockIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Eguana Technologies, Inc., Senior Secured 12023-12-310001717310Eguana Technologies, Inc., Senior Secured 22023-12-310001717310vll9:EguanaTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Fanimal, Inc., Senior Secured 12023-12-310001717310Fanimal, Inc., Senior Secured 22023-12-310001717310Fanimal, Inc., Senior Secured 32023-12-310001717310Fanimal, Inc., Senior Secured 42023-12-310001717310vll9:FanimalIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Hadrian Automation, Inc., Senior Secured2023-12-310001717310Heading Health Inc., Senior Secured 2023-12-310001717310Higher Ground Education, Inc., Senior Secured 12023-12-310001717310Higher Ground Education, Inc., Senior Secured 22023-12-310001717310vll9:HigherGroundEducationIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Hint, Inc., Senior Secured 2023-12-310001717310Holo, Inc., Senior Secured 12023-12-310001717310Holo, Inc., Senior Secured 22023-12-310001717310vll9:HoloIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Hyphen Technologies, Inc., Senior Secured 12023-12-310001717310Hyphen Technologies, Inc., Senior Secured 22023-12-310001717310vll9:HyphenTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Intuition Robotics, Inc., Senior Secured2023-12-310001717310Invert Robotics Group, Ltd., Senior Secured2023-12-310001717310Joy Memories, Inc, Senior Secured2023-12-310001717310Kibeam Learning, Inc., Senior Secured2023-12-310001717310Lacuna Technologies, Inc., Senior Secured 2023-12-310001717310LendTable Inc., Senior Secured 12023-12-310001717310LendTable Inc., Senior Secured 22023-12-310001717310vll9:LendTableIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Literati, Inc., Senior Secured 2023-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 12023-12-310001717310Logistech Solutions Pte. Ltd., Senior Secured 22023-12-310001717310vll9:LogistechSolutionsPteLtdMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Mavenform, Inc., Senior Secured 12023-12-310001717310Mavenform, Inc., Senior Secured 22023-12-310001717310Mavenform, Inc., Senior Secured 32023-12-310001717310Mavenform, Inc., Senior Secured 42023-12-310001717310vll9:MavenformIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Merlin Labs, Inc., Senior Secured2023-12-310001717310MinoMonsters, Inc., Senior Secured2023-12-310001717310Momentus Space LLC, Senior Secured2023-12-310001717310Natomas Labs, Inc., Senior Secured2023-12-310001717310Noteleaf, Inc., Senior Secured2023-12-310001717310Ocho Holdings Co., Senior Secured 2023-12-310001717310OnePointOne, Inc., Senior Secured 12023-12-310001717310OnePointOne, Inc., Senior Secured 22023-12-310001717310vll9:OnePointOneIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Phase Four, Inc., Senior Secured 12023-12-310001717310Phase Four, Inc., Senior Secured 22023-12-310001717310vll9:PhaseFourIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Plant Prefab, Inc., Senior Secured 12023-12-310001717310Plant Prefab, Inc., Senior Secured 22023-12-310001717310Plant Prefab, Inc., Senior Secured 32023-12-310001717310vll9:PlantPrefabIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310PlantBaby, inc., Senior Secured 12023-12-310001717310PlantBaby, inc., Senior Secured 22023-12-310001717310PlantBaby, inc., Senior Secured 32023-12-310001717310PlantBaby, inc., Senior Secured 42023-12-310001717310PlantBaby, inc., Senior Secured 52023-12-310001717310vll9:PlantBabyIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Platform Science, Inc., Senior Secured 12023-12-310001717310Platform Science, Inc., Senior Secured 22023-12-310001717310vll9:PlatformScienceIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Privoro Holdings, Inc., Senior Secured2023-12-310001717310Reali Inc., Senior Secured2023-12-310001717310Rise Gardens, Inc., Senior Secured 12023-12-310001717310Rise Gardens, Inc., Senior Secured 22023-12-310001717310vll9:RiseGardensIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Romaine Empire, Inc., Senior Secured 2023-12-310001717310Setex Technologies, Inc., Senior Secured2023-12-310001717310SISU Aesthetics Clinic, Inc., Senior Secured 12023-12-310001717310SISU Aesthetics Clinic, Inc., Senior Secured 22023-12-310001717310vll9:SISUAestheticsClinicIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310SMS OPCO LLC, Senior Secured2023-12-310001717310Supplant, Inc., Senior Secured 12023-12-310001717310Supplant, Inc., Senior Secured 22023-12-310001717310vll9:SupplantIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Sustainable Living Partners, LLC, Senior Secured2023-12-310001717310The Farm Project, PBC., Senior Secured2023-12-310001717310The Safe and Fair Food Company LLC, Senior Secured2023-12-310001717310TheSquareFoot, Inc., Senior Secured2023-12-310001717310Titan Health & Security Technologies, Inc., Senior Secured2023-12-310001717310TLNT Inc., Senior Secured 12023-12-310001717310TLNT Inc., Senior Secured 22023-12-310001717310TLNT Inc., Senior Secured 32023-12-310001717310TLNT Inc., Senior Secured 42023-12-310001717310vll9:TLNTIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Umbra Lab, Inc., Senior Secured 12023-12-310001717310Umbra Lab, Inc., Senior Secured 22023-12-310001717310Umbra Lab, Inc., Senior Secured 32023-12-310001717310vll9:UmbraLabIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Velo Holdings Limited, Senior Secured2023-12-310001717310Virtuix Holdings, Inc., Senior Secured2023-12-310001717310Wellth, Inc., Senior Secured 12023-12-310001717310Wellth, Inc., Senior Secured 22023-12-310001717310vll9:WellthIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Wheels Labs, Inc., Senior Secured2023-12-310001717310World Wrapps II, Inc., Senior Secured 12023-12-310001717310World Wrapps II, Inc., Senior Secured 22023-12-310001717310World Wrapps II, Inc., Senior Secured 32023-12-310001717310vll9:WorldWrappsIIIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Zeno Technologies, Inc., Senior Secured 12023-12-310001717310Zeno Technologies, Inc., Senior Secured 22023-12-310001717310vll9:ZenoTechnologiesIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Zimeno Inc., Senior Secured 12023-12-310001717310Zimeno Inc., Senior Secured 22023-12-310001717310vll9:ZimenoIncMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310vll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310Axiado Corporation, Senior Secured 12023-12-310001717310Axiado Corporation, Senior Secured 22023-12-310001717310vll9:AxiadoCorporationMembervll9:LoanInvestmentsSecurityMember2023-12-310001717310Lassen Peak, Inc., Senior Secured2023-12-310001717310Popily, Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsSecurityMember2023-12-310001717310Abacum Inc., Senior Secured2023-12-310001717310Afero, Inc., Senior Secured2023-12-310001717310BackboneAI Inc., Senior Secured2023-12-310001717310Bizly, Inc., Senior Secured2023-12-310001717310BlueCart, Inc., Senior Secured 12023-12-310001717310BlueCart, Inc., Senior Secured 22023-12-310001717310vll9:BlueCartIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Canopy Technology Corp., Senior Secured 12023-12-310001717310Canopy Technology Corp., Senior Secured 22023-12-310001717310vll9:CanopyTechnologyCorpMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Chowbus, Inc., Senior Secured2023-12-310001717310Common Sun, Inc, Senior Secured 12023-12-310001717310Common Sun, Inc, Senior Secured 22023-12-310001717310vll9:CommonSunIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Eskalera, Inc., Senior Secured2023-12-310001717310Form Remodel, Inc., Senior Secured 12023-12-310001717310Form Remodel, Inc., Senior Secured 22023-12-310001717310Form Remodel, Inc., Senior Secured 32023-12-310001717310Form Remodel, Inc., Senior Secured 42023-12-310001717310vll9:FormRemodelIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310FutureProof Technologies, Inc., Senior Secured2023-12-310001717310Grokker, Inc., Senior Secured 12023-12-310001717310Grokker, Inc., Senior Secured 22023-12-310001717310vll9:GrokkerIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310HaystacksAI, Inc., Senior Secured 12023-12-310001717310HaystacksAI, Inc., Senior Secured 22023-12-310001717310vll9:HaystacksAIIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Hoken Holdings Inc., Senior Secured2023-12-310001717310Journey Builders, Inc., Senior Secured 2023-12-310001717310Ketch Kloud, Inc., Senior Secured2023-12-310001717310Ocurate, Inc., Senior Secured 12023-12-310001717310Ocurate, Inc., Senior Secured 22023-12-310001717310vll9:OcurateIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Overalls, Inc., Senior Secured 12023-12-310001717310Overalls, Inc., Senior Secured 22023-12-310001717310vll9:OverallsIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Parkoursc, Inc., Senior Secured 2023-12-310001717310Ratio Technologies, Inc., Senior Secured 12023-12-310001717310Ratio Technologies, Inc., Senior Secured 22023-12-310001717310Ratio Technologies, Inc., Senior Secured 32023-12-310001717310vll9:RatioTechnologiesIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Safe Securities Inc., Senior Secured 12023-12-310001717310Safe Securities Inc., Senior Secured 22023-12-310001717310vll9:SafeSecuritiesIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310SF Insuretech, Inc., Senior Secured 12023-12-310001717310SF Insuretech, Inc., Senior Secured 22023-12-310001717310SF Insuretech, Inc., Senior Secured 32023-12-310001717310SF Insuretech, Inc., Senior Secured 42023-12-310001717310vll9:SFInsuretechIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Swiftly Systems, Inc., Senior Secured 12023-12-310001717310Swiftly Systems, Inc., Senior Secured 22023-12-310001717310vll9:SwiftlySystemsIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310Terragon, Inc., Senior Secured2023-12-310001717310Traction Apps, Inc., Senior Secured2023-12-310001717310Truthset, Inc., Senior Secured2023-12-310001717310UCM Digital Health, Inc., Senior Secured2023-12-310001717310Vesta Housing, Inc., Senior Secured 12023-12-310001717310Vesta Housing, Inc., Senior Secured 22023-12-310001717310vll9:VestaHousingIncMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310WorkRails, Inc., Senior Secured2023-12-310001717310Workspot, Inc., Senior Secured 2023-12-310001717310vll9:LoanInvestmentsSoftwareMember2023-12-310001717310iLearningEngines Inc., Senior Secured 12023-12-310001717310iLearningEngines Inc., Senior Secured 22023-12-310001717310iLearningEngines Inc., Senior Secured 32023-12-310001717310iLearningEngines Inc., Senior Secured 42023-12-310001717310iLearningEngines Inc., Senior Secured 52023-12-310001717310iLearningEngines Inc., Senior Secured 62023-12-310001717310vll9:ILearningEnginesIncMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310Klar Holdings Limited, Senior Secured 12023-12-310001717310Klar Holdings Limited, Senior Secured 22023-12-310001717310Klar Holdings Limited, Senior Secured 32023-12-310001717310vll9:KlarHoldingsLimitedMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310Loansnap Holdings Inc., Senior Secured2023-12-310001717310vll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310AirVine Scientific, Inc., Senior Secured 12023-12-310001717310AirVine Scientific, Inc., Senior Secured 22023-12-310001717310vll9:AirVineScientificIncMembervll9:LoanInvestmentsWirelessMember2023-12-310001717310Juvo Mobile, Inc., Senior Secured 12023-12-310001717310Juvo Mobile, Inc., Senior Secured 22023-12-310001717310vll9:JuvoMobileIncMembervll9:LoanInvestmentsWirelessMember2023-12-310001717310MeshPlusPlus, Inc., Senior Secured 12023-12-310001717310MeshPlusPlus, Inc., Senior Secured 22023-12-310001717310vll9:MeshPlusPlusIncMembervll9:LoanInvestmentsWirelessMember2023-12-310001717310vll9:LoanInvestmentsWirelessMember2023-12-310001717310First American Government Obligations Fund2023-12-310001717310vll9:InterestRateCollarCapRate1.36FloorRate0.42Maturity06302025Membervll9:ZionsBancorporationNAMembersrt:MaximumMember2023-12-310001717310vll9:InterestRateCollarCapRate1.36FloorRate0.42Maturity06302025Membervll9:ZionsBancorporationNAMembersrt:MinimumMember2023-12-310001717310vll9:InterestRateCollarCapRate1.36FloorRate0.42Maturity06302025Membervll9:ZionsBancorporationNAMember2023-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembersrt:MaximumMember2023-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMembersrt:MinimumMember2023-12-310001717310vll9:InterestRateCollarCapRate211FloorRate053Maturity3182024Membervll9:ZionsBancorporationNAMember2023-12-310001717310vll9:InterestRateCollarMember2023-12-310001717310vll9:VentureLendingLeasingIXIncMembervll9:VentureLendingLeasingIXLLCMember2024-01-012024-12-310001717310vll9:VentureLendingLeasingIXLLCMember2017-06-012017-06-300001717310vll9:VentureLendingLeasingIXLLCMember2017-06-300001717310vll9:FirstAmericanGovernmentObligationsFundMember2024-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2024-01-012024-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2023-12-310001717310vll9:FirstAmericanGovernmentObligationsFundMember2023-01-012023-12-310001717310srt:WeightedAverageMembervll9:PerformingLoansMember2024-01-012024-12-310001717310srt:WeightedAverageMembervll9:PerformingLoansMember2023-01-012023-12-310001717310srt:WeightedAverageMember2024-01-012024-12-310001717310srt:WeightedAverageMember2023-01-012023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsComputersAndStorageMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsEnterpriseNetworkingMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsInternetMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsOtherHealthcareMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsSecurityMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsSecurityMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsSoftwareMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsTechnologyServicesMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsTechnologyServicesMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:MinimumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsWirelessMember2024-12-310001717310srt:MaximumMembervll9:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2024-12-310001717310us-gaap:FairValueInputsLevel3Member2024-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsBiotechnologyMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsComputersAndStorageMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsEnterpriseNetworkingMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsEnterpriseNetworkingMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsInternetMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsMedicalDevicesMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsOtherHealthcareMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsOtherTechnologyMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsSecurityMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsSecurityMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMembervll9:LoanInvestmentsSecurityMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsSoftwareMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMembervll9:LoanInvestmentsTechnologyServicesMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputProbabilityWeighingOfAlternativeOutcomesMembervll9:ValuationAssetRecoveryMember2023-12-310001717310us-gaap:FairValueInputsLevel3Membervll9:ValuationMostAdvantageousMarketAnalysisMembervll9:LoanInvestmentsWirelessMember2023-12-310001717310srt:MinimumMembervll9:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:MaximumMembervll9:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310srt:WeightedAverageMembervll9:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Membervll9:MeasurementInputMostAdvantageousMarketCouponRateMembervll9:ValuationMostAdvantageousMarketAnalysisMember2023-12-310001717310us-gaap:FairValueInputsLevel3Member2023-12-310001717310us-gaap:FairValueInputsLevel1Member2024-12-310001717310us-gaap:FairValueInputsLevel2Member2024-12-310001717310us-gaap:FairValueInputsLevel1Member2023-12-310001717310us-gaap:FairValueInputsLevel2Member2023-12-310001717310us-gaap:LoansMember2023-12-310001717310us-gaap:WarrantMember2023-12-310001717310us-gaap:CommonStockMember2023-12-310001717310vll9:ConvertibleNotesMember2023-12-310001717310us-gaap:LoansMember2024-01-012024-12-310001717310us-gaap:WarrantMember2024-01-012024-12-310001717310us-gaap:CommonStockMember2024-01-012024-12-310001717310vll9:ConvertibleNotesMember2024-01-012024-12-310001717310vll9:DebtAndEquitySecuritiesRealizedGainLossMemberus-gaap:LoansMember2024-01-012024-12-310001717310vll9:DebtAndEquitySecuritiesUnrealizedGainLossMemberus-gaap:LoansMember2024-01-012024-12-310001717310us-gaap:LoansMember2024-12-310001717310us-gaap:WarrantMember2024-12-310001717310us-gaap:CommonStockMember2024-12-310001717310vll9:ConvertibleNotesMember2024-12-310001717310us-gaap:LoansMember2022-12-310001717310us-gaap:WarrantMember2022-12-310001717310us-gaap:CommonStockMember2022-12-310001717310us-gaap:LoansMember2023-01-012023-12-310001717310us-gaap:WarrantMember2023-01-012023-12-310001717310us-gaap:CommonStockMember2023-01-012023-12-310001717310vll9:DebtAndEquitySecuritiesRealizedGainLossMemberus-gaap:LoansMember2023-01-012023-12-310001717310vll9:DebtAndEquitySecuritiesUnrealizedGainLossMemberus-gaap:LoansMember2023-01-012023-12-310001717310vll9:CashDividendDistributionMember2024-01-012024-12-310001717310vll9:CashDividendDistributionMember2023-01-012023-12-310001717310vll9:CashDividendDistributionMember2022-01-012022-12-310001717310vll9:EquityDividendDistributionMember2024-01-012024-12-310001717310vll9:EquityDividendDistributionMember2023-01-012023-12-310001717310vll9:EquityDividendDistributionMember2022-01-012022-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-10-260001717310vll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembervll9:ReferenceRateMember2024-01-012024-12-310001717310vll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembervll9:ReferenceRateMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2024-01-012024-12-310001717310vll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2024-01-012024-12-310001717310vll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2024-01-012024-12-310001717310vll9:LoanAgreementFirstAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2024-01-012024-12-310001717310vll9:LoanAgreementThirdAmendmentMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2024-01-012024-12-310001717310vll9:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310001717310vll9:ManagementFeePeriodOneMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodTwoMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodThreeMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodFourMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodFiveMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodSixMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodSevenMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodEightMember2024-01-012024-12-310001717310vll9:ManagementFeePeriodNineMember2024-01-012024-12-3100017173102024-01-012024-06-3000017173102024-07-012024-09-3000017173102023-01-012023-06-3000017173102023-07-012023-12-310001717310vll9:InterestRateCollarCapRate1.36FloorRate0.42Maturity12182024Membervll9:ZionsBancorporationNAMember2023-12-310001717310vll9:InterestRateCollarMember2024-12-310001717310vll9:InterestRateCollarMember2024-01-012024-12-310001717310vll9:InterestRateCollarMember2023-01-012023-12-310001717310vll9:InterestRateCollarMember2022-01-012022-12-310001717310vll9:ZionsBancorporationNAMember2023-12-310001717310us-gaap:DerivativeFinancialInstrumentsAssetsMember2023-12-310001717310us-gaap:LiabilityMember2024-12-310001717310us-gaap:LiabilityMember2023-12-3100017173102021-01-012021-12-3100017173102020-01-012020-12-3100017173102020-12-3100017173102019-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K


[X]			ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, ~~2023~~2024


[ ]			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ______________

Commission File Number 814-01253

VENTURE LENDING & LEASING IX, INC.

(Exact name of registrant as specified in its charter)


Maryland			82-2040715
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

104 La Mesa Drive, Suite 102, Portola Valley, CA 94028

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (650) 234-4300

Securities registered pursuant to Section 12(b) of the Act: None

Securities Registered Pursuant to Section 12(g) of the Act: Common stock, $0.001 par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]

Indicate by check mark whether the registrant (i) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (ii) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]

Accelerated filer [ ]

Non-accelerated filer [x]

Smaller reporting company [ ]

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. [ ]

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. [ ]

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based

compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). [ ]

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [ ] No [X]

As the registrant’s shares are not publicly-traded, the aggregate market value of the voting stock held by non-affiliates of the registrant cannot be determined.

The number of shares outstanding of each of the issuer’s classes of common stock, as of March 1517, ~~2024~~2025, was 100,000.

Document Incorporated by Reference

Document Description						10-K Part
Specifically Identified Portions of the Registrant’s Proxy Statement for the Annual Meeting of Shareholders to be heldMay 15, 2024						III
Specifically Identified Portions of the Registrant’s Proxy Statement for the Annual Meeting of Shareholders to be heldMay 21, 2025						III

PART I.

ITEM 1. BUSINESS

Introduction.

Venture Lending & Leasing IX, Inc. (the “Fund”) was incorporated in Maryland on June 28, 2017 as a non-diversified, closed-end management investment company that elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”) and is managed by Westech Investment Advisors LLC (the “Manager” or “Management”). All of the issued and outstanding membership interests of the Manager were acquired by P10 Intermediate Holdings LLC, a Delaware limited liability company whose ultimate parent is P10, Inc., a Delaware corporation (together, “P10”) on October 13, 2022 (the “Transaction”). The management of day-to-day operations of the Manager remains substantially unchanged and continues to be directed by the Manager’s personnel following the closing of the Transaction. The Fund is a wholly-owned subsidiary of Venture Lending & Leasing IX, LLC, a Delaware limited liability company (the “Company”). The Fund’s investment objective is to achieve superior risk-adjusted investment returns. The Fund will primarily provide debt financing to carefully selected companies that have received equity funding from traditional sources of venture capital equity funding (i.e., a professionally managed venture capital firm), as well as non-traditional sources of venture capital equity funding (e.g., angel investors, strategic investors, family offices, crowdfunding investment platforms, etc.) (collectively, “Venture-Backed Companies”), generally in the form of secured loans. Secondarily, the Fund may provide debt financing to public and later-stage private companies. In most cases, the Fund will receive warrants for equity securities of the companies in connection with these loans. The Fund may make debt investments that are atypical in that, for example, the companies to which the financing is provided may be public companies, may not have venture backing, or may not offer senior securities (“Special Situation Financings”), including bridge financings and subordinated debt. The Fund may also make direct equity investments in Venture-Backed Companies. Prior to commencing its operations on May 2, 2018, the Fund had no operations other than ~~accruing~~incurring organizational expenses and the sale of 100,000 shares of common stock, $0.001 par value to the Company for $25,000 in June 2017. The Fund has elected to be treated for federal income tax purposes, as a regulated investment company (“RIC”) under the Internal Revenue Code of 1986 (the “Code”).

The Fund’s shares of common stock, $0.001 par value (“Shares”) are held entirely by the Company. As capital is required to finance the acquisition of loans, additional capital is provided by the Company.

Investment Program.

General. The Fund’s primary investment strategy is to provide debt financing, in the form of secured loans, to carefully selected Venture-Backed Companies. In most cases, the Fund receives warrants to acquire equity securities in connection with its venture loans. The Fund’s investment objective is to achieve superior risk-adjusted investment returns. The Fund may invest up to 20% of the aggregate cost of all investments of the Fund, determined cumulatively over the life of the Fund, in Special Situation Financings. In some instances, the Fund’s Special Situation Financing investments may be in companies that have been bootstrapped (i.e., funded solely by the personal assets of their founders or other individuals), without substantial equity investment from investors or participation of venture capital investors. The Fund does not intend to invest in any company to secure control of its securities primarily for the purpose of making a profit in the sale of the controlled company’s securities, and, for the avoidance of doubt, any such investment would not constitute a Special Situation Financing. The Fund may also invest up to 10% of the aggregate amount of all investments of the Fund (determined cumulatively over the life of the Fund) in direct equity investment opportunities such as convertible debt, secondary common stock purchases or other equity instruments issued by companies of diverse capitalization and creditworthiness, including, without limitation, early-stage private companies, public and later-stage private companies, and companies undergoing restructuring or recapitalization of their existing debt or equity financing (provided, however, that any amounts paid by the Fund to acquire equity securities pursuant to the receipt or exercise of warrants or stock received in connection with the Fund’s venture loans shall not be taken into account in determining whether such 10% threshold has been met). Such direct investments generally will be in equity securities of borrowers in the Fund’s portfolio, although equity securities of other companies could also be purchased. This aggregate investment strategy involves a high degree of risk, including: illiquidity of portfolio investments; risk of default by borrowers, many of whom have no or little operating profit or cash flow as of the commencement of a financing transaction; interest rate risk; litigation risk; the speculative nature of investments in warrants for stock or directly in stock; and the risks involved in investing in privately-held and emerging companies. The Fund will make available significant managerial assistance through its officers to certain companies whose securities are held in the Fund’s portfolio, as described herein under the caption “Regulation.”

The Fund intends to use a buy-and-hold strategy where debt investments are held to maturity. All securities are evaluated on a regular basis to determine whether there should be any change to this strategy. If debt investments are restructured, it may result in the extension of the original maturity date or other change in the instrument, including but not limited to, conversion of all or part of the instrument to equity. The Fund does not intend to purchase publicly-held securities; however, some publicly-held securities may be acquired through warrant exercises, mergers, acquisitions, and IPOs of the companies in which investments are made. Additionally, in some cases, publicly-traded securities may be issued in conjunction with loans made to public companies. When a company’s securities become publicly-traded, the Fund may hold these securities and sell them or may choose to distribute the securities directly to the Company. If held, publicly-traded securities are monitored on an ongoing basis, and a variety of factors regarding the issuing company (e.g., trend in stock price, underlying business fundamentals and potential for growth, information regarding the lock-up, etc.) are used to determine when to sell these securities.

As a BDC, the Fund must invest at least 70% of its total assets in qualifying assets (“Qualifying Assets”) consisting of (a) interests in Eligible Portfolio Companies and (b) certain other assets including cash and cash equivalents. An “Eligible Portfolio Company” is a United States company that is not an investment company as defined or excluded from the definition of an investment company in Section 3 of the 1940 Act, and that either: (i) does not have a class of securities listed on a national securities exchange, or does have a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250.0 million; or (ii) is actively controlled by a BDC and has an affiliate of a BDC on the Eligible Portfolio Company’s board of directors; or (iii) has total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million; or (iv) meets such other criteria as may be established by the Securities and Exchange Commission (“SEC”). Control under the 1940 Act is presumed to exist where a BDC owns more than 25% of the outstanding voting securities of the Eligible Portfolio Company. Also included in Qualifying Assets are follow-on investments in a company that met the definition of Eligible Portfolio Company at the time of the Fund’s initial investment, but subsequently does not meet such definition because it has a class of securities listed on a national securities exchange, if, at the time of the follow-on investment, the Fund (a) owns at least 50% of (i) the greatest number of equity securities of such company, including securities convertible into or exchangeable for such securities, and (ii) the greatest amount of certain debt securities of such company held by the Fund at any time during the period when such company was an Eligible Portfolio Company, and (b) is one of the twenty largest holders of record of the company’s outstanding voting securities. The Fund may invest up to 30% of its total assets in non-Qualifying Assets, including interests in companies that are not Eligible Portfolio Companies (for example, because the company’s securities are quoted on the NASDAQ Global Market ~~(“NASDAQ”~~)) and Eligible Portfolio Companies as to which the Fund does not offer to make available significant managerial assistance. As a BDC, the Fund is generally prohibited under the 1940 Act from investing in securities issued by broker/dealers, investment advisers, and underwriters unless certain conditions are met. As of December 31, ~~2023~~2024, the percentage of non-qualifying investments in the Fund was 13.32%.

BDCs cannot acquire any assets other than those Qualifying Assets described in subparagraphs (1) through (8) below unless, at the time of the acquisition, the assets described in subparagraphs (1) through (8) below represent at least 70% of the value of the BDC’s total assets. Below is a general summary of Qualifying Assets in which the Fund may invest.

1. Securities issued in transactions not involving a public offering from issuers ~~which~~that are Eligible Portfolio Companies (including affiliated persons or persons that have been affiliated persons within the preceding 13 months) or from any other person, subject to such rules and regulations as the SEC may prescribe;

2. Securities purchased in transactions not involving any public offering from an issuer, or from any person who is an officer or employee of the issuer, if the issuer is a U.S. company that is not an investment company, but the issuer is not an Eligible Portfolio Company because it has issued a class of margin securities that is eligible for margin loans, and at the time of purchase the BDC owns at least 50% of (i) the greatest number of equity securities (on a fully diluted basis) of the issuer and (ii) the greatest amount of such issuer’s debt securities held by the BDC at any point in time during the period when such issuer was an Eligible Portfolio Company, and, (iii) the BDC is one of the 20 largest holders of the issuer’s outstanding voting securities;

3. Securities of any Eligible Portfolio Company that is controlled by the BDC (either alone or as part of a group acting together) and the BDC exercises a controlling influence over the management or policies, and has an affiliated person who is a director of, the Eligible Portfolio Company;

4. Securities issued in transactions not involving a public offering from U.S. non-investment company issuers subject to bankruptcy, reorganization, insolvency or similar proceeding or otherwise unable to meet their obligations without assistance (purchase may be made from affiliated persons or persons that have been affiliated persons within the preceding 13 months or in limited circumstances other persons);

5. Securities of an Eligible Portfolio Company purchased from any person in transactions not involving a public offering when no public market for the securities exists and the BDC owned at least 60% of the outstanding equity (on a fully diluted basis) of the issuer immediately prior to the purchase;

6. Securities received in exchange for or distributed with respect to the foregoing securities (including securities obtained pursuant to the exercise of options, warrants or rights relating to such securities);

7. Cash, cash items, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment; and

8. Office furniture and equipment, interests in real estate, deferred organization and operating expenses, and other non-investment assets necessary and appropriate to the BDC’s operations.

“Making available significant managerial assistance” is defined under the 1940 Act, in relevant part, as (i) an arrangement whereby the BDC, through its officers, directors, employees or general partners, offers to provide and, if accepted, does provide, significant guidance and counsel concerning the management, operations or business objectives of a portfolio company; or (ii) the exercise by a BDC of a controlling influence over the management or polices of the portfolio company by the BDC acting individually or as part of a group acting together which controls the portfolio company. The officers of the Fund offer to provide managerial assistance, including advice on equipment acquisition and financing, cash flow and expense management, general financing opportunities, acquisition opportunities and opportunities to access the public securities markets, to the great majority of companies to whom the Fund provides venture loans. In some instances, directors of the Fund might serve on the board of directors or as officers of borrowers.

Venture Loans. Venture loans generally are made pursuant to a negotiated loan agreement and are evidenced by promissory notes secured by specific equipment or other assets of the borrower financed with the proceeds of such loans or secured by a broader lien on substantially all of the borrower’s assets where the purpose of the loan is to provide growth or general working capital to the borrower. The loans are typically secured by a first-position lien on such assets. The Fund generally receives periodic payments (usually monthly) and may receive a final payment equal to a percentage of the original loan amount, payable at maturity of the loan (whether as stated or accelerated). The interest rate and amortization terms of venture loans and all other transaction terms are individually negotiated between the Fund and each borrower.

The documentation for venture loans includes representations, warranties, covenants and events of default intended to protect the Fund and which are customary for commercial transactions of this type and size. Typical material terms include restrictions on additional debt, covenants to maintain the loan collateral and keep it adequately insured and free of liens, prohibitions against sale or other disposition of the assets except under specified conditions, and acceleration provisions making the remaining outstanding amounts under the loan immediately due and payable and giving rise to a right to take possession of the collateral upon certain events of default, including failure to make required payments, insolvency, and failure to comply with covenants. There can be no assurance that the value of the collateral at the time of default will be at least equal to the outstanding amount due under the loan.

Typically, loans are structured as non-revolving commitments by the Fund to provide financing, in one or more advances over a specified period of availability, determined as part of the underwriting process. The commitments of the Fund to finance future asset acquisitions or growth capital needs is typically subject to the absence of any default under the loan and compliance by the borrower with requirements relating to, among other things, the type of assets to be acquired and, if applicable, the borrower’s achievement of performance-based milestones. Although the Fund’s commitments generally provide that the Fund is not required to continue to fund additional asset purchases or growth capital if there has been a material adverse change in the borrower’s financial condition, a borrower’s financial condition may not be as strong at the time a loan is funded as it was when the related commitments were made.

Warrants. The Fund generally acquires warrants to purchase equity securities of the borrower in connection with financings. It is anticipated that such warrants, generally, will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition. The terms of the warrants, including the expiration date, exercise price, and terms of the equity security for which the warrant may be exercised, are negotiated individually with each borrower, and are likely to be affected by the price and terms of securities issued by the company to its venture capitalists and other holders in equity financings close in time to the Fund’s making of the loan commitment. Based upon the Manager’s past experience, it is anticipated that most warrants will have a contractual term of five to fifteen years, and will have an exercise price based upon the price at which the borrower most recently issued equity securities or, if a new equity offering is anticipated, the future price of such equity securities (and sometimes a “blended price”). In certain transactions, it is anticipated that warrants will be issued with an exercise price that is waived in connection with a liquidity event such as an initial public offering or acquisition. The equity securities for which the warrant will be exercised generally will be convertible preferred stock (of which there may be one or more classes) or common stock. Substantially all the warrants and underlying equity securities will be restricted securities under the Securities Act of 1933 (the “1933 Act”) at the time of issuance; the Fund generally negotiates registration rights with the borrower that may provide “piggyback” and S-3 registration rights, which permit the owner of the warrant under certain circumstances to include some or all of the securities that will be acquired upon exercise of the warrant in a registration statement filed by the borrower. The Fund generally will negotiate “net issuance” provisions in the warrants, which allow the owner of the warrant to exercise the warrant without payment of any cash, and thereby receive a net number of shares determined by the increase in the value of the issuer’s stock (at the time of exercise) above the exercise price stated in the warrant.

Equity Securities. The Fund may make direct investments in equity securities (including convertible notes) having an aggregate cost of up to 10% of the aggregate cost of all investments of the Fund determined cumulatively over the life of the Fund (provided, however, that any amounts paid by the Fund to acquire equity securities pursuant to the receipt or exercise of warrants or stock received in connection with the Fund’s venture loans shall not be taken into account in determining whether such 10% threshold has been met). For example, the Fund may invest equity in a follow-on round of financing to maintain or increase its ownership stake. In some cases, equity investments may be made in companies where the Fund does not have an existing loan. Additionally, the Fund anticipates selectively pursuing opportunistic equity purchases, which may take the form of primary or secondary stock purchases. The Manager expects that the equity securities generally will be convertible preferred stock, though it is possible the Fund would invest directly in common stock of Venture-Backed Companies or convertible notes which convert into common or preferred stock of Venture-Backed Companies. It is likely that, as in the case of warrants, direct equity investments, if made by the Fund, generally will be distributed to the Company simultaneously with, or shortly following, their acquisition. However, ~~although,~~ the Code and 1940 Act requirements could, in certain circumstances, compel the Fund to hold such securities for a longer period of time prior to their distribution to the Company.

Investment Policies. For purposes of the investment policies (other than the diversification standards below), references to the percentage of the Fund’s total assets “invested” in securities of a company will be deemed to refer, in the case of debt financings, to the total amount of financings that the Fund has committed to provide, and in the case of equity investments, to the cost basis of such equity investments; the Fund will not be required to divest securities in its portfolio or decline to fund an existing commitment because of a subsequent change in the value of securities the Fund has previously acquired or committed to purchase.

Diversification Standards. The Fund is classified as a “non-diversified,” closed-end investment company under the 1940 Act. However, the Fund seeks to continue to qualify as a RIC, and therefore must meet diversification standards under the Code.

To qualify as a RIC and obtain the special pass-through status available to RICs under the Code, the Fund must meet the issuer diversification standards under the Code that generally require that, at the close of each quarter of the Fund’s taxable year, (i) not more than 25% of the value of its total assets is invested in the securities of a single issuer, and (ii) at least 50% of the value of its total assets is represented by cash, cash items, government securities, securities of other RICs and other securities (counting each investment in such other securities only if the value of such securities does not exceed 5% of the value of the Fund’s total assets and the Fund does not own more than 10% of the outstanding voting securities of the issuer of such securities). For purposes of the diversification requirements under the Code, the percentage of the Fund’s total assets “invested” in securities of a company will be deemed to refer, in the case of financings in which the Fund commits to provide financing prior to funding the commitment, to the amount of the Fund’s total assets represented by the value of the securities issued by the borrower to the Fund at the time each portion of the commitment is funded.

If the Fund meets the initial requirements of a RIC, the Fund shall not lose its status as a RIC because of a discrepancy during a subsequent quarter between the value of its various investments unless the discrepancy exists immediately after the acquisition of any security and is wholly or partly the result of such acquisition. This is called the “fluctuation in value” exception. This exception also applies if distributions of cash cause the RIC to be out of compliance with either the 25% or 5%/50% tests.

Investment Guidelines. In selecting investments for the Fund’s portfolio, the Manager will endeavor to meet the investment guidelines established and approved by the Fund’s Board of Directors. The Fund may, however, make investments that do not conform to one or more of these guidelines when deemed appropriate by the Manager. Such investments might be made if the Manager believes that a failure to conform in one area is offset by exceptional strength in another or is compensated for by a higher yield, favorable warrant issuance or other attractive transaction terms or features.

Industry Segment Diversification. The Fund generally seeks to invest no more than 30% of its total assets in securities of companies in any single industry. Diversification is carefully considered at the inception of each loan, but percentages may vary from the guideline at any particular point in time. The broad industry categories in which the Fund anticipates that most of its investments will fall (and within each of which there may be several “industries” for purposes of the industry diversification policy) include computers and storage, semiconductor and equipment, internet, medical devices, software, and several other categories.

Stage of Development Guidelines. The Manager seeks to diversify the Fund’s portfolio based on the development stage of the companies in which it invests. Generally, Venture-Backed Companies fall into several lifecycle stages, including the following:

•Early or seed stage companies represent the initial stages of a start-up company’s development. These companies have raised varying amounts of equity capital to prove a concept and qualify for larger sums of start-up capital. Their activities generally are limited to product development, scientific and market research, recruiting a management team and proving early business traction. These companies generally have investor syndicates that include early stage investors such as high net worth angel investors, venture capitalists, incubators, and crowd funding platforms.

•Emerging growth stage companies have a proven early product/market fit and have initiated or are about to initiate full-scale operations and sales but may not be showing a profit.

•Mezzanine stage companies are approaching or have attained break-even or profitability and are continuing to expand.

The Manager refers to its investments in seed and start-up companies as “Early Stage” and investments in emerging growth companies and mezzanine companies as “Expansion Stage.” The Manager seeks to diversify its investments across stages. The classification of companies by stages of development involves a subjective judgment by the Manager, and it is possible that other investors or market analysts would classify the same companies differently than the classifications used by the Fund.

Quality Guidelines. The Manager seeks to invest the majority of the Fund’s aggregate investments (determined cumulatively over the life of the Fund) in investments that meet many of the following guidelines:

Company Guidelines.

•The company has a minimum capitalization of at least $1.0 million.

•The company has at least six months’ worth of available cash to fund its operations or indications from its equity investors that they will make investments necessary to provide such cash.

•The company’s equity investors have indicated a current intention to make additional equity financing available to the company, or the company has a forecasted positive cash flow.

•The company’s business plan contemplates sales of at least $25.0 million within five years.

•The company has previously closed equity financing or will close equity financing prior to the funding of the loan.

Transaction Guidelines for Loans.

•The term of the loan does not exceed 60 months and does not extend beyond December 31, 2028.

•Debt service requirements of the loan are, in the opinion of the Manager, not likely to become an impediment to the company raising additional capital.

•The loan is secured by all or substantially all of the borrower’s assets.

Equity Venture Capital Support Guidelines.

•The company’s equity investors have (i) in the opinion of the Manager, significant venture capital and/or industry experience, and (ii) follow-on capital to support the company.

Special Situation Financings. The Manager may invest up to 20% of the Fund’s aggregate investments determined cumulatively over the life of the Fund in Special Situation Financings. Such Special Situation Financings could include investments targeted towards late-stage or public companies seeking additional growth capital to expand product offerings, increase market penetration or fund strategic acquisitions of other companies or technology. In these situations, the Fund would only consider investing in this Special Situation Financings if it determined it to be of equivalent or better quality as compared to a senior secured loan made to the Fund’s more typical portfolio companies. Further, the Fund may also choose to subordinate existing outstanding debt as part of a restructuring or work-out arrangement in order to allow the company to successfully complete a transaction such as an acquisition or round of financing. There can be no assurance that the subordination will work to the benefit of the Fund. The Manager will target companies whose cash flow from operations and cash reserves are expected to service the Fund’s investment on a current basis. Investments may be structured as senior debt, convertible debt, or other debt/equity structures. In addition, Special Situation Financings could include investments in a “troubled” company undergoing a restructuring or recapitalization of its existing debt or equity, and making investments in subordinated debt, providing bridge financing to a company which is in the process of raising additional private equity, planning an initial public offering or is seeking to enter into a business combination through which it would be acquired. In some instances, these companies will have been bootstrapped (i.e., funded solely by the personal assets of their founders or other individuals), without any substantial investment from venture capital or other investors. As of December 31, ~~2023~~2024, ~~the Fund made~~ Special Situation Financings ofaccounted ~~about~~for 1.4% of total commitments.

International Investments. As a BDC, the Fund may invest in companies which are not Qualifying Assets, as long as at the time of such investment, at least 70% of the value of the Fund’s total assets are invested in Qualifying Assets. An Eligible Portfolio Company must be organized under the laws of, and have its principal place of business in, the United States. Therefore, the Fund could invest up to 30% of its total assets in foreign-based companies. If reasonably practicable, investments in foreign-based companies would be secured by foreign-based assets in addition to being secured by any assets located in the United States.

Leverage. The Fund has borrowed money from and entered into secured contracts, which instruments are considered debt securities, with banks to obtain additional funds to originate loans (and possibly for Special Situation Financings). The borrowings of the Fund are subject to the asset coverage requirements under the 1940 Act, including borrowings in excess of 5% of total assets for temporary purposes, and all borrowings for emergency purposes that are not “temporary.” In April 2019, the Fund’s sole shareholder approved the Fund to apply the reduced asset coverage requirements in Section 61(a)(2) of the 1940 Act, which permits the Fund to double the maximum amount of leverage that it may incur by reducing the asset coverage requirement applicable to the Fund from 200% to 150%.

Temporary Investments. Pending investment, and until distributions to ~~the~~its ~~stockholders~~shareholder are made, the Fund will invest excess cash in: (i) time deposits, certificates of deposit and similar instruments of highly-rated banks; (ii) securities issued or guaranteed by the U.S. government, its agencies or instrumentalities; (iii) repurchase agreements that are: (a) issued by highly-rated banks or securities dealers and (b) fully collateralized by U.S. government securities; (iv) short-term high-quality debt instruments of U.S. corporations; and (v) money market funds and other pooled investment funds whose investments are restricted to those described above. The average maturity of such investments, weighted by their par value, will not exceed 90 days.

Other Investment Policies. The Fund will not sell securities short (except to the extent the Fund has a warrant for, or owns, shares equal to the number of shares which is the subject of the proposed short sale), purchase securities on margin (except to the extent the Fund’s permitted borrowings are deemed to constitute margin purchases), purchase or sell commodities or commodity contracts (except interest rate hedging transactions in connection with the Fund’s permitted borrowings), or purchase or sell real estate. The Fund may, however, write puts and calls, and acquire options, as a hedge for equity investments or to increase return through a covered call. The Fund will not underwrite the securities of other companies, except to the extent ~~they~~it may be deemed ~~underwriters~~an underwriter upon the disposition of restricted securities acquired in the ordinary course of ~~their~~its business. The Fund may, however, use borrowed funds for its lending activities. See the discussion herein under the caption “Risk Factors - General - Leverage.”

The Fund’s investment objectives, investment policies and investment guidelines (other than its intended status as a BDC) are not fundamental policies and may be changed by the Fund’s Board of Directors at any time.

Regulation. As a BDC, the Fund is required to invest in Eligible Portfolio Companies and (with certain exceptions) make available to them significant managerial assistance. Eligible Portfolio Companies, and the regulations governing assets a BDC can acquire, are described under the heading “Investment Program” above.

The Fund, as a BDC, may sell its securities at a price that is below its net asset value per share, provided that a majority of the Fund’s directors, who are not interested persons of the Fund within the meaning of Section 2(a)(19) of the 1940 Act (“disinterested directors”), has determined that such sale would be in the best interests of the Fund and its shareholder and upon the approval by the holders of a majority of its outstanding voting securities, including a majority of the voting securities held by non-affiliated persons, of such policy or practice within one year of such sale. A majority of the disinterested directors also must determine in good faith, in consultation with the underwriters of the offering if the offering is underwritten, that the price of the securities being sold is not less than a price which closely approximates market value of the securities, less any distribution discounts or commissions. As defined in the 1940 Act, the term “majority of the outstanding voting securities” of the Fund means the vote of (i) 67% or more of the Fund’s Shares present at a meeting, if the holders of more than 50% of the outstanding Shares are present or represented by proxy, or (ii) more than 50% of the Fund’s outstanding Shares, whichever is less.

Many of the transactions involving a company and its affiliates (as well as affiliates of those affiliates) which were prohibited without the prior approval of the SEC under the 1940 Act prior to its amendment by the 1980 provisions are permissible for BDCs, including the Fund, upon the prior approval of a majority of the Fund’s disinterested directors and a majority of the directors having no financial interest in the transactions. However, certain transactions involving certain persons related to the Fund, including its directors, officers, and the Manager, may still require the prior approval of the SEC. In general, (i) any person who owns, controls, or holds power to vote, more than 5% of the Fund’s outstanding Shares; (ii) any director, executive officer, or general partner of that person; and (iii) any person who directly or indirectly controls, is controlled by, or is under common control with, that person, must obtain the prior approval of a majority of the Fund’s disinterested directors, and, in some situations, the prior approval of the SEC, before engaging in certain transactions involving the person or any company controlled by the Fund. The 1940 Act generally does not restrict transactions between the Fund and its eligible portfolio companies. While a BDC may change the nature of its business so as to cease being a BDC (and in connection therewith withdraw its election to be treated as a BDC) only if authorized to do so by a majority vote (as defined by the 1940 Act) of its outstanding voting securities, shareholder approval of changes in other fundamental investment policies of a BDC is not required (in contrast to the general 1940 Act requirement, which requires shareholder approval for a change in any fundamental investment policy).

Dividends and Distributions. The Fund intends to distribute to its shareholder all equity securities received from portfolio companies simultaneously, or shortly following, their acquisition and substantially all of its net investment income and net realized capital gains, if any, as determined for income tax purposes, less appropriate reserves. Applicable law, including provisions of the 1940 Act, may limit the amount of dividends and other distributions payable by the Fund. Income dividends will generally be paid quarterly to shareholders of record on the last day of each preceding calendar quarter end. Substantially all of the Fund’s net capital gain (the excess of net long-term capital gain over net short-term capital loss) and net short-term capital gain, if any, will be distributed annually, or on a more frequent basis as determined by the Manager.

The Manager exercised, and the Board of Directors ratified, its discretion to extend the Fund’s investment period for two additional quarters after June 30, 2022, thereby allowing the Fund to make new commitments through December 31, 2022 and to fund commitments through December 31, 2023, the end of the Fund’s investment period. Following the end of the commitment period, the Fund began to distribute to investors all proceeds received from principal payments and sales of investments, net of reserves and expenses, principal repayments on the Fund’s borrowings, amounts required to fund financing commitments entered into before such date, and any amounts paid on exercise of warrants. Distributions of such amounts are likely to cause annual distributions to exceed the earnings and profits of the Fund available for distribution, in which case such excess will be considered a tax-free return of capital to a shareholder to the extent of the shareholder’s adjusted basis in its shares and then as capital gain. The Fund may borrow money to fund shareholder distributions, to the extent consistent with the 1940 Act and a prudent capital structure.

Competition. Other entities and individuals compete for investments similar to those proposed to be made by the Fund, some of whom may have greater resources than the Fund. Furthermore, the Fund’s need to comply with provisions of the 1940 Act pertaining to BDCs and provisions of the Code pertaining to RICs might restrict the Fund’s flexibility as compared with its competitors. The need to compete for investment opportunities may make it necessary for the Fund to offer borrowers more attractive transaction terms than otherwise might be the case.

Segment Information. The Fund operates through a single operating and reportable segment for financial reporting purposes, consistent with how the officers of the Fund (inclusive of the Chief Executive Officer and Chief Financial Officer, among others), who are the Fund's chief operation decision maker (“CODM”), evaluate financial performance and allocate resources.

Executive Officers. The following are the executive officers of the Fund. All officers serve at the pleasure of the Fund’s Board of Directors.

Name and Position with Fund	Age	Occupation During Past Five Years
Maurice C. Werdegar, Chairmanand Director	5960	Chairman of the Fund since 2022. Mr. Werdegar has held the position of Chairman of Westech Investment Advisors since 2022. Mr. Werdegar served as President and Chief Executive Officer of Westech Investment Advisors from 2015 to 2021, served as Chief Operating Officer and Vice President of Westech Investment Advisors from 2011 to 2015 and served in various other positions with Westech Investment Advisors since 2001. Mr. Werdegar has served as a Director of the Fund since 2017. Mr. Werdegar is Chairman of WTI Fund X, Inc. (“Fund X”) and WTI Fund XI, Inc. (“Fund XI”).
David R. Wanek, President and Chief Executive Officer	51	Chief Executive Officer of the Fund since 2022. Mr. Wanek has held the position of President of the Fund since 2019. Mr. Wanek has held the position of Chief Executive Officer and President of Westech Investment Advisors since 2022 and held other positions with Westech Investment Advisors since 2001. Mr. Wanek is the President and CEO of Fund X and Fund XI. Mr. Wanek is also a member of the board of directors of Fund X and Fund XI.

Name and Position with Fund	Age	Occupation During Past Five Years
Jared S. Thear, Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary	46	Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary for the Fund since 2021. Mr. Thear has held the same positions with Westech Investment Advisors since 2021. Prior to joining Westech Investment Advisors, he worked at Deloitte & Touche for 20 years and held various leadership roles. From 2014 to 2021, he led Deloitte's Northwest region Asset Management practice for the audit function. Mr. Thear is also the Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary of Fund X and Fund XI.
David R. Wanek, President and Chief Executive Officer	52	Chief Executive Officer of the Fund since 2022. Mr. Wanek has held the position of President of the Fund since 2019. Mr. Wanek has held the position of Chief Executive Officer and President of Westech Investment Advisors since 2022 and held other positions with Westech Investment Advisors since 2001. Mr. Wanek is the President and CEO of Fund X and Fund XI. Mr. Wanek is also a member of the board of directors of Fund X and Fund XI.
Rodolfo Ruano, Vice President and Assistant Secretary	56	Vice President and Assistant Secretary for the Fund since 2021. Mr. Ruano has held the position of Vice President of Westech Investment Advisors since 2021. Investment Partner for Westech Investment Advisors since 2011. Mr. Ruano is also the Vice President and Assistant Secretary for Fund X and Fund XI.
Jared S. Thear, Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary	47	Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary for the Fund since 2021. Mr. Thear has held the same positions with Westech Investment Advisors since 2021. Prior to joining Westech Investment Advisors, he worked at Deloitte & Touche for 20 years and held various leadership roles. From 2014 to 2021, he led Deloitte's Northwest region Asset Management practice for the audit function. Mr. Thear is also the Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary of Fund X and Fund XI.
Rodolfo Ruano, Vice President and Assistant Secretary	57	Vice President and Assistant Secretary for the Fund since 2021. Mr. Ruano has held the position of Vice President of Westech Investment Advisors since 2021, and has been an Investment Partner for Westech Investment Advisors since 2011. Mr. Ruano is also the Vice President and Assistant Secretary for Fund X and Fund XI.

Employees. The Fund has no employees; all of its officers are officers and/or employees of the Manager, and all of its required services are performed by officers and employees of the Manager.

Available Information. The Fund’s office is located at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028, and its phone number is (650) 234-4300. The Manager maintains a website at https://westerntech.com/.

The SEC maintains a website, www.sec.gov, that contains reports, proxies and information statements filed by the Fund.

ITEM 1A. RISK FACTORS

GENERAL

Reliance on Management. The Fund is wholly dependent for the selection, structuring, closing and monitoring of its investments on the diligence and skill of the Manager, acting under the supervision of the Fund’s Board of Directors. Although the operating principals of the Manager have a long history of combined experience in investing in venture lending transactions and equity investments, there can be no assurance that the Fund will attain its investment objective. Furthermore, the Manager does not have substantial experience investing in Special Situation Financings such as convertible and subordinated debt of public and late-stage private companies. The officers of the Manager have primary responsibility for the selection of the companies in which the Fund will invest, the negotiation of the terms of such investments and the monitoring and servicing of such investments after they are made. Although the officers of the Manager intend to devote such time as is necessary to the affairs of the Fund, they are not required to devote full time to the management of the Fund. Furthermore, the departure of key personnel or of a significant number of the investment professionals of the Manager could have a material adverse effect on the Fund's ability to achieve its investment objective. There can be no assurance that any investment professional will remain associated with the Manager or that, if any investment professional ceased to be associated with the Manager, the Manager would be able to find a qualified person or persons to fill the position.

Illiquid and Long-Term Investment. After December 31, 2022, the Fund ceased making any new equity investments as well as investments in venture loans (except pursuant to commitments made before the fourth anniversary, or if applicable, the extended commitment date (up to 2 calendar quarters)), and will distribute to its shareholder all proceeds received from principal payments and sales net of: (i) reserves and expenses; (ii) principal repayments on the Fund’s borrowings; (iii) amounts required to fund financing commitments entered into before such fourth anniversary, or if applicable, the extended commitment date; and (iv) any amounts paid on exercise of warrants or otherwise paid to protect the value of existing investments (including, for example, pay-to-play provisions and purchases of equity securities in “down rounds” to avoid dilution). The Fund’s Amended and Restated Articles of Incorporation provide that, on December 31, 2028, the Fund automatically will be dissolved without any action by its shareholder. From and after such dissolution, the Fund’s activities will be limited to the winding-up of its affairs, the liquidation of its remaining assets and the distribution of the net proceeds thereof to its shareholder. Although the Fund generally would not make any loan with a stated maturity date later than December 31, 2028, it is possible that, due to a default by a borrower or a transaction restructuring due to a borrower’s financial difficulties, such a loan may remain outstanding in whole or in part beyond its original maturity date. Furthermore, the Fund may not be able to sell warrants it receives from borrowers, or the equity securities (including those received upon exercise of warrants or conversion of debt instruments or in connection with restructuring of a troubled loan), to the extent those investments were retained by the Fund and not distributed earlier to its shareholder, for a significant period of time due to legal or contractual restrictions on resale or the absence of a liquid secondary market. As a result, the liquidation process might not be completed for a significant period after the Fund’s dissolution. In addition, it is possible that, if certain of the Fund’s assets are not liquidated within a reasonable time after the Fund’s dissolution, the Fund may elect to make a distribution in kind of all or part of such assets to its shareholders. In such case, the shareholders would bear any expenses attendant to the liquidation of such assets.

Although shares of the Fund have been registered under the Securities Exchange Act of 1934 (the “Exchange Act”), there will be no trading market for shares in the Fund (which are all owned by the Company), and thus shares of the Fund should be considered illiquid.

Competition. Other entities and individuals compete for investments similar to those made by the Fund, some of whom, with respect to investments in the form of loans, and many of whom, with respect to the equity investments and convertible and subordinated debt, have greater resources than the Fund. Furthermore, competition could increase given the low barriers to entry in the industry. Additionally, the Fund’s need to comply with provisions of the 1940 Act pertaining to BDCs and provisions of the Code pertaining to RICs, might restrict the Fund’s flexibility as compared with its competitors. The need to compete for investment opportunities may make it necessary for the Fund to offer borrowers or companies in which it makes equity investments more attractive terms than otherwise might be the case. If the Fund encounters increased competition from other entities or individuals or is hindered by the provisions of the regulations governing BDCs or RICs, the Fund may not fund new investments, which would impact the operations of the Fund.

Convertible Debt. Convertible debt instruments issued by public and late-stage private companies may comprise some of the Special Situation Financings in which the Fund may invest. Convertible debt generally offers lower interest yields than non-convertible debt of similar quality. The market value of debt tends to decline as interest rates increase and, conversely, to increase as interest rates decline. The market value of convertible debt, however, often reflects the market price of common stock of the issuing company when that stock price is greater than the conversion price of the convertible debt. The conversion price is the predetermined price at which the debt instrument could be exchanged for the associated stock. As the market price of the underlying common stock declines, the price of the convertible debt tends to be influenced more by the yield of the debt instrument. Thus, it may not decline in price to the same extent as the underlying common stock.

Subordinated Debt. Some of the Special Situation Financings in which the Fund may invest may consist of subordinated debt instruments, which tend to be predominantly high-yield non-convertible debt securities. Investments in high-yield securities involve substantial risk of loss. Sub-investment grade non-convertible debt securities, or comparable unrated securities, are commonly referred to as “junk debt” and are considered speculative with respect to the issuer’s ability to pay interest and principal and are susceptible to default or decline in market value due to adverse economic or business developments. The market values for high-yield securities tend to be very volatile, and these securities are less liquid than investment grade debt securities.

Leverage. The Fund borrowed money and entered into secured contracts, which instruments are considered debt securities, with banks to obtain additional funds to originate loans (and possibly Special Situation Financings). The borrowings of the Fund are subject to the asset coverage requirements under the 1940 Act, including borrowings in excess of 5% of total assets for temporary purposes, and all borrowings for emergency purposes that are not “temporary.” Under the 1940 Act, the Fund may not incur borrowings unless, immediately after the borrowing is incurred, such borrowings would have “Asset Coverage” of at least 200%, generally, and of at least 150% if certain conditions are met. “Asset Coverage” means the ratio which the value of the Fund’s total assets, less all liabilities not represented by (i) the borrowings and (ii) any other liabilities constituting “senior securities” under the 1940 Act, bears to the aggregate amount of such borrowings and senior securities. The practical effect of this limitation is to limit the Fund’s borrowings and other senior securities to 50% of its total assets less its liabilities other than the borrowings and other senior securities. The 1940 Act also requires that, if the Fund borrows money, provisions be made to prohibit the declaration of any dividend or other distribution on the shares (other than a dividend payable in shares), or the repurchase by the Fund of shares, if, after payment of such dividend or repurchase of shares, the Asset Coverage of such borrowings would be below 200% (or 150%, as applicable). In April 2019, the Fund’s sole shareholder approved the Fund to apply the reduced asset coverage requirements in Section 61(a)(2) of the 1940 Act, which permits the Fund to double the maximum amount of leverage that it may incur by reducing the asset coverage requirement applicable to the Fund from 200% to 150%. If the Fund is unable to pay dividends or distributions in the amounts required under the Code, it might not be able to qualify for the pass-through status as a RIC or, if qualified, to continue to so qualify.

The Fund has a secured, syndicated loan facility with a borrowing availability of $~~166~~79.5 million and the outstanding balance under the facility as of December 31, ~~2023~~2024 was $~~142~~39.5 million.

The use of leverage increases investment risk. The Fund’s use of leverage is premised upon the expectation that the Fund’s all-in borrowing costs would be lower than the return the Fund achieves on its investments. To the extent the income or capital gains derived from investments purchased with borrowed funds exceeds the cost of borrowing, the Fund’s overall return will be greater than if leverage had not been used. Conversely, if the income or capital gain from the investments purchased with borrowed funds is not sufficient to cover the cost of borrowing, or if the Fund incurs capital losses, the return to the Fund will be less than if leverage had not been used, and therefore the amount available for distribution will be reduced or potentially eliminated.

Lenders have required that the Fund pledge all assets as collateral for borrowings and have required that the Company provide guarantees or other credit enhancements. The Company, however, will not pledge its assets to secure such borrowings as this could result in unrelated business taxable income to its tax-exempt members. If the Fund is unable to service the borrowings, the Fund may risk the loss of such pledged assets.

Lenders have required that the Fund agree to loan covenants limiting the Fund’s ability to incur additional debt or otherwise limiting the Fund’s flexibility, and loan agreements may provide for acceleration of the maturity of the indebtedness if certain financial tests are not met. To minimize risks associated with borrowing money at floating rates and lending money at fixed rates, the Fund may enter into interest rate hedging transactions with respect to all or any portion of the Fund’s borrowings. There can be no assurance that such interest rate hedging transactions will be available in forms acceptable to the Fund. In addition, entering into interest rate hedging transactions increases costs to the Fund. Finally, it is possible that the Fund could incur losses from being “over-hedged,” which would result if the debt that was hedged is repaid faster than expected.

BDC Regulation. The Fund has elected to be treated as a BDC under the Small Business Incentive Act of 1980, which modified the 1940 Act. Although BDCs are not required to register under the 1940 Act and are relieved from compliance with a number of the provisions of the 1940 Act, there are now greater restrictions in some respects on permitted types of investments for BDCs. Moreover, the applicable provisions of the 1940 Act continue to impose numerous restrictions on the activities of the Fund, including restrictions on leverage and on the nature of its investments. While the Fund is not aware of any judicial rulings under, and is aware of only a few administrative interpretations of, the Small Business Incentive Act of 1980, there can be no assurance that such Act will be interpreted or administratively implemented in a manner consistent with the Fund’s objectives or manner of operation.

Changes in Laws or Regulations. The Fund and its portfolio companies are subject to regulation by laws and regulations at the local, state, federal and, in some cases, foreign levels. These laws and regulations, as well as their interpretation, may be changed from time to time, and new laws and regulations may be enacted. Accordingly, any change in these laws or regulations, changes in their interpretation, or enacted laws or regulations could require changes to certain business practices of the Fund or its portfolio companies, negatively impact the operations, cash flows or financial condition of the Fund or its portfolio companies, impose additional costs on the Fund or its portfolio companies or otherwise adversely affect the Fund’s business or the business of its portfolio companies. Over the past several years, there also has been increasing regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion of the non-bank financial sector may be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased regulation of non-bank lending could be materially adverse to the Fund’s business, financial conditions and results of operations.

Regulators are also increasing scrutiny and considering regulation of the use of artificial intelligence technologies. The Fund cannot predict what, if any, actions may be taken with respect to such technologies or the impact such actions may have on portfolio companies or the Fund’s business and results of operations.

Litigation. The Fund could be subject to litigation by borrowers, based on theories of breach of contract to lend, “lender liability,” or otherwise in connection with its loan and investment transactions. The defense of such a lawsuit, even if ultimately determined to be without merit, could be costly and time-consuming to the Fund. The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operation. Management is not aware of any pending material legal proceedings involving the Fund.

Tax Status. The Fund must meet a number of requirements, including those described herein under the caption “Diversification Standards” and in Note 9 to the financial statements included in this filing, to qualify for the pass-through status as a RIC and, if qualified, to continue to so qualify. For example, the Fund must meet specified asset diversification standards under the Code which might prove difficult if certain borrowers with larger commitments drew on their committed financing at a rate faster than other borrowers to whom smaller commitments were made. If the Fund experiences difficulty in meeting the diversification requirement for any fiscal quarter of its taxable year, it might accelerate capital calls or, if available, borrowings in order to increase the portion of the Fund’s total assets represented by cash, cash items, and U.S. government securities as of the close of the following fiscal quarter and thus attempt to meet the diversification requirement. The Fund, however, would incur additional interest and other expenses in connection with any such accelerated borrowings, and increased investments by the Fund in cash, cash items, and U.S. government securities (whether the funds to make such investments are derived from called equity capital or from accelerated borrowings) are likely to reduce the Fund’s return. Furthermore, there can be no assurance that the Fund would be able to meet the diversification requirements through such actions. Failure to qualify as a RIC would deny the Fund pass-through status and, in a year in which the Fund has taxable income, would have a significant adverse effect on the return of the Fund. Tax laws are dynamic and tax laws either in the U.S. or in foreign jurisdictions could change causing a different than expected outcome.

The Fund has received an opinion that, assuming the Fund’s election to be a BDC under Sections 6(f) and 54 of the 1940 Act is valid and ~~will~~remains ~~remain~~ in effect and that the Fund otherwise meets the qualification requirements set forth in Section 851(b) and the distribution requirements in Section 852(a) of the Code, if the Fund’s status as a RIC is challenged by the Internal Revenue Service (the “IRS”) in court and properly litigated, a court of competent jurisdiction will respect that status for federal income tax purposes. If the SEC were to disallow the Fund’s election to be treated as a BDC, then the Fund would not be eligible to be treated as a RIC and, therefore, would be subject to federal corporate tax on its income and gains. The opinion referred to above is based on the Code, regulations thereunder, IRS rulings, procedures and pronouncements, court decisions and other applicable law as of the date hereof, and certain representations that the Fund has made to its legal counsel. Legal opinions, however, are not binding on the IRS or the courts, and no ruling has been or will be requested from the IRS. No assurance can be given that the IRS will concur with such opinion.

Allocation of Expenses. If the Fund is not deemed to be engaged in a trade or business, individuals and certain other persons who are members of the Company will be required to include in their gross income an amount of certain Fund expenses relating to the production of gross income that are allocable to the Company. These members, therefore, will be deemed to receive gross income from the Fund in excess of the distributions they actually receive. Such allocated expenses were deductible by an individual member as a miscellaneous itemized deduction for the year 2017, subject to the limitation on miscellaneous itemized deductions not exceeding 2.0% of adjusted gross income to the extent the Fund is not engaged in a trade or business. However, for the years 2018 through 2025, no deduction for such expense would be allowed. For the tax years 2026 and beyond, the provision will expire and the expenses would be deductible under the pre-2018 law as currently written.

Calculation of Management Fee. As compensation for its services to the Fund, the Manager will receive an investment management fee from the Fund (the “Management Fee”), commencing when capital is first called from the members of the Company. The aggregate annual amount of Management Fee for each annual period (which will be comprised of four whole fiscal quarters and which, in the case of the first year, will commence on the first day of the first fiscal quarter commencing on or following the first capital commitment) will be calculated as a percentage of committed capital, as follows:


						Management Fee
Year 1						1.575%
Year 2						1.600%
Year 3						1.575%
Year 4						1.500%
Year 5						1.250%
Year 6						0.900%
Year 7						0.600%
Year 8						0.350%
Year 9						0.150%

There will be no Management Fee payable after the ninth-year anniversary of the first capital contribution date.

The calculation of the Management Fee could result in fees being disproportionately large relative to the value of the Fund’s portfolio if the total assets of the Fund are low compared to the committed capital. This could occur, for example, if the Fund does not originate as many loans as anticipated, or if the loans in the Fund’s portfolio are repaid at a rapid rate during such period.

Risks Related to Cybersecurity. Increased reliance on technology by the Fund and its service providers and portfolio companies has increased the risks posed to their respective information systems. The Fund and its service providers and portfolio companies are susceptible to operational and information security risks that include, among other things: human error and negligence; theft; the unauthorized monitoring, release, misuse, loss, destruction or corruption of confidential and highly restricted data; denial of service attacks; unauthorized access to relevant systems; compromises to networks or devices that the Fund and its service providers use to service the Fund’s operations; and operational disruption or failures of physical infrastructure or operating systems. The rapid evolution and increasing prevalence of artificial intelligence technologies may also increase the cybersecurity risk of the Fund and its service providers and portfolio companies.

Cyber-attacks against or security breakdowns of the Fund or its service providers or portfolio companies may adversely impact the Fund and its shareholders, potentially resulting in, among other things: financial losses; the inability of Fund shareholders to transact business and the Fund to process transactions; exposure of personal information belonging to the Fund and its shareholders and violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage, reimbursement or other compensation costs; and/or additional compliance costs. The Fund may incur additional costs for cybersecurity risk management and remediation purposes. In addition, cybersecurity and privacy risks may also impact the Fund’s transactional counterparties, governmental and other regulatory authorities, exchange and other financial market operators, banks, brokers, dealers, insurance companies and other financial institutions, which could cause the Fund to suffer losses.

In general, cybersecurity attacks and breaches include, but are not limited to, efforts by bad actors to gain unauthorized access to systems, networks, devices or other digital systems (e.g., through “hacking” or malicious software coding) for purposes of misappropriating assets or sensitive information, corrupting data or causing operational disruption. Cyber-attacks also may be carried out in a manner that does not require gaining unauthorized access, such as causing denial-of-service attacks on websites (i.e., efforts to make services unavailable to intended users) or using a phishing scheme to impersonate an executive or vendor to cause an unauthorized transfer of funds. There can be no assurance that the Fund or its service providers or portfolio companies will not suffer losses relating to cyber-attacks or other information security breaches in the future.

While information risk management systems and business continuity plans have been developed which are designed to reduce the risks associated with cybersecurity, there are inherent limitations in any cybersecurity risk management systems or business continuity plans, including the possibility that certain risks have not been identified and that cyber-attacks may be highly sophisticated. There can be no assurance that the programs, plans and systems in place will prevent a cyber-attack or otherwise prevent cyber losses.

In addition, federal, state and foreign governments and agencies have adopted and could in the future adopt regulations covering issues such as user privacy. If the Fund’s and/or its services providers’ or portfolio companies’ privacy or data security measures fail to comply with current or future laws and regulations, they may be subject to additional litigation, regulatory investigations or other liabilities that could result in financial loss, litigation, regulatory investigations and penalties, and other liabilities that could damage their reputation and adversely impact the Fund’s and/or its service providers’ or portfolio companies’ performance and financial condition.

In addition, federal, state and foreign governments and agencies have adopted and could in the future adopt regulations covering issues such as user privacy. For example, in May 2024, the SEC adopted amendments to Regulation S-P, which, beginning in December 2025, will require investment companies and SEC-registered investment advisers to adopt written policies and procedures for incident response programs to address unauthorized access to, or use of, customer information, including providing notice to certain individuals affected by any such incident. If the Fund’s and/or its services providers’ or portfolio companies’ privacy or data security measures fail to comply with current or future laws and regulations, they may be subject to additional litigation, regulatory investigations or other liabilities that could result in financial loss, litigation, regulatory investigations and penalties, and other liabilities that could damage their reputation and adversely impact the Fund’s and/or its service providers’ or portfolio companies’ performance and financial condition.

Climate Change, Natural Disaster, Public Health Crises and Other Catastrophes Risk. Climate change is widely considered to be a significant threat to the global economy. Extreme weather patterns or natural disasters, such as hurricanes, floods, fires and earthquakes, or the threat thereof, could also adversely impact Fund portfolio companies’ facilities, operations, and services, as well as certain industries, or group of industries, and regions related to the Fund’s investments. Climate change related legislation, regulation, and accords, both domestic and international, intended to control the impact of climate change may produce direct or indirect adverse consequences to the Fund’s investments, significantly affecting their value. Climate related business trends, such as the process of transitioning to a lower carbon economy, could also adversely affect the Fund’s investments. Health crises, such as pandemic and epidemic diseases, as well as other catastrophes that interrupt the expected course of events, such as natural disasters, war or civil disturbance, acts of terrorism, power outages and other unforeseeable and external events, and the public response to or fear of such diseases or events, may have an adverse effect on the Company’s or the Fund’s investments and the Company’s and the Fund’s operations. All such events could also result in travel restrictions, sanctions and shipping and labor disruptions, which may adversely affect Fund portfolio companies’ facilities, operations, and services.

INVESTMENT RISKS

International Investments. The Fund may invest up to, but not more than, 30% of its total assets in foreign based companies. Foreign investments are subject to most of the same risks as domestic investments, as well as the political, economic and other uncertainties associated with foreign activities, including war and political unrest, political conflict (including between the U.S. and China), the impact of laws and policies of foreign governments and the United States affecting foreign investment, including tariffs, and the possibility of being subject to the jurisdiction of foreign courts in connection with legal disputes or the inability to subject foreign persons to the jurisdiction of courts in the United States. Furthermore, there may be practical and local law impediments to cost-effective recovery against collateral located in a foreign country. Moreover, it is possible that taxes may be required to be withheld by the foreign company on dividend and interest payments received by the Fund with respect to such foreign investments. Although capital gains derived by the Fund with respect to such investments in such foreign company may often be exempt from non-U.S. income or withholding taxes, the treatment of capital gains varies among jurisdictions. If the income from such foreign investments is subject to non-U.S. income or withholding taxes, the Fund will attempt to negotiate offsetting gross-up payments from the foreign-based company. No assurances, however, can be given that the Fund would be able to negotiate such offsetting payments. Following Russia’s invasion of Ukraine in February 2022, the U.S., the European Union (“E.U.”) and its member states, and other countries announced and implemented major sanctions against Russia. The U.S., E.U. nations and other countries could impose wider sanctions and take other actions as the conflict continues. It is difficult to anticipate the long-term impact on the Fund of war in Ukraine, sanctions, and any retaliatory measures by Russia in response. Similarly, war in the Middle East, or the outbreak of other hostilities or conflict in other regions, creates uncertainty as to impacts on global markets. Any or all of these may cause significant turmoil in the global markets, including domestic and global credit markets and market liquidity, impact the domestic and global economy, disrupt supply chains, increase the risk of inflation, limit the ability of the Fund to invest in companies impacted by the sanctions or involved in conflict, or negatively impact the operations of portfolio companies, which could in turn have a material adverse impact on the Fund.

Foreign Currency and Exchange Rate Risks. Fund assets and income may be denominated in various currencies. Contributions and distributions, however, will be denominated in U.S. dollars. As a result, the return of the Fund on any investment may be adversely affected by fluctuations in currency exchange rates, any future imposed devaluations of local currencies, inflationary pressures, and the success of the investment itself. In addition, the Fund may incur costs related to conversions between various currencies. As of December 31, ~~2023~~2024, all Fund assets and income, as well as contributions and distributions, are denominated in U.S. dollars.

Accounting and Disclosure Standards. Accounting, auditing, financial, and other reporting standards, practices, and disclosure requirements in countries in which the Fund may invest are not necessarily equivalent to those required under United States Generally Accepted Accounting Principles (“U.S. GAAP”). Accordingly, less information may be available to investors.

Credit Risks. Most of the companies with which the Fund will enter into financing transactions will not have achieved profitability, may experience substantial fluctuations in their operating results or, in many cases, will not have significant operating revenues. The ability of any borrower to meet its obligations to the Fund, therefore, will depend to a significant extent on the willingness of such borrower’s venture capital equity investors or outside investors to provide additional equity financing, which in turn will depend on the borrower’s success in meeting its business plan, the market climate for venture capital investments generally, among other factors. Additionally, these Companies typically retain their cash for operations within one or more bank accounts. These accounts may hold cash in excess of the Federal Deposit Insurance Corporation’s (“FDIC”) limit of $250,000. As a result, they are subject to concentration risk and liquidity risk associated with the underlying custodial banks with whom their deposits of cash and cash equivalents in excess of the FDIC limits are held. If access to these accounts is delayed or suspended indefinitely, it could have a material adverse impact on the company’s ability to meet its financial obligations required for operations. This could affect the Fund’s ability to be paid back on its outstanding commitments and result in a reduction to capital available to borrow within the Fund's underlying credit facilities. The companies to which the Fund will provide financing will frequently be engaged in the development of new products or technologies, and the success of these efforts, or the ability of the companies to successfully manufacture or market products or technologies developed, cannot be assured. These companies frequently face intense competition, including competition from companies with greater resources, and may face risks of product or technological obsolescence, non-acceptance in the market, or rapidly changing regulatory environments, any of which could adversely affect their prospects. The success of such companies often depends on the management talents and efforts of one person or a small group of persons whose death, disability, resignation or other form of departure would adversely affect the company.

Remedies Upon Default. In the event of a default on a portfolio loan, the available remedies to the Fund would include legal action against the borrower and foreclosure or repossession of collateral given by the borrower. However, the Fund could experience significant delays in exercising its rights as a secured lender and might incur substantial costs in taking possession of and liquidating its collateral and in taking other steps to protect its investment. The Fund generally will require that it have a first priority security interest in any equipment of a borrower financed with the proceeds of the Fund’s loans, although that security interest may extend to the borrower’s other assets in which another lender might have a senior or parity security interest. It is anticipated that the Fund will make loans to a borrower that has one or more other secured lenders. In such circumstances, the Fund may share all or a portion of its collateral with the other lender(s) and will enter into intercreditor agreements governing the respective rights of the Fund and such other lender(s), which could limit the Fund’s flexibility in pursuing its remedies as a secured creditor, and reduce the proceeds realized from foreclosing or taking possession of the collateral. In the case of growth capital or working capital loans (where the loan proceeds can be used by the company for general corporate purposes), the Fund will typically receive either a broader lien on substantially all of the borrower’s assets, including its intellectual property, or a lien on substantially all of the borrower’s assets, excluding intellectual property, and a negative pledge on such intellectual property.

As noted above, the Fund may utilize certain of its funds in investments that involve the financing of equipment assets. Equipment assets are often subject to rapid depreciation or obsolescence such that it is likely that the value of the assets underlying a loan to finance such assets will depreciate during the term of the loan transaction below the amount of the borrower’s obligations. In addition, although borrowers will be required under the transaction documents to provide customary insurance for the assets underlying a loan and will be prohibited from disposing of the assets without the Fund’s consent, compliance with these covenants cannot be assured and, in the event of non‑compliance, the assets could become unavailable to the Fund due to destruction, theft, sale or other circumstances. Realization of value from intellectual property collateral can also be time consuming and present special challenges, given the often-unique nature and limited market for such assets. The Fund’s ability to obtain payment beyond the collateral underlying the loan from the borrower might be limited by bankruptcy or similar laws affecting creditors’ rights. In limited instances where the Fund takes security interests in a borrower’s assets located in a foreign country, there may be practical and local law impediments to cost-effective recovery against such collateral. Therefore, there can be no assurance that the Fund would ultimately collect the full amount owed on a defaulted loan.

Emerging Company Risks. The possibility that the companies in which the Fund invests will not be able to commercialize their technology or product concept presents significant risk. Additionally, although some of such companies may already have a commercially successful product or product line at the time of investment, technology products and services often have a more limited market or life span than products in other industries. Thus, the ultimate success of these companies may depend on their ability to continually innovate in increasingly competitive markets. Most of the companies in which the Fund invests will require substantial additional equity financing to satisfy their continuing growth and working capital requirements. Each round of venture financing is typically intended to provide a company with enough capital to reach the next stage of development. The circumstances or market conditions under which such companies will seek additional capital is unpredictable. It is possible that certain companies will not be able to raise additional financing or may be able to do so only at a price or on terms which are unfavorable to the Fund.

Privately-Held Company Risks. The Fund invests primarily in privately-held companies. Generally, very little public information exists about these companies and the Fund is required to rely on the ability of the Manager to obtain adequate information to evaluate the potential returns from investing in these companies. Moreover, these companies typically depend upon the management talents and efforts of a small group of individuals and the loss of one or more of these individuals could have a significant impact on the investment returns from a particular company. Also, these companies frequently have less diverse product lines and smaller market presence than larger companies. They are thus generally more vulnerable to economic downturns and may experience substantial variations in operating results.

Due Diligence Risks. Before making investments, the Manager conducts a limited amount of due diligence that it deems reasonable and appropriate based on the facts and circumstances applicable to each investment. When conducting due diligence and making an assessment regarding an investment, the Manager will be required to rely on resources available to it, including information provided by the target of the investment and, in some circumstances, third party investigations. The due diligence process may at times be subjective with respect to newly organized companies for which only limited information is available. Accordingly, there can be no assurance that the due diligence investigation that the Manager will carry out with respect to any investment opportunity will reveal or highlight all relevant facts that may be necessary or helpful in evaluating such investment opportunity. Further, there can be no assurance that such an investigation will result in an investment being successful.

Financial Market Risk. The ability of the Fund to provide an acceptable return may be adversely affected by economic factors to which the marketplace is subject. Additionally, market turmoil could have a deleterious effect on the Company’s investors which could impede the ability to provide capital to the Fund. This could impair the Fund’s ability to honor commitments to lend, pay expenses of the Fund, or repay the Fund’s loans. The volatility in the global financial markets, which reached unprecedented levels during 2008 and 2009, and continued for some period thereafter (albeit to a lesser extent), may recur in the future. This and other types of market turmoil could have a material adverse effect on the Fund’s business and operations. Tightening of the credit markets or prolonged higher interest rates could impair the Fund’s ability to either acquire or utilize leverage to maximize the return it achieves on investments. The Fund’s predecessors (Venture Lending & Leasing I, Inc., Venture Lending & Leasing II, Inc., Venture Lending & Leasing III, Inc., Venture Lending & Leasing IV, Inc., Venture Lending & Leasing VI, Inc., Venture Lending & Leasing VII, Inc., Venture Lending & Leasing VIII, Inc., and to a lesser extent, Venture Lending & Leasing V, Inc.), utilized leverage to increase returns to investors. If the Fund is unable to utilize leverage to the same extent as its predecessors, or unable to utilize leverage at all, there could be a material difference in the Fund’s return as compared to these funds.

It is possible that market conditions could decrease the demand for venture loans, especially where the U.S. and global economic conditions deteriorate and remain weak for an extended period of time. Furthermore, market conditions could also adversely impact either or both the ability of the Fund’s borrowers to meet their obligations to the Fund and the value of the Fund’s direct investments in companies. Most of the companies in which the Fund will invest will not have achieved profitability and will require substantial equity financing to satisfy their continuing growth and working capital requirements. An economic downturn could decrease the demand for such borrower’s products and technology, thereby impairing such borrower’s financial condition and its ability to raise additional equity financing from outside investors. Should these events occur, there could be an increase in borrower defaults under their obligations to the Fund, or a decrease in the value of the Fund’s direct equity investments.

Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and 2023 and the current anticipation is that the high rates will hold steady for the next quarter or two at a minimum. These developments, along with the U.S. government's credit and deficit concerns, any prolonged U.S. government shutdown, global economic uncertainties, global conflicts, and market volatility, could cause interest rates to be volatile, which may negatively impact the Fund's ability to access the debt markets and capital markets on favorable terms.

Other U.S. and Global Economic Risks. In addition to the crisis in the financial markets discussed above, the ability of the Fund to provide an acceptable return may be adversely affected by other economic and business factors to which the U.S. marketplace is subject. These factors, which generally are beyond the control of the Manager, include: general economic conditions, such as inflation and fluctuations in general business conditions; social and political circumstances in the U.S., such as ~~uncertainty~~the ~~related~~impact toof the new U.S. ~~elections;~~government administration, the impact of global conflict, such as the Russia-Ukraine war, ~~the Israel-Hamas war~~ and the ~~Houthi~~conflicts ~~attacks on marine vessels~~ in the ~~Red~~Middle ~~Sea~~East; the impact of terrorist attacks within or against the United States or other countries where investments are made; the effects of strikes, labor disputes and domestic and foreign political unrest; and uncertainty in the U.S. economy.

~~Inflation~~Uncertainty About Presidential Administration Initiatives. ~~Certain~~There ofis ~~the~~significant ~~Fund’s~~uncertainty ~~portfolio~~with ~~companies~~respect ~~are~~to inlegislation, ~~industries~~regulation ~~that~~and ~~may~~government bepolicy ~~impacted~~at bythe ~~inflation~~U.S. Iffederal ~~such~~level, ~~portfolio~~as ~~companies~~well ~~are~~as ~~unable~~the tostate ~~pass~~and ~~any~~local ~~increases~~levels. inRecent ~~their~~events, ~~costs~~including ofthe ~~operations~~2024 ~~along~~U.S. topresidential ~~their customers~~election, ithave ~~could~~created ~~adversely~~a ~~affect~~climate ~~their~~of ~~operating~~heightened ~~results~~uncertainty and ~~impact~~introduced ~~their~~new ~~ability~~and difficult-to-quantify ~~pay~~macroeconomic ~~interest~~ and ~~principal~~political onrisks ~~the~~with ~~Fund’s~~potentially ~~loans,~~far-reaching ~~particularly~~implications. inTo ~~light~~the ofextent ~~Federal~~the ~~Reserve~~U.S. ~~actions~~Congress inor ~~response~~the presidential administration implements changes to ~~inflation~~U. InS. ~~addition~~policy, ~~any~~those ~~projected~~changes ~~future~~may ~~decreases~~impact, inamong other things, the ~~Fund’s~~U.S. ~~portfolio~~and ~~companies’~~global ~~operating~~economy, ~~results~~international ~~due~~trade toand ~~inflation~~relations, ~~could~~unemployment, ~~adversely~~immigration, ~~impact~~corporate taxes, healthcare, the ~~fair~~U.S. ~~value~~regulatory ofenvironment, ~~those~~inflation ~~investments~~and other areas. ~~Any~~Although ~~decreases~~the inFund cannot predict the ~~fair~~impact, ~~value~~if any, of these changes to its business, they could adversely affect the Fund’s ~~investments~~business, ~~could~~financial ~~result~~condition, inoperating ~~future~~results ~~realized~~and orcash ~~unrealized~~flows. ~~losses~~Until the Fund knows what policy changes are made and ~~therefore~~how ~~reduce~~those changes impact its business and the business of its competitors over the long term, the Fund’s ~~net~~will ~~assets~~not ~~resulting~~know if, overall, it will benefit from ~~operations~~them or be negatively affected by them.

~~Changes to U~~Inflation.S. High ~~Trade~~rates ~~Policy~~of ~~May~~inflation ~~Have a Negative Effect on the Global Economy~~ and~~/or~~ ~~the~~rapid ~~Fund’s~~increases ~~Portfolio Companies and,~~ in ~~Turn, Harm~~ the ~~Fund. Significant~~rate ~~changes~~of toinflation ~~U.S.~~generally ~~trade~~have ~~policy,~~a ~~including~~negative ~~changes~~impact toon ~~current~~financial ~~legislation~~markets and ~~trade agreements and~~ the ~~imposition~~broader ~~of tariffs can result in extended “trade wars” between the U~~economy.S. ~~and~~In ~~its~~an ~~trading~~attempt ~~partners, resulting in additional barriers~~ to ~~the~~stabilize ~~international market~~inflation, ~~inclusive~~governments ofmay ~~customers,~~impose ~~vendors,~~wage and ~~potential~~price ~~investors. Under~~controls ~~these~~or ~~circumstances,~~otherwise ~~the~~intervene ~~cost of goods for some portfolio companies could increase, resulting~~ in ~~lower~~a ~~consumer~~country’s ~~demand for their goods and reduced cash flows~~economy. ~~While~~ itGovernmental isefforts ~~unknown whether and~~ to ~~what~~curb ~~extent~~inflation, ~~new~~including ~~legislation~~by ~~will~~increasing beinterest ~~enacted~~rates ~~into law, the enactment~~ or ~~amendment~~reducing offiscal ~~trade legislation and/~~or ~~renegotiation~~monetary ofstimuli, ~~trade~~often ~~agreements~~have ~~may~~negative ~~impose~~effects ~~additional compliance costs~~ on ~~portfolio~~the ~~companies,~~level ~~restrict~~of ~~their~~economic ~~ability to participate in international markets and otherwise disrupt their current operations~~activity.

Certain of the Fund’s portfolio companies are in industries that may be impacted by inflation. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on the Fund’s loans, particularly in light of Federal Reserve actions in response to inflation. In addition, any projected future decreases in the Fund’s portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of the Fund’s investments could result in future realized or unrealized losses and therefore reduce the Fund’s net assets resulting from operations.

Changes to U.S. Trade Policy May Have a Negative Effect on the Global Economy and/or the Fund’s Portfolio Companies and, in Turn, Harm the Fund. Significant changes to U.S. trade policy, including changes to current legislation and trade agreements, issuance of executive orders, and the imposition of tariffs can result in extended “trade wars” between the U.S. and its trading partners, resulting in additional barriers to the international market, inclusive of customers, vendors, and potential investors. Under these circumstances, the cost of goods for some portfolio companies could increase, resulting in lower consumer demand for their goods and reduced cash flows. While it is unknown whether and to what extent new legislation will be enacted into law, the enactment or amendment of trade legislation, issuance of executive orders, and/or renegotiation of trade agreements may impose additional compliance costs on portfolio companies, restrict their ability to participate in international markets and otherwise disrupt their current operations.

Special Risk Considerations Relating to China. The Fund may invest in portfolio companies that are based in China, have significant operations in China or are otherwise connected to China. Markets in China can be volatile due to uncertain social, economic, regulatory and political factors, in addition to the effects of public health crises. See the discussion herein under the caption “Climate Change, Natural Disaster, Public Health Crises and Other Catastrophes Risk.” The severity and duration of any adverse economic conditions may be driven by governmental or quasi-governmental policies; in particular, geopolitical risk and the imposition of sanctions by outside governments could severely disrupt the Chinese economy and the value of securities tied to it.

Speculative Nature of Warrants and Equity Investments. The value of the warrants that the Fund generally will receive and distribute to its shareholder in connection with its financing investments is dependent on the value of the equity securities for which the warrants can be exercised. The value of such warrants, direct equity investments, and equities received upon conversion of debt instruments is dependent primarily on the success of the company’s business strategy and the growth of its earnings, but also depends on general economic and equity market conditions. The prospects for achieving consistent profitability, in the case of many companies in which the Fund invests, are speculative. The warrants, equity securities for which the warrants can be exercised, direct equity investments, and equities received upon conversion of debt instruments generally will be restricted securities that cannot readily be sold for some period of time. If the value of the equity securities underlying a warrant does not increase above the exercise price during the life of the warrant, the Fund may permit the warrant to expire unexercised and the warrant would then have no value.

Illiquidity of Investments. Substantially all of the Fund’s portfolio investments (other than short-term investments) will consist of securities that, at the time of acquisition, are subject to restrictions on sale and for which no ready market will exist. Restricted securities cannot be sold publicly without prior agreement with the issuer to register the securities under the 1933 Act, or by selling such securities under Rule 144 or other provisions of the 1933 Act which permit only limited sales under specified conditions. Venture loans and equity investments are privately negotiated transactions, and there is no established trading market in which such loans and equity investments can be sold. Special Situation Financings may also be privately negotiated transactions. In the case of warrants or equity securities, the Fund generally will realize the value of such securities only if the issuer is able to make an initial public offering of its shares or enters into a business combination with another company which purchases the Fund’s warrants or equity securities or exchanges them for publicly-traded securities of the acquirer. The feasibility of such transactions depends upon the entity’s financial results as well as general economic and equity market conditions. In the past, crises in the financial markets have dramatically reduced the volume of initial public offerings and mergers and acquisitions in the marketplace. If such a crisis recurs, the Fund’s ability to realize liquidity through its investments would likely be impaired. Furthermore, even if the restricted warrants or equity securities owned become publicly-traded, the Fund’s ability to sell such securities may be limited by the lack (or limited nature) of a trading market for such securities. If the Fund holds material nonpublic information regarding the issuer of the securities, the Fund’s ability to sell such securities may also be limited by insider trading laws. When restricted securities are sold to the public, the Fund, under certain circumstances, may be deemed an “underwriter” or a controlling person with respect thereto for the purposes of the 1933 Act, and be subject to liabilities as such under that Act.

Because of the illiquidity of the Fund’s investments, most of its assets will be carried at fair value as determined by the Manager in accordance with the Fund’s policy, as approved by the Fund’s Board of Directors. This value will not necessarily reflect the amount ultimately realized upon a sale of the assets.

Non-Diversified Status. The Fund is classified as a “non-diversified” investment company under the 1940 Act, but the Fund may, from time to time, act as a diversified investment company within the meaning of Section 5(b)(1) of the 1940 Act. The Fund elected to be treated as a RIC under the Code and operates in a manner to qualify for the tax treatment applicable to RICs, including the diversification requirement. Nevertheless, the Fund’s assets may be subject to a greater risk of loss than if its investments were more widely diversified.

Proposed Tax Legislation Adversely Affecting the Managing Member and Affiliated Members. Congress has previously proposed legislation that would treat carried interest as ordinary income for U.S. federal income tax purposes beyond the current requirements of Section 1061 (treating a carried interest as ordinary income unless the underlying entity has held such investment for more than three (3) years). Enactment of such legislation could adversely affect the ~~Fund~~Company’s managing member (the “Managing Member”), affiliated members and others who benefit from carried interest, which could make it more difficult to incentivize, attract and retain individuals to perform services for the Company and the Fund. Any such developments could adversely affect the Fund’s ~~performance~~ investment returns allocable to the Members. It is unclear whether any proposed legislation, if enacted, would apply to the Managing Member or any affiliated members who benefit from carried interest.

Foreign Investment Review. Pursuant to Section 721 of the Defense Production Act of 1950, as amended (the “DPA”), the U.S. Government has the authority to restrict and prevent foreign acquisitions of and investments in U.S. companies (collectively, “Foreign Investments”) on national security grounds, actions that could adversely affect the Company’s and the Fund’s investment activities. The Committee on Foreign Investment in the United States (“CFIUS”), a U.S. Government interagency committee, conducts national security reviews of Foreign Investments and, in the interest of national security, may impose mitigation (i.e., restrictions) on such investments. CFIUS-imposed mitigation can take a variety of forms, including (i) restrictions on the foreign investor’s access to the U.S. company’s technology or facilities, (ii) restrictions on the foreign investor’s role in the governance or decision making of the U.S. company, (iii) mandatory divestiture of a foreign investor’s capital contribution and termination of its participation in the Company, (iv) mandatory U.S. Government approvals of changes to the U.S. company’s suppliers or the locations of its source code repositories, and (v) the appointment of a U.S. Government-approved monitor to verify the transaction parties’ compliance with the mitigation. The President of the United States (the “President”) may block a Foreign Investment that threatens to impair U.S. national security or order a foreign investor to divest of its Foreign Investment.

If the Fund has foreign investors, its investments are potentially subject to CFIUS review. In addition, foreign investors’ indirect investments in portfolio companies could subject such companies to CFIUS review. Finally, subsequent proposed financings, investments, acquisitions, or mergers or other transactions related to portfolio companies involving foreign persons also could be subject to CFIUS review.

Parties to transactions within CFIUS’s jurisdiction, potentially including the Company, the Fund and portfolio companies, may choose to submit a voluntary declaration or notice to CFIUS for its review. Rules implementing the Foreign Investment Risk Review Modernization Act (“FIRRMA”) of 2018 revised the CFIUS process to (i) expand CFIUS’s jurisdiction—notably to certain non-controlling investments in U.S. companies that are involved in critical technologies or critical infrastructure or that hold sensitive personal data of U.S. citizens—and (ii) mandate filings in certain instances. Specifically, mandatory filings may be required when a foreign investor acquires certain rights with respect to a U.S. business that deals in critical technology, or when a foreign government has a substantial interest in the foreign investor. Some of the Company’s and the Fund’s investments could fall within this expanded jurisdiction.

Due to these CFIUS considerations, the Company, the Fund and portfolio companies could incur increased costs, including legal fees, related to (i) evaluating whether a particular portfolio investment or other transaction related to a portfolio company requires the submission of a filing to CFIUS, (ii) evaluating whether the submission of a declaration or notice to CFIUS is warranted, (iii) drafting a filing and submitting it to CFIUS, (iv) undergoing a CFIUS review or investigation, (v) negotiating and implementing CFIUS-imposed mitigation, and (vi) complying with any Presidential order. Submission of a filing to CFIUS in connection with an investment or other transaction related to a portfolio company also could result in significant delays, as the CFIUS review and investigation process can last several months. CFIUS could condition its clearance of a Foreign Investment on adjustments to the terms of such Foreign Investment or other mitigation (including, if applicable, exclusion of a foreign investor of the Company from a Foreign Investment), and these conditions could adversely affect one or more portfolio companies and decrease the Company’s and the Fund’s return on its investment in any such portfolio company. In rare cases, the President could block a Foreign Investment or order the Company and the Fund to divest of a Foreign Investment. Finally, the Company and the Fund may choose not to make certain investments, or a portfolio company may choose not to solicit or pursue certain subsequent investments or other transactions, that are otherwise attractive based on an evaluation of the associated CFIUS risks.

to a portfolio company also could result in significant delays, as the CFIUS review and investigation process can last several months. CFIUS could condition its clearance of a Foreign Investment on adjustments to the terms of such Foreign Investment or other mitigation (including, if applicable, exclusion of a foreign investor of the Company from a Foreign Investment), and these conditions could adversely affect one or more portfolio companies and decrease the Company’s and the Fund’s return on its investment in any such portfolio company. In rare cases, the President could block a Foreign Investment or order the Company and the Fund to divest of a Foreign Investment. Finally, the Company and the Fund may choose not to make certain investments, or a portfolio company may choose not to solicit or pursue certain subsequent investments or other transactions, that are otherwise attractive based on an evaluation of the associated CFIUS risks.

CONFLICTS OF INTEREST

Transactions with Venture Lending & Leasing VIII, Inc. (“Fund VIII”). The Manager also served as the investment manager for Fund VIII. The Fund’s Board of Directors determined that so long as Fund VIII had capital available to invest in loan transactions with final maturities earlier than December 31, 2025, the Fund was able to invest in each portfolio company in which Fund VIII invested. Generally, the amount of each investment was allocated 50% to the Fund and 50% to Fund VIII, or such other allocations as determined by the respective funds' board of directors, so long as the Fund had capital available to invest. The Fund co-invested with Fund VIII through March 31, 2021, which was the end of Fund VIII's investment period. Fund VIII was deregistered as a BDC with the SEC on October 12, 2023 and distributed all of its remaining assets to its parent, Venture Lending & Leasing VIII, LLC during the year ended December 31, 2023.

Transactions with Fund X. The Manager also serves as the investment manager for Fund X. The Fund’s Board of Directors determined that so long as Fund X had capital available to invest in loan transactions with final maturities earlier than December 31, 2028 (the date on which the Fund's term of existence automatically expires), the Fund was able to invest in each portfolio company in which Fund X invested. Generally, the amount of each investment was allocated 50% to the Fund and 50% to Fund X, or such other allocations as determined by the respective funds' board of directors, so long as the Fund had capital available to invest. The Fund co-invested with Fund X through December 31, 2023, which was the end of the Fund’s investment period.

The ability of the Fund to co-invest with Fund VIII, Fund X, and other clients advised by the Manager, was subject to the conditions (“Conditions”) with which the funds were complying while seeking certain exemptive relief from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. To the extent that clients, other than Fund VIII and Fund X, advised by the Manager (but in which the Manager had no proprietary interest) invested in opportunities available to the Fund, the Manager allocated such opportunities among the ~~funds~~Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.

Intercreditor Agreements. In all transactions in which the Fund and other funds managed by the Manager invest or those in which another lender(s) has either invested or may later invest (or in the event a successor fund is raised, in which the Fund and the successor fund invest), it is expected that the Fund and other funds managed by the Manager (or the successor fund as the case may be), and/or the other lender(s) will enter into an intercreditor agreement pursuant to which the Fund and other funds managed by the Manager (or the successor fund), and/or the other lender(s), along with any predecessor funds which still have a balance outstanding, will cooperate in pursuing their remedies following a default by the common borrower. Generally, under such intercreditor agreements, each party would agree that its security interest would be treated in parity with the security interest of the other party, regardless of which security interest would have priority under applicable law. Accordingly, proceeds realized from the sale of any collateral or the exercise of any other creditor’s rights will be allocated between the Fund and other funds managed by the Manager, and any predecessor funds as described above, pro rata in accordance with the amounts of their respective investments. An exception to the foregoing arrangement would occur in situations where, for example, one of the lenders financed specific items of equipment collateral; in that case, usually the lender who financed the specific assets will have a senior lien on that asset, and the other lenders will have a junior priority lien (even though they may ratably share liens of equal priority on other assets of the common borrower). As a result of such intercreditor agreements, the Fund may have less flexibility in pursuing its remedies following a default than it would have had had there been no intercreditor agreement, and the Fund may realize fewer proceeds. In addition, because the Fund and other funds managed by the Manager (or the successor fund) invest at the same time in the same borrower, such borrower would be required to service two loans rather than one. Any additional administrative costs or burdens resulting therefrom may make the Fund a less attractive lender and may make it more difficult for the Fund to acquire such loans. 17

Intercreditor Agreements. In all transactions in which the Fund and other funds managed by the Manager invest or those in which another lender(s) has either invested or may later invest (or in the event a successor fund is raised, in which the Fund and the successor fund invest), it is expected that the Fund and other funds managed by the Manager (or the successor fund as the case may be), and/or the other lender(s) will enter into an intercreditor agreement pursuant to which the Fund and other funds managed by the Manager (or the successor fund), and/or the other lender(s), along with any predecessor funds which still have a balance outstanding, will cooperate in pursuing their remedies following a default by the common borrower. Generally, under such intercreditor agreements, each party would agree that its security interest would be treated in parity with the security interest of the other party, regardless of which security interest would have priority under applicable law. Accordingly, proceeds realized from the sale of any collateral or the exercise of any other creditor’s rights will be allocated between the Fund and other funds managed by the Manager, and any predecessor funds as described above, pro rata in accordance with the amounts of their respective investments. An exception to the foregoing arrangement would occur in situations where, for example, one of the lenders financed specific items of equipment collateral; in that case, usually the lender who financed the specific assets will have a senior lien on that asset, and the other lenders will have a junior priority lien (even though they may ratably share liens of equal priority on other assets of the common borrower). As a result of such intercreditor agreements, the Fund may have less flexibility in pursuing its remedies following a default than it would have had had there been no intercreditor agreement, and the Fund may therefore realize fewer proceeds. In addition, because the Fund and other funds managed by the Manager (or the successor fund) invest at the same time in the same borrower, such borrower would be required to service two loans rather than one. Any additional administrative costs or burdens resulting therefrom may make the Fund a less attractive lender and may make it more difficult for the Fund to acquire such loans.

Valuation. The Manager is responsible for valuing the Fund’s assets and liabilities, subject to oversight by the Fund’s Board of Directors, and has an inherent conflict in performing this function such that it has an incentive to increase the value of the assets for its performance record. In accordance with Rule 2a-5 under the 1940 Act, the Manager has been designated as the valuation designee within the meaning of the rule. The rule requires the Manager to periodically assess any material risks associated with the determination of the fair value of the Fund’s assets (“valuation risks”), including material conflicts of interest, and managing those identified valuation risks. The Fund does not intend to engage an independent valuation agent to value its assets and therefore is entirely reliant upon the Manager and its delegates for valuing the assets.

Indemnification and Exculpation. The organizational documents of the Fund provide for indemnification of directors, officers, employees, advisory board members and agents (including the Manager) of the Fund, generally to the full extent permitted by applicable state law and the 1940 Act, including the advance of expenses and reasonable counsel fees. The charter of the Fund also contains a provision eliminating personal liability of a Fund director or officer to the Fund or its stockholder for money damages, subject to specified exceptions. In addition, the Fund has entered into indemnification agreements with its directors and officers. A successful claim for such indemnification, including payment of any expenses and counsel fees, would reduce the Fund’s assets by the amounts paid. Furthermore, Fund assets are used to obtain insurance policies that generally protect the Fund’s directors and officers from personal liability of actions taken in their roles as the Fund’s directors and officers.

Disinterested Directors and Advisory Board Members. The members of the Fund’s Board of Directors will overlap with the members of the Company’s advisory board, and the members of the Company’s advisory board are generally the same as, or a subset of, the disinterested directors of the Fund. Although the Manager expects that, given the Company’s 100% ownership of the Fund, the interests of the two entities will not diverge, it is conceivable that a conflict of interest could exist between the Fund and the Company. In addition, as compensation for their services, the disinterested directors will receive an annual fee of $40,000 (plus $1,000 per meeting attended in person and an additional $15,000 for the chair of the Audit Committee). Any future changes to the compensation to be paid to the disinterested directors will be determined by the Nominating Committee of the Fund’s Board of Directors. Upon the liquidation of the Fund, the disinterested advisory board members will receive an annual fee in an amount determined by the Member (it is currently anticipated that such annual amount shall be $25,000). The disinterested directors and advisory board members will also be reimbursed for certain expenses. While courts have generally held that the receipt of reasonable and customary directors’ fees and benefits does not alter the status of a director as disinterested, the payment of such fees may impact the objectivity of the disinterested directors and the advisory board members on behalf of the members.

Personal Trading. The Manager has a code of ethics that contains personal securities trading procedures that apply to its “access persons.” Access persons are required to report if they have an investment in a company in which the Fund is considering making an investment. Pre-approval is required before an access person may buy or sell securities in an initial public offering, private placement, or any security listed on a “restricted list” maintained by the Manager.

Interests in Potential Portfolio Companies. The Manager may recommend that the Fund invest in companies in which a principal or employee has a prior personal investment or for which a principal or employee may serve as a director or advisor. The Manager also may recommend that the Fund invest in companies in which venture capital funds, private equity funds or other institutional investors (“Unaffiliated Funds”) also have made investments, where one or more principals or employees of the Manager may have made an investment in, or served as an advisor to, an investing Unaffiliated Fund. Such a relationship presents potential conflicts of interest in that the relationship could provide the principal or employee with an incentive to influence the Manager’s decision to recommend an investment in the company in question. There is also a potential conflict of interest in that such principal or employee could use information acquired through association with the Manager to influence or benefit Unaffiliated Funds’ investment decisions. The Manager addresses these potential conflicts through its policies and procedures that are designed to insulate its investment decision-making process and its research from these incentives. For example, the policies require that principals with a prior direct investment in a company be recused from the investment decision-making process with respect to that company.

Principals that serve as advisors to Unaffiliated Funds may make investment recommendations to these Unaffiliated Funds, which may be the same investment that the Fund has made or may make. The Manager’s policies and procedures require such principals to arrange for any such investment opportunity to be first offered to the Fund (or a predecessor fund) and for such investment opportunity to only subsequently be offered to an Unaffiliated Fund once declined by the Fund (or a predecessor fund).

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 1C. CYBERSECURITY

Through its Manager, the Fund maintains a cybersecurity risk management program designed to identify, assess, manage, and mitigate threats, as well as respond to and recover from cybersecurity incidents. This program is coupled with an enterprise risk management program and covers the Fund’s key information systems.

The cybersecurity risk management program includes a comprehensive risk assessment that is applicable to the Fund’s operations. This assessment is based on recognized standards for cybersecurity and information technology as set forth in the National Institute of Standards and Technology (“NIST”) Cybersecurity Framework (“CSF”). It is reviewed and updated at least annually. Internal controls designed to mitigate risks presented in the assessment are tested annually by an independent third party. Additionally, the Manager, on behalf of the Fund, contracts with a qualified third party to perform annual assessments of the Company’s cybersecurity risk management program and to perform cybersecurity risk evaluations of selected key vendors. Another third party is engaged to provide day to day IT services which include implementing, monitoring, and maintaining the preventative and detective measures specified as part of the Fund’s cybersecurity risk management program.

The Manager’s Chief Compliance Officer led the development and oversees the implementation of the cybersecurity program, and is the head of the Manager’s cybersecurity team, supported by the Director of Compliance. The Chief Compliance Officer is responsible for assessing and managing the Manager’s cyber risk management program, informs senior management regarding the prevention, detection, mitigation, and remediation of cybersecurity incidents and supervises such efforts. The cybersecurity team, inclusive of all third parties engaged to provide operations, monitoring, detection, and remediation, has extensive experience selecting, deploying, and operating cybersecurity technologies, initiatives, and processes.

The Audit Committee of the Board of Directors oversees the Fund’s cybersecurity risk exposures and the steps taken by management to monitor and mitigate identified risks. The Chief Compliance Officer briefs the Audit Committee on the effectiveness of the cyber risk management program at least on a quarterly basis. In addition, cybersecurity risks and cyber incidents, if any, are reviewed by the Fund’s Board of Directors at least annually as part of the risk mapping exercise, or as warranted in the event of material incidents.

The Fund faces risks from cybersecurity threats that could have a material adverse effect on its business, financial condition, results of operations, cash flows or reputation. See “Risk Factors – Risks Related to Cybersecurity"” for further information on how our operations are subject to cyber incidents that could have a material adverse effect on our business, financial condition, results of operations, or cash flows.

ITEM 2. PROPERTIES

All of the Fund’s office space is provided by the Manager. The executive offices are located at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028.

ITEM 3. LEGAL PROCEEDINGS

The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund's financial condition or results of operation. Management is not aware of any pending legal proceedings involving the Fund. The Fund is not currently a party to any material legal proceedings.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II.

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER

PURCHASES OF EQUITY SECURITIES

The Fund’s common stock is not listed on any securities exchange, and all holders of the Fund’s common stock are subject to agreements significantly restricting the transferability of their shares.

The number of holders of record of the Fund’s common stock at March 1517, ~~2024~~2025 was 1.

The Fund has a policy of distributing securities as acquired. The Fund values these securities at fair value at the time of acquisition in accordance with the Fund’s policy on valuation detailed in Note 2 to the financial statements included in this filing. In addition, some expenses of the Company may be paid by the Fund and will be deemed as distributions to the Company. The Fund has established a policy of declaring dividends on a quarterly basis to the extent that taxable income of the Fund, less applicable reserves, exceeds warrant distributions and deemed distributions. As of December 31, ~~2023~~2024, the Fund had distributed $~~395~~468.82 million to date to its sole shareholder, of which $~~301~~363.0 million was in cash.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

The following discussion should be read in connection with our Financial Statements and the notes thereto included elsewhere in this Annual Report on Form 10-K.

In addition to the historical information contained herein, the information in this Annual Report on Form 10-K contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this Annual Report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. When used in this report, the words “will,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise, except as required by law.

The reader of this Annual Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors including those set forth in Item 1A - “Risk Factors” in this Annual Report on Form 10-K. This entire Annual Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.

Overview

The Fund is 100% owned by the Company. The Fund’s shares of common stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.

The Fund provides financing and advisory services to a variety of carefully selected Venture-Backed Companies primarily throughout the United States, with a focus on growth-oriented companies. The Fund’s portfolio consists of companies in the communications, information services, media, technology (including software and technology-enabled business services), biotechnology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. On May 1, 2018, the Company called and received its first capital from investors. On May 2, 2018, the Fund made its first investment and became a non-diversified, closed-end investment company under the 1940 Act. While the Fund intends to operate as a non-diversified investment company within the meaning of Section 5(b)(2) of the 1940 Act, from time to time the Fund may act as a diversified investment company within the meaning of Section 5(b)(1) of the 1940 Act.

The Fund elected to be treated as a RIC under the Code for federal income tax purposes. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes if a sufficient amount of income is distributed to its shareholder as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.

The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the members of the Company) and all distributions out of its earnings and profits will be taxable to the members of the Company as taxable income; thus, such income will be subject to a double layer of ~~tax~~taxation. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.

The Fund’s investment objective is to achieve superior risk-adjusted investment returns and it seeks to achieve that objective by providing debt financing to portfolio companies, most of which are private debt securities. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets that are invested in different types of assets.

The portfolio investments of the Fund primarily consist of debt financing to Venture-Backed Companies in the technology sector. The borrower’s ability to repay its loans may be adversely impacted by several factors, and as a result, the loan may not be fully repaid. Furthermore, the Fund’s security interest in any collateral over the borrower’s assets may be insufficient to make up any shortfall in payments. Some of our portfolio companies may be impacted by rising inflation, which could have a material impact on their results of operations, specifically ~~cost~~costs and revenues. As such, rising inflation may have an adverse impact on the portfolio borrowers’ ability to maintain their good credit standing, as well as their ability to pay their interest and principal obligations to the Fund. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future unrealized losses and therefore reduce our net assets resulting from operations.

The ~~Impact~~Fund ofoperates ~~the~~through ~~Ukraine~~a ~~War,~~single ~~the~~operating ~~Israel~~and -reportable ~~Hamas~~segment ~~War~~for financial reporting purposes, ~~Worldwide~~consistent ~~Inflation~~with ~~and~~how ~~Rising~~the ~~Interest~~officers ~~Rates~~of onthe ~~Results~~Fund (inclusive of ~~Operations~~the Chief Executive Officer and ~~Liquidity~~Chief &Financial ~~Capital~~Officer, ~~Resources~~among others), who are the Fund's CODM, evaluate financial performance and allocate resources.

~~Global~~The ~~and~~Impact ~~domestic financial markets have experienced an increase in volatility as concerns about the impact~~ of ~~higher inflation, rising interest rates, a potential recession,~~ the ~~current conflicts in~~ Ukraine ~~and~~War, ~~Israel~~Conflicts ~~and the outbreak of other hostilities or conflict (such as the Houthi attacks on marine vessels~~ in the ~~Red~~Middle ~~Sea)~~East, ~~have~~Worldwide ~~weighed~~Inflation, onInterest ~~market~~Rate ~~participants.~~Volatility ~~These factors have created disruptions in supply chains~~ and ~~economic~~Natural ~~activity~~Disasters ~~and have had a particularly adverse impact~~ on ~~certain~~Results ~~industries. These uncertainties can ultimately impact the overall supply and demand~~ of ~~the~~Operations ~~market through changing spreads, deal terms~~ and ~~structures. The~~Liquidity ~~Fund~~& isCapital ~~unable~~Resources ~~to predict the full impact of these macroeconomic events on the Fund's liquidity and capital resources.~~

Global and domestic financial markets have experienced an increase in volatility as concerns about the impact of higher inflation, interest rate volatility, a potential slowdown in economic activity, the conflicts in the Middle East, the Ukraine War, and the outbreak of other hostilities or conflict (such as the Houthi attacks on marine vessels in and around the Red Sea), the impact of the new U.S. government administration and extreme weather patterns or natural disasters (such as the 2025 Southern California wildfires) have weighed on market participants. These factors have created disruptions in supply chains and economic activity and have had a particularly adverse impact on certain industries. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures. The Fund is unable to predict the full impact of these macroeconomic events on the Fund's liquidity and capital resources.

The Fund is continuing to maintain close communications with its loan portfolio companies to proactively assess and manage potential risks. In addition, Management is continuing to maintain oversight analysis of credits across the Fund's loan investment portfolio in an attempt to manage the potential credit risk and improve loan performance. Certain loans may have inherent increased credit risk due to the nature of the underlying business and its ability to maintain operations in the current economic environment.

Management is also monitoring the Fund’s continued access to capital resources through periodic and timely communication with the bank syndicate and the Company’s members. In addition, the Fund will take proactive steps to ensure and maintain an appropriate liquidity position based on its circumstances. The Fund believes its existing cash balance, scheduled monthly payments from borrowers, and access to capital from its debt facility and the Company’s members will be sufficient to satisfy its working capital needs, debt repayments, and other liquidity requirements associated with its existing operations.

Critical Accounting Policies, Practices and Estimates

Critical Accounting Policies and Practices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates on net assets or operating performance is material.

In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments along with the completeness of loans exhibiting indicators of potential credit deterioration as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with U.S. GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no readily available market price or secondary market for the loans made by the Fund to borrowers, hence the Manager determines fair value based on a hypothetical market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value. In particular, the Manager has identified the fair value of the Fund’s loan investments that exhibit indicators of the potential for credit deterioration and the completeness of those loan investments, as a critical accounting matter that may involve significant and material estimates and inputs from the Manager in determining the fair value of those loan investments.

~~Critical~~In ~~judgments~~evaluating ~~and~~the ~~inputs~~most incritical ~~determining~~accounting ~~the~~policies ~~fair~~and ~~value~~estimates, ofthe aManager ~~loan~~has ~~include~~identified the ~~estimated~~estimation ~~timing~~of ~~and~~fair ~~amount~~value of ~~future~~the ~~cash~~Fund’s ~~flows~~loan ~~and~~investments ~~probability~~along ofwith ~~future payments, based on~~ the ~~assessment~~completeness of ~~payment~~loans ~~history,~~exhibiting ~~available~~indicators ~~cash~~of ~~and~~potential ~~“burn~~credit ~~rate,”~~deterioration ~~revenues,~~as ~~net~~the ~~income~~most orcritical ~~loss,~~of ~~operating~~the ~~results,~~accounting ~~financial~~policies ~~strength~~and ofaccounting ~~borrower,~~estimates ~~prospects~~applied ~~for~~to the ~~borrower~~Fund’s ~~raising~~reporting ~~future~~of ~~equity~~net ~~rounds,~~assets ~~likelihood~~or ofoperating ~~sale~~performance. orIn ~~acquisition~~accordance ofwith ~~the~~U.S. ~~borrower~~GAAP, ~~length~~the ofFund ~~expected~~defines ~~holding~~fair ~~period~~value ofas the ~~loan,~~price ~~collateral~~that ~~position,~~would ~~the~~be ~~timing~~received ~~and~~to ~~amount~~sell ofan ~~liquidation~~asset ofor ~~collateral~~paid ~~for~~to ~~loans~~transfer ~~that~~a ~~are~~liability ~~experiencing~~in ~~significant~~an ~~credit~~orderly ~~deterioration~~transaction ~~and,~~between asmarket aparticipants ~~result,~~at ~~collection~~the ~~becomes~~measurement ~~collateral-dependent~~date; that is, asan ~~well~~exit asprice. anThe ~~evaluation~~exit ofprice assumes the ~~general~~asset ~~interest~~or ~~rate~~liability ~~environment. Management~~was ~~has~~exchanged ~~evaluated~~in ~~these~~an ~~factors~~orderly ~~and~~transaction; ~~has~~it ~~concluded~~was ~~that~~not ~~the~~a ~~effect~~forced ofliquidation aor ~~deterioration~~distressed insale. ~~the~~There ~~quality~~is ofno ~~the~~readily ~~underlying~~available ~~collateral,~~market ~~increase~~price inor ~~the~~secondary ~~size~~market offor the ~~loan,~~loans ~~increase~~made inby the ~~estimated~~Fund ~~time~~ to ~~recovery~~borrowers, ~~and~~hence ~~increase~~the inManager ~~the~~determines ~~hypothetical~~fair ~~market~~value ~~coupon~~based ~~rate~~on a transaction that would ~~have~~occur in the ~~effect~~most ofadvantageous ~~decreasing~~market and the ~~fair~~estimates ~~value~~are subject to high levels of ~~loan~~judgment ~~investments~~and uncertainty. The ~~risk~~Fund’s ~~profile~~loan ofinvestments aare ~~loan~~considered ~~changes~~Level ~~when~~3 ~~events~~fair ~~occur~~value ~~that~~measurements ~~impact~~in the ~~credit~~fair ~~analysis~~value ofhierarchy due to the ~~borrower~~lack ~~and~~of observability over many of the ~~loan. Such~~important ~~changes~~inputs ~~result~~used in ~~the~~determining fair value. In ~~being~~particular, ~~adjusted~~the ~~from~~Manager ~~par~~has identified the fair value of the ~~individual~~Fund’s loan~~. Where~~ investments that exhibit indicators of the ~~risk~~potential ~~profile~~for iscredit ~~consistent~~deterioration ~~with~~and the ~~original~~completeness ~~underwriting~~of those loan investments, ~~the~~as ~~par~~a ~~value~~critical ofaccounting matter that may involve significant and material estimates and inputs from the ~~loan~~Manager ~~often~~in ~~approximates~~determining the fair value of those loan investments.

Critical judgments and inputs in determining the fair value of a loan include the estimated timing and amount of future cash flows and probability of future payments, based on the assessment of payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and, as a result, collection becomes collateral-dependent, as well as an evaluation of the general interest rate environment. Management has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the market coupon rate would each have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the cost basis of substantially all loans approximates fair value.

The actual value of the loans may differ from Management’s estimates, which would affect net change in net assets resulting from operations as well as assets.

Results of Operations - For the Years Ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

For the most recent discussion on the results of operations for the year ending December 31, ~~2021~~2022, refer to the management discussion and analysis on the prior period annual report, Form 10-K, filed on March 15, ~~2023~~2024.

Analysis of Interest Income

Total investment income for the years ended December 31, ~~2023~~2024 and ~~2022~~2023 was $6832.30 million and $8468.03 million, respectively. Investment income primarily consisted of interest on the venture loans outstanding and early payoffs. The remaining income consisted of interest and dividends on the temporary investment of cash and other income from commitment fees and warrants.

Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the year.

Warrants and equity securities received in connection with loan transactions are considered to be free standing contracts that are both legally detachable and separately exercisable from the related loan transactions and are measured at fair value at the time of acquisition; the non-cash portion of interest income represents the accretion of the discount of these warrants over the life of the loan.

The following table shows the average outstanding balance, interest income, and weighted average interest rate for the cash and non-cash portion of interest income for the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

	For the Year Ended December 31, 2023						For the Year Ended December 31, 2022
	For the Year Ended December 31, 2024						For the Year Ended December 31, 2023
	Average Outstanding Balance		Interest Income		Weighted Average Interest Rate - Cash Portion	Weighted Average Interest Rate - Non-Cash Portion	Average Outstanding Balance		Interest Income		Weighted Average Interest Rate - Cash Portion	Weighted Average Interest Rate - Non-Cash Portion
Performing Loans	$	~~374~~176,~~743~~804,~~563~~278	$	6630,~~079~~710,~~971~~220	14.1307%	3.5130%	$	~~478~~374,~~831~~743,~~623~~563	$	8066,~~313~~079,~~480~~971	1314.2113%	3.5751%
All Loans	$	~~402~~216,~~980~~401,~~480~~353	$	6631,~~204~~115,~~909~~312	1311.1768%	32.2670%	$	~~490~~402,~~007~~980,~~676~~480	$	8266,~~096~~204,~~477~~909	13.2717%	3.4826%

Interest income for both performing loans and all loans decreased by $1435.24 million and $1535.91 million, or 1753.75% and 1953.40%, respectively, for the year ended December 31, ~~2023~~2024 compared to the same period in ~~2022~~2023. The decrease is primarily due to decrease in the loan investment portfolio. The average outstanding balance for performing loans and all loans decreased by $~~104~~197.19 million and $87186.06 million, or 2152.78% and 1746.83%, respectively, for the year ended December 31, ~~2023~~2024 compared to the same period in ~~2022~~2023.

Analysis of Interest Expense

Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused credit line fees, and amounts amortized from deferred fees incurred in conjunction with the debt facility.

The following table shows the average outstanding balance, interest expense, and weighted average interest rate for the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

For the Year Ended December 31, 2023

For the Year Ended December 31, 2022

For the Year Ended December 31, 2024

For the Year Ended December 31, 2023

Average Balance

Interest Expense

Weighted Average Interest Expense Rate

Average Balance

Interest Expense

Weighted Average Interest Expense Rate

Bank Facility

~~198~~84,~~192~~153,~~308~~846

167,~~950~~588,~~891~~450

89.5502%

~~264~~198,~~153~~192,~~846~~308

1216,~~449~~950,~~209~~891

48.7155%

Interest expense ~~increased~~decreased by $49.54 million, or 3655.2%, for the year ended December 31, ~~2023~~2024 compared to the same period in ~~2022~~2023. The ~~increase~~decrease is primarily due to athe ~~higher~~decrease ~~weighted~~in the borrowings under the debt facility. The average ~~interest~~outstanding ~~rate~~balance for borrowings under the facility decreased by $114.0 million, or 57.5%, for the year ended December 31, 2024 compared to the same period in 2023.

22The Fund also used derivative instruments to manage its exposure to interest rates on its borrowings under the debt facility. The Fund terminated all of its derivative contracts on December 18, 2024.

The Fund also uses derivative instruments to manage its exposure to interest rates on its borrowings under the debt facility. See the discussion herein under the caption “Quantitative and Qualitative Disclosures About Market Risk” for the approximate annualized effect of hypothetical interest rate changes in components of net assets resulting from operations.

Analysis of Operating Expense

The following table shows the components of operating expense for the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

Operating Expense	For the Year Ended December 31, ~~2023~~2024		For the Year Ended December 31, ~~2022~~2023		Change ($)
Management fees	$	43,~~945~~450,000	$	64,~~325~~945,000	$	(1,~~380~~495,000)
Banking and professional fees	$	~~500~~608,~~508~~771	$	~~605~~500,~~195~~508	$	~~(104~~108,~~687)~~263
Other operating expenses	$	~~208~~371,~~041~~373	$	~~189~~208,~~809~~041	$	18163,~~232~~332
Total Operating Expense	$	54,~~653~~430,~~549~~144	$	75,~~120~~653,~~004~~549	$	(1,~~466~~223,~~455~~405)

For the period from January 1, ~~2023~~2024 through June 30, ~~2023~~2024, Management Fees were calculated at 10.2590% of the Company's committed capital and for the period from July 1, ~~2023~~2024 through December 31, ~~2023~~2024, Management Fees were calculated at 0.9060% of the Company's committed capital. For the period from January 1, ~~2022~~2023 through June 30, ~~2022~~2023, Management Fees were calculated at 1.5025% of the Company's committed capital and for the period from July 1, ~~2022~~2023 through December 31, ~~2022~~2023, Management Fees were calculated at 10.2590% of the Company's committed capital.

Banking and professional fees ~~decreased~~increased by $0.1 million or 1721.36% for the year ended December 31, ~~2023~~2024 compared to the same period in ~~2022~~2023. ~~Decrease~~The increase in banking and professional fees were primarily due to ~~lower~~higher legal fees associated with non-performing loans and reversal of litigation reserves during the year ended December 31, 2023.

Other operating expenses ~~did~~increased ~~not~~by ~~materially~~$0.2 ~~increase~~million, or 78.5% for the year ended December 31, ~~2023~~2024 compared to the same period in ~~2022~~2023. ~~These~~The increase is primarily due to annual conference expense incurred during the period ended December 31, 2024. Other expenses included director fees, custody fees, tax fees and other expenses related to the operations of the Fund.

Non-recurring fees

The Fund may receive non-recurring fees in connection with the origination and servicing of portfolio loans. Transactions in this category may include forfeited commitment fees and deferred income from warrants received that become recognized as other income after the loan commitment period expires. Other non-recurring fees include pre-payment fees which are recognized as other income in the period received. Legal fee reimbursements for deal due diligence and drafting of documents are recognized as offsets against legal expenses. Non-recurring fees for the years ended December 31, ~~2023~~2024 and ~~2022~~2023 totaled $10.13 million and $21.81 million, respectively.

Net Investment Income

Net investment income for the years ended December 31, ~~2023~~2024 and ~~2022~~2023 was $4520.70 million and $6445.47 million, respectively.

Realized and Change in Unrealized Gains (Losses)

Net realized loss from loans was $621.17 million and $36.41 million for the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively. Realized losses consisted of loans that were written off.

Net realized gain from derivative instruments was $8.9 million and $1.9 million for the years ended December 31, 2023 and 2022, respectively. Realized gains were the result of interest being received by the Fund on the derivative instruments when the cap rates of the interest rate collars were lower than the floating rate. Realized gains for the years ended December 31, 2023 and 2022 also include proceeds from termination of collar contracts with Zions Bancorporation, N.A. and MUFG Union Bank, N.A.

Net change in unrealized loss from loans was $15.6 million and $14.4 million for the years ended December 31, 2023 and 2022, respectively. The net change in unrealized loss from loans consisted of fair value adjustments to the loans resulting from the improvement or deterioration in certain portfolio companies’ performance.

Net change in unrealized gain (loss) from derivative instruments was $(7.6) million and $9.8 million for the years ended December 31, 2023 and 2022, respectively. The net change in unrealized loss from derivative instruments for the year ended December 31, 2023 is primarily due to the realization of prior year unrealized gains, including gains from the termination of collar contracts with Zion Bancorporation, N.A. during the year. The net change in unrealized gain from derivative instruments for the year ended December 31, 2022 consisted of fair market value adjustments to the derivative instruments and is a reflection of the market’s outlook on the economy and the future of interest rate changes.

Net increase in net assets resulting from operations for the years ended December 31, 2023 and 2022 was $25.4 million and $58.4 million, respectively. On a per share basis, the net increase in net assets resulting from operations for the years ended December 31, 2023 and 2022 was $253.61 and $583.68, respectively.

~~Liquidity~~Net realized gain from derivative instruments was $3.5 million and ~~Capital~~$8.9 ~~Resources~~million –for the years ended December 31, ~~2023~~2024 and 2023, respectively. Realized gains were the result of interest being received by the Fund on the derivative instruments when the cap rates of the interest rate collars were lower than the floating rate. Realized gains for the years ended December 31, ~~2022~~2024 and 2023 also include proceeds from termination of collar contracts with Zions Bancorporation, N.A.

~~The~~Net ~~Fund~~change isin ~~owned~~unrealized ~~entirely~~gain by(loss) ~~the~~from ~~Company. The~~loans ~~Company~~was ~~may make further contributions to the capital of the Fund to the extent of the Company’s members’ capital commitment to the Company and excess cash balances of the Company~~$4.4 Asmillion ~~of both December 31, 2023~~ and ~~December 31, 2022, the Company's subscriptions for capital in the amount of~~ $~~460~~(15.06) million ~~had~~for ~~been fully called and received. Total capital contributed to~~ the ~~Fund~~years ~~was~~ended ~~$407.1 million as of~~ December 31, ~~2023~~2024 and ~~December 31~~2023, ~~2022~~respectively. The ~~Company~~net ~~has~~change ~~made~~in ~~$46.0~~unrealized ~~million~~gain in(loss) ~~recallable~~from ~~distributions~~loans toconsisted ~~its~~of ~~investors,~~fair asvalue ~~permitted~~adjustments ~~under~~to ~~its~~the ~~operating~~loans ~~agreement~~resulting ~~between~~from the ~~Company’s~~improvement ~~managing~~or ~~member~~deterioration ~~and~~in ~~members~~certain ofportfolio ~~the~~companies’ ~~Company~~performance.

~~The~~Net ~~changes~~change in ~~cash~~unrealized loss from derivative instruments was $3.0 million and $7.6 million for the years ended December 31, 2024 and 2023, respectively. The net change in unrealized loss from derivative instruments for the years ended December 31, 2024 and ~~2022~~2023 ~~were~~is asprimarily ~~follows:~~due to the realization of prior year unrealized gains, including gains from the termination of collar contracts with Zion Bancorporation, N.A. during those years. The net change in unrealized gain from derivative instruments consisted of fair market value adjustments to the derivative instruments and is a reflection of the market’s outlook on the economy and the future of interest rate changes.

	For the Year Ended December 31, 2023		For the Year Ended December 31, 2022
Net cash provided by operating activities	$	209,392,303	$	18,120,417
Net cash used in financing activities	(194,949,552)		(17,984,886)
Net increase in cash and cash equivalents	$	14,442,751	$	135,531

Net increase in net assets resulting from operations for the years ended December 31, 2024 and 2023 was $3.1 million and $25.4 million, respectively. On a per share basis, the net increase in net assets resulting from operations for the years ended December 31, 2024 and 2023 was $30.93 and $253.61, respectively.

AsLiquidity ofand Capital Resources – December 31, ~~2023~~2024 and December 31, ~~2022,~~2023 ~~11.40% and 2.64%, respectively, of the Fund’s net assets consisted of cash and cash equivalents.~~

OnThe ~~December 20, 2018, the~~ Fund ~~entered~~is ~~into~~owned aentirely ~~syndicated loan agreement led~~ by ~~MUFG~~the ~~Union Bank, N~~Company.~~A.,~~ The ~~Wells~~Company ~~Fargo~~may ~~Securities,~~make ~~LLC~~further ~~and~~contributions ING Capital LLC, with participation from Zions Bancorporation, N.A., doing business as California Bank & Trust, Bank Leumi USA, Umpqua Bank, HSBC Bank USA, N.A., and First Bank that established a secured revolving loan facility in an initial amount of up to ~~$200.0 million with~~ the ~~option~~capital toof ~~request that borrowing availability be increased up to $400.0 million, subject to further negotiation and credit approval. On March 18, 2021,~~ the Fund ~~entered into an Amendment~~ to the ~~Loan~~extent and Security Agreement with MUFG Union Bank, N.A., Wells Fargo Securities, LLC, Wells Fargo Bank, N.A. and ING Capital, LLC, with participation from TIAA, FSB, Bank Leumi USA, HSBC Bank USA, N.A., Umpqua Bank, Zions Bancorporation, N.A., doing business as California Bank & Trust, Hitachi Capital America Corp, First Bank, and Bank of ~~Hope, that increased~~ the ~~size~~Company’s ofmembers’ ~~the~~capital ~~facility~~commitment to ~~$350~~the ~~million~~Company and ~~extended~~excess ~~the~~cash ~~term~~balances of the ~~facility~~Company. ~~(the~~As ~~“Amended~~of ~~and~~both ~~Restated~~December 31, ~~Loan~~2024 and ~~Security Agreement”). On May 17~~December 31, ~~2022~~2023, the ~~Fund,~~Company's ~~entered~~subscriptions ~~into a First Amendment to the Amended and Restated Loan and Security Agreement (the “First Amendment”) with lenders named therein. The First Amendment provides~~ for, ~~among~~capital ~~other modifications (i) an increase~~ in the ~~size~~amount of ~~the facility to~~ $~~400~~460.0 million, ~~(ii)~~had ~~replacement~~been offully ~~the~~called ~~interest rate benchmark from LIBOR to Secured Overnight Financing Rate (“SOFR”),~~ and ~~(iii)~~received. ~~conversion~~Total ofcapital ancontributed ~~existing LIBOR Market Index Rate Loan~~ to ~~a Daily Simple SOFR Rate Loan. On October 26, 2023,~~ the Fund ~~entered~~was ~~into~~$407.1 million aas ~~Third~~of ~~Amendment to the~~December ~~Amended~~31, ~~and~~2024 ~~Restated Loan~~ and ~~Security Agreement~~December ~~(the~~31, ~~“Third Amendment”) with lenders named therein~~2023. The ~~Third~~Company ~~Amendment~~has ~~provides~~made ~~for, among other modifications (i) a decrease in the size of the facility to~~ $~~185~~46.0 million ~~with a scheduled reduction~~ in ~~commitments~~recallable ondistributions ~~a quarterly basis by an amount equal~~ to ~~10%~~its ~~(subject to adjustment)~~investors, ~~commencing~~as ~~with~~permitted ~~the~~under ~~calendar~~its ~~quarter~~operating ~~ending~~agreement ~~December~~between ~~31, 2023 (ii) an increase in~~ the ~~margin~~Company’s ~~paid~~managing onmember ~~SOFR Rate Loans (as defined in the Third Amendment)~~ and ~~Reference~~members ~~Rate Loans (as defined in the Third Amendment), and (iii) an extension~~ of the ~~term of the facility to March 31, 2026~~Company. ~~The size of the facility as of December 31, 2023 was $166.5 million.~~

Borrowings by the Fund are collateralized by all the assets of the Fund and the Manager's right to receive management fees from the Fund. In the event of default, the Manager's right to receive management fees from the Fund is subordinate to the liens of the lenders. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a SOFR Rate Loan (calculated at Daily Simple SOFR or another applicable Term SOFR Reference Rate). The ~~Fund~~changes ~~pays interest on its borrowings and also pays a fee on the unused portion of the facility. The facility terminates on March 31, 2026, but can be accelerated~~ in ~~the~~cash ~~event~~for ~~of default, such as~~ the ~~failure~~years byended ~~the Fund to make timely interest or principal payments. As of~~ December 31, ~~2023,~~2024 ~~$142.5 million~~and ~~was~~2023 ~~outstanding~~were ~~under~~as ~~the facility.~~follows:

For the year ended December 31, 2023, and since the start of its investment operation in May 2018, the Fund invested its assets in venture loans. Amounts disbursed under the Fund’s loan commitments were $29.7 million for the year ended December 31, 2023. Net loan amounts outstanding after amortization and valuation adjustments decreased by $186.9 million for the same period. All of the Fund's unfunded commitments had expired as of December 31, 2023.


	For the Year Ended December 31, 2024		For the Year Ended December 31, 2023
Net cash provided by operating activities	$	145,938,243	$	209,392,303
Net cash used in financing activities	(162,371,950)		(194,949,552)
Net increase (decrease) in cash and cash equivalents	$	(16,433,707)	$	14,442,751

As of

Cumulative Amount Disbursed

Principal Reductions and Fair Market Adjustments

Balance Outstanding - Fair Value

Unexpired Unfunded Commitments

December 31, 2023

$1,088.0 million

$785.3 million

$302.8 million

$—

December 31, 2022

$1,058.3 million

$568.6 million

$489.7 million

$68.1 million

As of December 31, 2024 and December 31, 2023, 4.26% and 11.40%, respectively, of the Fund’s net assets consisted of cash and cash equivalents.

The ~~unexpired~~Fund ~~unfunded~~is ~~commitments~~a byparty ~~portfolio~~to ~~company~~a asloan ofand ~~December 31,~~security ~~2023~~agreement (as amended and ~~2022~~restated ~~are~~from ~~detailed~~time into ~~Note~~time) 10with toMUFG Union Bank Ltd. acting as the ~~financial~~administrative ~~statements~~agent ~~included~~and inother ~~this~~lenders ~~filing~~named therein, that established a secured revolving credit facility with a commitment size of $79.5 million as of December 31, 2024.

Borrowings by the Fund are collateralized by all the assets of the Fund and the Manager's right to receive management fees from the Fund. In the event of default, the Manager's right to receive management fees from the Fund is subordinate to the liens of the lenders. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a SOFR Rate Loan (calculated at Daily Simple SOFR or another applicable Term SOFR Reference Rate). The Fund pays interest on its borrowings and also pays a fee on the unused portion of the facility. The facility terminates on March 31, 2026, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or principal payments. As of December 31, 2024, $39.5 million was outstanding under the facility.

For the year ended December 31, 2024 and since the start of its investment operations in May 2018, the Fund invested its assets in venture loans. Amounts disbursed under the Fund’s loan commitments were $0.5 million for the year ended December 31, 2024. Net loan amounts outstanding after amortization and valuation adjustments decreased by $151.7 million for the same period.

As of

Cumulative Amount Disbursed

Principal Reductions and Fair Market Adjustments

Balance Outstanding -
Fair Value

December 31, 2024

$1,088.5 million

$937.4 million

$151.1 million

December 31, 2023

$1,088.0 million

$785.3 million

$302.8 million

Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is Management’s experience that not all unexpired unfunded commitments will be used by borrowers. Many credit agreements contain provisions that are milestone dependent and not all borrowers will achieve these milestones. Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a materially adverse change in its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investments for the Fund.

The Fund seeks to maintain the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (the “Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.

As of December 31, ~~2023~~2024, the Fund had a cash balance of $~~21.~~5.1 million and approximately $~~165~~74.1 million in scheduled loan receivable payments over the next twelve months. Additionally, the Fund has access to recallable capital of $46.0 million as a liquidity source, as well as access to capital from the Fund's debt facility as needed. These amounts are sufficient to meet operational expenses of the Fund over the next year.

On April 24, 2019, the Fund’s sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. Accordingly, the Fund is permitted to borrow in any amount so long as its asset coverage ratio, as defined in the 1940 Act, is at least 150% after giving effect to such borrowings. As of December 31, ~~2023~~2024, the Fund’s asset coverage ratio was ~~231~~400%.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Fund’s business activities contain various elements of risk, of which Management considers interest rate and credit risk to be the principal types of risks. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.

The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower. The Fund has limited exposure to public market price fluctuations as the Fund primarily invests in private business enterprises and distributes all equity investments upon receipt to the Company.

The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate,” revenue income, security interest, secondary markets for collateral, the size of the loan, term of the loan and the ability to exit via initial public offering or merger and acquisition.

The Fund’s exposure to interest rate sensitivity is regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. As of December 31, ~~2023~~2024, the outstanding debt balance was $~~142~~39.5 million at a floating interest rate based on a Daily Simple SOFR Rate of 54.31%~~, for which the Fund had derivative instruments in place with a weighted-average ceiling of 1~~.~~84% on $140.0 million with an interest rate collar, leaving the Fund with exposure to interest rate changes on the un-hedged portion of the loan.~~

Because all of the Fund’s loans impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of December 31, ~~2023~~2024. However, changes in short-term interest rates could also affect interest rate expense, realized gain from investments and interest on the Fund’s short-term investments.

Based on the Fund’s Statements of Assets and Liabilities as of December 31, ~~2023~~2024, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments, borrowings, and cash balances: ~~and derivative instruments.~~

Effect of Interest Rate Change By	Increase (Decrease) Other Income		~~Gain (Loss) from Interest Rate Collar~~		(Increase) Decrease Interest Expense		Increase (Decrease) in Total Income
(0.50)%	$	(107,587)	$	(700,000)	$	712,500	$	(95,087)
(2.00)%	$	(101,674)			$	790,000	$	688,326
1%	$	215,174	$	1,400,000	$	(1,425,000)	$	190,174
(1.00)%	$	(50,837)			$	395,000	$	344,163
2%	$	430,348	$	2,800,000	$	(2,850,000)	$	380,348
(0.50)%	$	(25,419)			$	197,500	$	172,081
3%	$	645,522	$	4,200,000	$	(4,275,000)	$	570,522
0.50%	$	25,419			$	(197,500)	$	(172,081)
4%	$	860,696	$	5,600,000	$	(5,700,000)	$	760,696
1.00%	$	50,837			$	(395,000)	$	(344,163)
5%	$	1,075,870	$	7,000,000	$	(7,125,000)	$	950,870
2.00%	$	101,674			$	(790,000)	$	(688,326)

Additionally, a change in the interest rate may affect the fair value of the derivative instruments and affect net change in unrealized gain or loss from derivative instruments. The amount of any such effect will be contingent upon market expectations for future interest rate changes. Any increases in expected future rates will increase the fair value of the derivative instruments while any rate decreases will decrease the fair value.

Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.

Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended. ~~The Fund, therefore, attempts to limit its interest rate risk by acquiring derivative instruments to hedge its interest rate exposure.~~

The Fund is not sensitive to changes in foreign currency exchange rates, commodity prices and other market rates or prices.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The Fund’s financial statements, together with the Report of Independent Registered Public Accounting Firm issued by Deloitte & Touche LLP (PCAOB ID No. 34), are included elsewhere in this Annual Report on Form 10-K.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

At the end of the period covered by this report, the Fund carried out an evaluation under the supervision and with the participation of its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures pursuant to Rules 13a-15(b) and 15d-15(b) of the Exchange Act. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s disclosure controls and procedures were effective as of the end of the period covered by this Annual Report on Form 10-K in ensuring that information required to be disclosed was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and in providing reasonable assurance that information required to be disclosed by the Fund in such reports is accumulated and communicated to the Fund’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Management’s Annual Report on Internal Control over Financial Reporting

Pursuant to Rules 13a-15d and 15d-15(d) of the Exchange Act, the Fund’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Under the supervision of and with the participation of the Fund’s management, including its Chief Executive Officer and Chief Financial Officer, the Fund conducted an evaluation of the effectiveness of its internal control over financial reporting based on the Committee of Sponsoring Organizations of the Treadway Commission 2013 (“COSO 2013”) updated Internal Control - Integrated Framework. Based on its evaluation under the COSO 2013 Internal Control - Integrated Framework, the Fund’s management concluded that its internal control over financial reporting was effective as of December 31, ~~2023~~2024.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

This report of management on internal control over financial reporting shall not be deemed to be filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section.

Changes in Internal Controls

There have not been any changes in the Fund’s internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the Fund’s quarter ended December 31, ~~2023~~2024 that has materially affected, or is reasonably likely to materially affect, the Fund’s internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

During the fiscal quarter ended December 31, ~~2023~~2024, no director or officer of the Fund adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

PART III.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The list of executive officers and biographical information appears in Part I, Item 1 of this Annual Report on Form 10-K.

The information required by this item concerning the directors of the Fund and the structure of its Board of Directors and Section 16(a) compliance will be contained in the Fund’s Proxy Statement filed in connection with the Annual Meeting of Shareholders to be held on May 1521, ~~2024~~2025 (“Proxy Statement”) under the ~~caption~~captions “Proposal 1 -- To Elect Four Directors of the Fund” and “Delinquent Section 16(a0 Reports” and is incorporated herein by reference.

The Fund has adopted a Code of Ethics that is applicable to all of its officers. A free copy of the Code of Ethics may be requested by contacting the Chief Financial Officer of the Fund at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028.

As of the date hereof, the Fund has not adopted any insider trading policies and procedures governing the purchase, sale, and/or other dispositions of the Fund’s securities by directors, officers and employees, or the Fund itself, that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and any listing standards applicable to the Fund. The Fund has not done so because the Fund’s shares are not publicly-traded and there is generally no market for the shares of the Fund. However, as discussed above, each of the Fund and the Manager has adopted a Code of Ethics which includes an insider trading policy that applies to the purchase or sale of securities of portfolio companies.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this item will be contained in the Fund’s Proxy Statement under the caption “Proposal 1 -- To Elect Four Directors of the Fund” and is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item will be contained in the Fund’s Proxy Statement under the caption “Annex A -- Beneficial Ownership of Fund Shares” and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item will be contained in the Fund’s Proxy Statement under the caption: “Other Information -- Manager” and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Information about aggregate fees billed to the Fund by the Fund's principal accountant, Deloitte & Touche LLP (PCAOB ID No. 34) will be contained in the Fund's Proxy Statement under the caption: “Other Information - Independent Registered Public Accounting Firm.”

PART IV.

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

1. Index to Financial Statements and Financial Statement Schedules

Report of Independent Registered Public Accounting Firm

Statements of Assets and Liabilities as of December 31, ~~2023~~2024 and ~~2022~~2023

Statements of Operations for the years ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

Statements of Changes in Net Assets for the years ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

Statements of Cash Flows for the years ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

Schedules of Investments as of December 31, ~~2023~~2024 and ~~2022~~2023

Notes to Financial Statements

No schedules are required because the required information is not present or not present in amounts sufficient to require submission of the schedule, or because the required information is included in the financial statements and the notes thereto.

2. Exhibits


Exhibit			Exhibit Title

3.1			Amended and Restated Articles of Incorporation of the Fund as filed with the Maryland Secretary of State on September 25, 2017, incorporated by reference to Exhibit 3.1 to the Fund’s Registration Statement on Form 10 filed with the Securities and Exchange Commission on October 18, 2017.

3.2			Amended and Restated Bylaws of the Fund, incorporated by reference to Exhibit 3.2 to the Fund’s Registration Statement on Form 10 filed with the Securities and Exchange Commission on October 18, 2017.

4.1			Purchase Agreement, dated June 28, 2017, between the Fund and the Company, incorporated by reference to Exhibit 4.1 to the Fund’s Registration Statement on Form 10 filed with the Securities and Exchange Commission on October 18, 2017.

4.2			Description of the Registrant’s securities registered pursuant to Section 12(G) of the Securities and Exchange Act of 1934, incorporated by reference to Exhibit 4.2 to the Fund’s Form 10-K filed with the Securities and Exchange Commission on March 15, 2021.

10.1			Investment Management Agreement, dated October 13, 2022, by and between the Fund and Westech Investment Advisors LLC, incorporated by reference to Exhibit 10.1 to the Fund’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 18, 2022.

10.2			Global Custody Agreement dated July 27, 2015, between the Fund and MUFG Union Bank, N.A., as supplemented by Schedule I attached thereto, dated April 26, 2021, incorporated by reference to Exhibit 10.1 to the Fund’s 10-K filed with the Securities and Exchange Commission on March 14, 2022.

10.3			Custody Agreement between the Fund and Wells Fargo Bank, National Association effective December 11, 2019, incorporated by reference to Exhibit 10.3 to the Fund’s Form 10-K filed with the Securities and Exchange Commission on March 16, 2020.

10.4			Letter, dated August 15, 2021, from U.S. Bank National Association (“US Bank”), acknowledging assumption of custodial duties and transfer of custody agreements from MUFG Union Bank, N.A. (Exhibit 10.1 to this 10-K) to US Bank by operation of law pursuant to Depository Corporation Sale, Merger, and Conversion Law, CA Fin Code § 4800 (2016), effective March 15, 2021, incorporated by reference to Exhibit 10.4 to the Fund’s 10-Q filed with the Securities and Exchange Commission on November 12, 2021.

31.1			Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Rules 13a -14(a) and 15d-14(a) Certification)

31.2			Chief Financial Officer certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Rules 13a -14(a) and 15d-14(a) Certification).

32.1			Chief Executive Officer certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Section 1350 Certification).

32.2			Chief Financial Officer certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Section 1350 Certification).

ITEM 16. FORM 10-K SUMMARY

None.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VENTURE LENDING & LEASING IX, INC.

(Registrant)

By:

/S/David R. Wanek

By:

/S/Jared S. Thear

David R. Wanek

Jared S. Thear

President and Chief Executive Officer

Chief Financial Officer

(Principal Executive Officer)

(Principal Financial Officer)

Date:

March 1517, ~~2024~~2025

Date:

March 1517, ~~2024~~2025

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NAME

TITLE

DATE

By:

/S/ Maurice C. Werdegar

Chairman & Director

March 1517, ~~2024~~2025

Maurice C. Werdegar

By:

/S/ Robert Hutter

Director

March 1517, ~~2024~~2025

Robert Hutter

By:

/S/ Roger V. Smith

Director

March 1517, ~~2024~~2025

Roger V. Smith

By:

/S/ Scott Taylor

Director

March 1517, ~~2024~~2025

Scott Taylor

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholder and the Board of Directors of Venture Lending & Leasing IX, Inc.

Opinion on the Financial Statements and Financial Highlights

We have audited the accompanying statements of assets and liabilities of Venture Lending & Leasing IX, Inc. (the "Fund"), including the schedules of investments, as of December 31, ~~2023~~2024 and ~~2022~~2023, the related statements of operations, changes in net assets, and cash flows for each of the three years in the period ended December 31, ~~2023~~2024, the financial highlights for each of the five years in the period then ended, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of December 31, ~~2023~~2024 and ~~2022~~2023, and the results of its operations, changes in net assets, and cash flows for each of the three years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements and financial highlights are the responsibility of the Fund'’s management. Our responsibility is to express an opinion on the Fund'’s financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of loans owned as of December 31, 2024 and 2023, by correspondence with the borrowers; when replies were not received, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Fair Value — Level 3 Investments — Refer to Note 2 and Note 3 to the financial statements

Critical Audit Matter Description

As of December 31, ~~2023~~2024, the Fund has nonmarketable investments in loans. There is no readily available market price or secondary market for the loans made by the Fund to its borrowers; hence the Fund determines fair value based on a ~~hypothetical~~transaction that would occur in the most advantageous market and the estimates are subject to a ~~higher~~high degree of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over certain significant inputs used in determining fair value.

Certain nonmarketable investments in loans held by the Fund have exhibited indicators of credit deterioration subsequent to the initial funding date. The valuation of these loans had an elevated risk profile because the estimates of fair value involve a higher degree of management judgment and uncertainty associated with the expectation of timing and amount of future cash flows under various cash flow scenarios. The valuation of these loans required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists who possess significant valuation expertise, to evaluate the appropriateness of the model and methodology.

We identified the completeness of loans exhibiting indicators of potential credit deterioration and the valuation of loans exhibiting credit deterioration as a critical audit matter.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to the completeness of loans exhibiting indicators of potential credit deterioration and the unobservable inputs used by management to estimate the fair value of the loans with credit deterioration included the following, among others:

•We tested loan payments throughout the year and subsequent to year end to identify inconsistent payments or missed payments which could indicate a potential credit risk.

•With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation techniques used by management to estimate fair value.

•We tested and evaluated the appropriateness of the unobservable inputs by comparing them to external sources, including financial information provided by the borrower, and those used by management in the prior year.

/s/ Deloitte & Touche LLP

March 1517, ~~2024~~2025

San Francisco, California

We have served as the auditor of one or more Venture Lending & Leasing investment companies since 2001.

VENTURE LENDING & LEASING IX, INC.

Statements of Assets and Liabilities

As of December 31, ~~2023~~2024 and ~~2022~~2023

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
ASSETS:
Loans, at estimated fair value
(cost of $350,627,997 and $521,905,950)	$	302,804,781	$	489,691,665
(amortized cost of $194,533,292 and $350,627,997, respectively)	$	151,064,673	$	302,804,781
Derivative assets	~~3,049,177~~—		103,~~644~~049,~~351~~177
Cash and cash equivalents	215,~~517~~083,~~408~~701		721,~~074~~517,~~657~~408
Dividend and interest receivables	31,~~869~~424,~~697~~095		63,~~374~~869,~~578~~697
Other assets	2,~~233~~394,~~766~~009		32,~~411~~233,~~846~~766
Total assets	~~333~~159,~~474~~966,~~829~~478		~~517~~333,~~197~~474,~~097~~829
LIABILITIES:
Borrowings under debt facility	~~142~~39,500,000		~~244~~142,500,000
Accrued management fees	1690,~~035,~~000		1,~~437~~035,~~500~~000
Accounts payable and other accrued liabilities	1430,~~249,996~~267		31,~~047~~249,~~302~~996
Total liabilities	~~144~~40,~~784~~620,~~996~~267		~~248~~144,~~984~~784,~~802~~996
NET ASSETS:	$	~~188~~119,~~689~~346,~~833~~211	$	~~268~~188,~~212~~689,~~295~~833
Analysis of Net Assets:
Capital paid in on shares of capital stock	$	407,125,000	$	407,125,000
Cumulative return of capital distributions	(~~172~~243,~~512~~161,~~838~~880)		(~~116~~172,~~194~~512,~~481~~838)
Total distributable losses	(4544,~~922~~616,~~329~~909)		(2245,~~718~~922,~~224~~329)
Net assets (equivalent to $1,886.90 and $2,682.12 per share based on 100,000 shares of capital stock outstanding - See Note 5 and Note 11)	$	188,689,833	$	268,212,295
Net assets (equivalent to $1,193.46 and $1,886.90 per share based on 100,000 shares of capital stock outstanding - see Note 5 and Note 12)	$	119,346,211	$	188,689,833
Commitments & Contingent Liabilities:
Unexpired unfunded commitments (See Note 10)	$	—	$	68,075,000

See notes to financial statements.

VENTURE LENDING & LEASING IX, INC.

Statements of Operations

For the Years Ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

For the Year Ended

December 31, 2023

December 31, 2022

December 31, 2021

December 31, 2024

December 31, 2023

December 31, 2022

INVESTMENT INCOME:

Interest on loans

6631,~~204~~115,~~909~~312

8266,~~096~~204,~~477~~909

8582,~~555~~096,~~014~~477

Other income

2866,~~122,338~~576

12,~~876~~122,~~106~~338

~~410~~1,~~493~~876,106

Total investment income

6831,~~327~~981,~~247~~888

8368,~~972~~327,~~583~~247

8583,~~965~~972,~~507~~583

EXPENSES:

Management fees

43,~~945~~450,000

64,~~325~~945,000

76,~~072~~325,~~500~~000

Interest expense

167,~~950~~588,~~891~~450

1216,~~449~~950,~~209~~891

612,~~333~~449,~~348~~209

Banking and professional fees

~~500~~608,~~508~~771

~~605~~500,~~195~~508

1605,~~395,114~~195

Other operating expenses

~~208~~371,~~041~~373

~~189~~208,~~809~~041

~~214~~189,~~396~~809

Total expenses

2212,~~604~~018,~~440~~594

1922,~~569~~604,~~213~~440

1519,~~015~~569,~~358~~213

Net investment income

4519,~~722~~963,~~807~~294

6445,~~403~~722,~~370~~807

7064,~~950~~403,~~149~~370

Net realized loss from loans

(621,~~106~~669,~~352~~030)

(36,~~387~~106,~~060~~352)

(~~119~~3,~~127~~387,060)

Net realized gain (loss) from derivative instruments

8,948,922

1,891,885

(1,348,685)

Net realized gain from derivative instruments

3,493,050

8,948,922

1,891,885

Net change in unrealized loss from loans

(15,608,931)

(14,352,707)

(5,372,700)

Net change in unrealized gain (loss) from loans

4,354,597

(15,608,931)

(14,352,707)

Net change in unrealized gain (loss) from derivative instruments

(73,~~595~~049,~~174~~177)

9(7,~~812~~595,~~446~~174)

29,~~086~~812,~~119~~446

Net realized and change in unrealized loss from loans and derivative instruments

(2016,~~361~~870,~~535~~560)

(620,~~035~~361,~~436~~535)

(46,~~754~~035,~~393~~436)

Net increase in net assets resulting from operations

253,~~361~~092,~~272~~734

5825,~~367~~361,~~934~~272

6658,~~195~~367,~~756~~934

Amounts per common share:

Net increase in net assets resulting from operations per share

~~253~~30.6193

~~583~~253.6861

~~661~~583.9668

Weighted average shares outstanding

100,000

See notes to financial statements.

VENTURE LENDING & LEASING IX, INC.

Statements of Changes in Net Assets

For the Years Ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

	Common Stock
	Shares	Par Value		Additional Paid-in Capital		Return of Capital Distributions		Total Distributable Losses		Net Assets
Balance at December 31, 2020	100,000	$	100	$	243,124,900	$	(44,906,782)	$	(14,891,383)	$	183,326,835
Net increase in net assets resulting from operations	—	—		—		—		66,195,756		66,195,756
Distributions of income to shareholder	—	—		—		—		(69,482,336)		(69,482,336)
Return of capital to shareholder	—	—		—		(52,346,704)		—		(52,346,704)
Contributions from shareholder	—	—		102,500,000		—		—		102,500,000
Balance at December 31, 2021	100,000	$	100	$	345,624,900	$	(97,253,486)	$	(18,177,963)	$	230,193,551
Net increase in net assets resulting from operations	—	—		—		—		58,367,934		58,367,934
Distribution of income to shareholder	—	—		—		—		(62,908,195)		(62,908,195)
Distributions of income to shareholder	—	—		—		—		(62,908,195)		(62,908,195)
Return of capital to shareholder	—	—		—		(18,940,995)		—		(18,940,995)
Contributions from shareholder	—	—		61,500,000		—		—		61,500,000
Balance at December 31, 2022	100,000	$	100	$	407,124,900	$	(116,194,481)	$	(22,718,224)	$	268,212,295
Net increase in net assets resulting from operations	—	—		—		—		25,361,272		25,361,272
Distributions of income to shareholder	—	—		—		—		(48,565,377)		(48,565,377)
Return of capital to shareholder	—	—		—		(56,318,357)		—		(56,318,357)
Balance at December 31, 2023	100,000	$	100	$	407,124,900	$	(172,512,838)	$	(45,922,329)	$	188,689,833
Net increase in net assets resulting from operations	—	—		—		—		3,092,734		3,092,734
Distributions of income to shareholder	—	—		—		—		(1,787,314)		(1,787,314)
Return of capital to shareholder	—	—		—		(70,649,042)		—		(70,649,042)
Balance at December 31, 2024	100,000	$	100	$	407,124,900	$	(243,161,880)	$	(44,616,909)	$	119,346,211

See notes to financial statements.

VENTURE LENDING & LEASING IX, INC.

Statements of Cash Flows

For the Years Ended December 31, ~~2023~~2024, ~~2022~~2023 and ~~2021~~2022

For the Year Ended

December 31, 2023

December 31, 2022

December 31, 2021

December 31, 2024

December 31, 2023

December 31, 2022

CASH FLOWS FROM OPERATING ACTIVITIES:

Net increase in net assets resulting from operations

253,~~361~~092,~~272~~734

5825,~~367~~361,~~934~~272

6658,~~195~~367,~~756~~934

Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:

Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating activities:

Net realized loss from loans

621,~~106~~669,~~352~~030

36,~~387~~106,~~060~~352

~~119~~3,~~127~~387,060

Net realized (gain) loss from derivative instruments

(8,948,922)

(1,891,885)

1,348,685

Net realized gain from derivative instruments

(3,493,050)

(8,948,922)

(1,891,885)

Net change in unrealized loss from loans

15,608,931

14,352,707

5,372,700

Net change in unrealized (gain) loss from loans

(4,354,597)

15,608,931

14,352,707

Net change in unrealized (gain) loss from derivative instruments

73,~~595~~049,~~174~~177

(97,~~812~~595,~~446)~~174

(29,~~086~~812,~~119~~446)

Amortization of deferred costs related to borrowing facility

1562,~~009,982~~022

~~998~~1,~~440~~009,982

~~794~~998,~~264~~440

Origination of loans

(29545,~~750,000~~652)

(~~236~~29,~~094~~750,~~146~~000)

(~~358~~236,~~801~~094,~~269~~146)

Principal payments on loans, net of accretion

~~185~~124,~~767~~576,~~580~~971

~~206~~185,~~727~~767,~~836~~580

~~179~~206,~~332~~727,~~130~~836

Proceeds from sale of loans

~~6,043,138~~—

16,~~800~~043,~~000~~138

—1,800,000

Acquisition of equity securities

~~(780,851)~~—

(15780,~~166,668~~851)

(3515,~~577~~166,~~222~~668)

Change in operating assets and liabilities:

Net (increase) decrease in dividend and interest receivables

2,504,881

498,220

(3,016,200)

Net decrease in dividend and interest receivables

2,445,602

2,504,881

498,220

Net (increase) decrease in other assets

1100,~~074,572~~735

(1,~~923~~074,~~110)~~572

98(1,~~387~~923,110)

Net increase (decrease) in accounts payable, other accrued liabilities and accrued management fees

(2,199,806)

(3,123,525)

4,627,579

Net decrease in accounts payable, other accrued liabilities and accrued management fees

(1,164,729)

(2,199,806)

(3,123,525)

Net cash provided by (used in) operating activities

209,392,303

18,120,417

(141,592,182)

Net cash provided by operating activities

145,938,243

209,392,303

18,120,417

CASH FLOWS FROM FINANCING ACTIVITIES:

Cash distributions to shareholder

(~~100~~62,~~992~~042,000)

(62100,~~500~~992,000)

(8562,~~800~~500,000)

Contributions from shareholder

—

~~61,500,000~~—

~~102~~61,500,000

Borrowings under debt facility

~~6,500,000~~—

~~109~~6,500,000

~~251~~109,~~200~~500,000

Repayments of borrowings under debt facility

(~~108~~103,~~500~~000,000)

(~~128~~108,~~000~~500,000)

(128,~~200~~000,000)

Payments made for derivative instruments

—

~~(202,417)~~—

(1202,~~348,685~~417)

Payments received from derivative instruments

82,~~948~~670,~~922~~050

28,~~094~~948,~~302~~922

—2,094,302

Payments of bank facility fees and costs

~~(906,474)~~—

(~~376~~906,~~771~~474)

(2376,~~317,250~~771)

Net cash provided by (used in) financing activities

(194,949,552)

(17,984,886)

136,034,065

Net cash used in financing activities

(162,371,950)

(194,949,552)

(17,984,886)

Net increase (decrease) in cash and cash equivalents

14(16,~~442~~433,~~751~~707)

~~135~~14,~~531~~442,751

(5135,~~558,117)~~531

CASH AND CASH EQUIVALENTS:

Beginning of year

721,~~074~~517,~~657~~408

67,~~939~~074,~~126~~657

126,~~497~~939,~~243~~126

End of year

215,~~517~~083,~~408~~701

721,~~074~~517,~~657~~408

67,~~939~~074,~~126~~657

SUPPLEMENTAL DISCLOSURES:

CASH PAID DURING THE YEAR:

Interest - Debt facility

167,~~400~~767,~~251~~317

1016,~~557~~400,~~659~~251

410,~~992~~557,~~998~~659

NON-CASH OPERATING AND FINANCING ACTIVITIES:

Distributions of equity securities to shareholder

310,~~891~~394,~~734~~356

193,~~349~~891,~~190~~734

3619,~~029~~349,~~040~~190

Receipt of equity securities as repayment of loans

310,~~110~~394,~~883~~356

43,~~182~~110,~~522~~883

~~451~~4,~~817~~182,522

See notes to financial statements.

VENTURE LENDING & LEASING IX, INC.

Schedule of Investments

As of December 31, ~~2023~~2024

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date
Biotechnology
	Calysta, Inc.		Senior Secured	11.8%		$	41,~~034~~424,~~272~~098	$	31,~~915~~408,~~776~~179	$	31,~~915~~408,~~776~~179	6/1/2025
	Genomic Prediction, Inc.		Senior Secured	11.0%		~~462~~37,~~427~~551		~~450~~37,~~632~~410		~~450~~37,~~632~~410		1/1/2025
	GLO Pharma, Inc.		Senior Secured	10.5%		855,052		842,954		842,954		12/1/2024
	Ukko Inc.		Senior Secured	11.5%		2,107,295		2,051,686		2,051,686		5/1/2026
	GLO Pharma, Inc.		Senior Secured	10.5%		1,281,930		1,270,942		1,270,942		12/1/2024
Biotechnology Total		2.9%				$	3,568,944	$	3,497,275	$	3,497,275
	GLO Pharma, Inc. Subtotal					2,136,982		2,113,896		2,113,896
	Ukko Inc.		Senior Secured	11.5%		3,398,473		3,253,318		3,253,318		5/1/2026
Biotechnology Total		5.2%				$	10,032,154	$	9,733,622	$	9,733,622
Computers & Storage
	Canary Connect, Inc.		Senior Secured	1211.08%		$	~~225~~9,~~469~~879,021	$	~~224~~9,~~872~~758,853	$	~~224~~9,~~872~~758,853	3/1/~~2024~~2026
	Canary Connect, Inc.		Senior Secured	12.0%		901,528		896,305		896,305		3/1/2024
	Proto, Inc.		Senior Secured	12.5%		507,469		495,929		495,929		10/1/2025
	Canary Connect, Inc.		Senior Secured	11.8%		13,521,618		13,193,287		13,193,287		3/1/2026
	Proto, Inc.		Senior Secured	12.8%		508,460		508,460		508,460		10/1/2025
	Canary Connect, Inc. Subtotal					14,648,615		14,314,464		14,314,464
	Proto, Inc. Subtotal					1,015,929		1,004,389		1,004,389
	Proto, Inc.		Senior Secured	12.5%		1,049,740		1,001,515		1,001,515		10/1/2025
Computers & Storage Total		9.0%				$	10,894,950	$	10,763,242	$	10,763,242
	Proto, Inc.		Senior Secured	12.8%		1,050,540		1,050,539		1,050,539		10/1/2025
	Proto, Inc. Subtotal					2,100,280		2,052,054		2,052,054
Computers & Storage Total		8.7%				$	16,748,895	$	16,366,518	$	16,366,518
Enterprise Networking
	Diamanti, Inc.		Senior Secured	11.0%		$	5,404,212	$	3,~~687~~310,~~334~~413	$	3,~~687~~310,~~334~~413	*
Enterprise Networking Total		2.08%				$	5,404,212	$	3,~~687~~310,~~334~~413	$	3,~~687~~310,~~334~~413
Internet
	10club Pte Ltd. ** ^		Senior Secured	12.0%		$	5,~~264~~350,~~876~~238	$	4,~~762~~821,~~966~~628	$	24,~~801~~014,~~583~~479	~~11/1/2025~~*
	Ainsly, Inc. ** ^		Senior Secured	12.5%		133,826		133,821		133,821		7/1/2025
	D2C Store, Inc.		Senior Secured	10.0%		1,305,572		912,688		912,688		*
	Ainsly, Inc. ** ^		Senior Secured	12.5%		200,739		153,231		153,231		7/1/2025
	Good Counsel, Inc.		Senior Secured	12.3%		1,996,772		1,697,833		1,697,833		9/1/2026
	Ainsly, Inc. Subtotal ** ^					334,565		287,052		287,052
	iZENEtech, Inc. ** ^		Senior Secured	12.3%		3,001,339		2,976,442		1,752,559		*
	D2C Store, Inc.		Senior Secured	10.0%		1,905,572		1,572,688		1,572,688		*
	Miami Labs, Inc.		Senior Secured	13.3%		5,877,795		5,626,862		5,626,862		5/1/2026
	Good Counsel, LLC		Senior Secured	12.3%		2,707,456		2,431,880		2,431,880		4/1/2026
	OneLocal, Inc. ** ^		Senior Secured	12.3%		772,050		744,720		744,720		7/1/2026
	iZENEtech, Inc. ** ^		Senior Secured	12.3%		3,001,339		2,997,442		2,790,190		*
	Quantcast Corp.		Senior Secured	12.0%		9,529,103		9,134,951		9,134,951		*
	Kings Mountain I LLC		Senior Secured	11.5%		94,770		76,620		71,768		*
	Residently USA, LLC ** ^		Senior Secured	12.0%		376,963		361,961		178,319		4/1/2026
	Miami Labs, Inc.		Senior Secured	13.3%		7,500,000		7,162,069		7,162,069		5/1/2026
	RetailerX, Inc.		Senior Secured	11.3%		5,527,786		5,450,354		4,794,090		*
	OneLocal, Inc. ** ^		Senior Secured	12.0%		1,245,475		1,201,210		1,201,210		1/1/2025
	Osix Corporation		Senior Secured	12.3%		3,679,812		3,369,724		3,369,724		*
	Pixalate, Inc.		Senior Secured	12.5%		3,389,495		3,271,244		3,271,244		4/1/2025
	Quantcast Corp.		Senior Secured	12.0%		12,500,000		11,779,146		11,779,146		7/1/2026
	RenoFi, Inc.		Senior Secured	11.5%		988,490		929,802		929,802		7/1/2025
	RenoFi, Inc.		Senior Secured	11.5%		1,082,499		1,070,622		1,070,622		9/1/2025
	RenoFi, Inc. Subtotal					2,070,989		2,000,424		2,000,424
	Residently USA, LLC ** ^		Senior Secured	12.0%		422,364		389,326		389,326		4/1/2026
	RetailerX, Inc.		Senior Secured	11.3%		5,769,455		5,446,191		5,446,191		7/1/2026
	Serface Care, Inc.		Senior Secured	12.3%		597,411		344,785		—		*
	Stay Alfred, Inc.		Senior Secured	18.0%		4,921,822		3,408,326		—		*
	Usual Beverage Co.		Senior Secured	12.0%		1,699,532		1,629,519		284,813		*
	Vinvesto, Inc.		Senior Secured	15.0%		153,163		153,163		153,163		5/1/2026
	Verishop, Inc.		Senior Secured	12.6%		1,145,286		1,139,192		1,139,192		12/1/2024
	Vinvesto, Inc.		Senior Secured	14.8%		152,975		145,097		145,097		5/1/2026
	Vinvesto, Inc.		Senior Secured	15.0%		243,054		243,054		243,054		5/1/2026
	Vinvesto, Inc. Subtotal					306,138		298,260		298,260
	Vinvesto, Inc.		Senior Secured	14.8%		243,033		223,116		223,116		5/1/2026
Internet Total		24.4%				$	39,562,989	$	35,778,810	$	29,154,761
	Vinvesto, Inc. Subtotal					486,087		466,170		466,170
Medical Devices
	Anutra Medical, Inc.		Senior Secured	18.0%		$	398,742	$	346,750	$	—	*
	Medrobotics Corporation, Inc.		Senior Secured	18.0%		10,000,000		8,918,414		—		*
	Siren Care, Inc.		Senior Secured	13.5%		310,920		310,783		310,783		1/1/2025
Medical Devices Total		0.3%				$	10,709,662	$	9,575,947	$	310,783
Other Healthcare
	Elysium Health, Inc.		Senior Secured	12.0%		$	485,515	$	481,710	$	481,710	2/1/2025
	GoForward, Inc.		Senior Secured	11.5%		118,797		95,051		46,363		*
	Hello Heart Inc.		Senior Secured	11.0%		439,894		438,841		438,841		6/1/2025
	Honeybee Health, Inc.		Senior Secured	11.0%		679,770		666,022		666,022		9/1/2025
	Julie Products Inc.		Senior Secured	15.3%		237,698		234,650		234,650		4/1/2026
	Julie Products Inc.		Senior Secured	13.0%		366,753		358,529		358,529		9/1/2025
	Julie Products Inc.		Senior Secured	15.8%		264,681		261,019		261,019		6/1/2026
	Julie Products Inc. Subtotal					869,132		854,198		854,198
	KBS, Inc.		Senior Secured	14.0%		160,491		152,256		152,256		6/1/2026
	Open Inc.		Senior Secured	13.5%		271,270		263,850		263,850		3/1/2026

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date
Internet Total		24.6%				$	58,736,306	$	53,735,974	$	46,464,670
	Open Inc.		Senior Secured	14.8%		273,217		270,883		270,883		3/1/2026
Medical Devices
	Open Inc. Subtotal					544,487		534,733		534,733
	Anutra Medical, Inc.		Senior Secured	18.0%		$	398,742	$	346,750	$	—	*
	PrecisionOS Technology Inc. ** ^		Senior Secured	12.0%		261,096		257,207		257,207		7/1/2025
	CytoVale, Inc.		Senior Secured	12.0%		1,217,661		1,205,201		1,205,201		1/1/2025
	Therapydia, Inc.		Senior Secured	12.5%		453,077		306,075		306,075		*
	Medrobotics Corporation, Inc.		Senior Secured	18.0%		10,000,000		8,932,603		—		*
	Vessel Health, Inc.		Senior Secured	12.0%		711,734		618,971		471,310		*
	Norbert Health, Inc.		Senior Secured	12.3%		222,648		217,849		217,849		6/1/2024
	Yuva Biosciences, Inc.		Senior Secured	13.3%		151,845		143,005		143,005		5/1/2026
	Siren Care, Inc.		Senior Secured	13.5%		606,861		604,374		604,374		1/1/2025
Other Healthcare Total		3.6%				$	4,875,838	$	4,548,069	$	4,351,720
Medical Devices Total		1.1%				$	12,445,912	$	11,306,777	$	2,027,424
Other Healthcare
	Elysium Health, Inc.		Senior Secured	12.0%		$	3,204,172	$	3,083,630	$	3,083,630	2/1/2025
	GoForward, Inc.		Senior Secured	11.5%		690,974		688,087		688,087		6/1/2024
	Grayce, Inc.		Senior Secured	11.8%		215,439		213,798		213,798		12/1/2024
	Grayce, Inc.		Senior Secured	14.0%		664,671		631,909		631,909		2/1/2026
	Grayce, Inc.		Senior Secured	11.8%		327,838		322,236		322,236		9/1/2024
	Grayce, Inc. Subtotal					1,207,948		1,167,943		1,167,943
	Hello Heart Inc.		Senior Secured	11.0%		440,421		434,449		434,449		6/1/2024
	Hello Heart Inc.		Senior Secured	11.0%		1,250,622		1,242,667		1,242,667		6/1/2025
	Hello Heart Inc. Subtotal					1,691,043		1,677,116		1,677,116
	Honeybee Health, Inc.		Senior Secured	11.0%		1,503,502		1,438,883		1,438,883		9/1/2025
	Julie Products Inc.		Senior Secured	15.3%		375,000		366,817		366,817		4/1/2026
	Julie Products Inc.		Senior Secured	15.8%		375,000		366,153		366,153		6/1/2026
	Julie Products Inc.		Senior Secured	13.0%		802,628		764,447		764,447		9/1/2025
	Julie Products Inc. Subtotal					1,552,628		1,497,417		1,497,417
	KBS, Inc.		Senior Secured	14.0%		250,000		229,967		229,967		6/1/2026
	Minded, Inc.		Senior Secured	11.2%		2,224,305		2,008,841		—		*
	Open Inc.		Senior Secured	14.8%		457,878		451,414		451,414		3/1/2026
	Open Inc.		Senior Secured	13.5%		457,247		436,107		436,107		3/1/2026
	Open Inc. Subtotal					915,125		887,521		887,521
	Oula Health, Inc.		Senior Secured	12.0%		56,647		56,322		56,322		2/1/2024
	Oula Health, Inc.		Senior Secured	12.0%		90,275		89,868		89,868		7/1/2024
	Oula Health, Inc. Subtotal					146,922		146,190		146,190
	PrecisionOS Technology Inc. ** ^		Senior Secured	12.0%		667,730		643,612		643,612		7/1/2025
	Therapydia, Inc.		Senior Secured	12.0%		1,777,402		1,753,942		1,753,942		2/1/2027
	Tia, Inc.		Senior Secured	11.8%		371,042		364,011		364,011		5/1/2024
	Tia, Inc.		Senior Secured	11.8%		818,984		815,087		815,087		9/1/2024
	Tia, Inc. Subtotal					1,190,026		1,179,098		1,179,098
	Vessel Health, Inc.		Senior Secured	12.0%		711,734		588,211		553,968		1/1/2026
	Yes Health, Inc.		Senior Secured	12.0%		1,773,262		1,705,392		—		*
	Yuva Biosciences, Inc.		Senior Secured	13.3%		242,902		220,407		220,407		5/1/2026
Other Healthcare Total		8.0%				$	19,749,675	$	18,916,257	$	15,167,781
Other Technology
	8i Corporation		Senior Secured	12.0%		$	390,777	$	386,909	$	243,768	10/1/2025
	Azumo, Inc.		Senior Secured	12.8%		$	957,356	$	913,213	$	548,094	*
	Aclima, Inc.		Senior Secured	12.0%		321,219		298,126		298,126		*
	Bankroll Club, LLC		Senior Secured	12.9%		4,262,576		3,955,801		1,051,870		*
	Airspeed, Inc.		Senior Secured	11.0%		532,573		505,660		505,660		1/1/2026
	Beautiful Beanfields, Inc.		Senior Secured	6.0%		275,000		255,543		125,523		*
	Airspeed, Inc.		Senior Secured	11.0%		625,000		625,000		625,000		7/1/2026
	BloomTech Inc.		Senior Secured	11.3%		299,416		299,416		299,416		5/1/2026
	Airspeed, Inc. Subtotal					1,157,573		1,130,660		1,130,660
	Brave Care Technologies, Inc.		Senior Secured	12.0%		738,617		681,178		212,314		12/1/2026
	Azumo, Inc.		Senior Secured	12.8%		1,282,604		1,203,696		1,203,696		1/1/2026
	Bryte, Inc.		Senior Secured	10.0%		1,694,943		1,708,964		1,003,561		*
	Bankroll Club, LLC		Senior Secured	12.9%		4,262,576		3,955,801		970,983		*
	Candy Club Holdings, Inc.		Senior Secured	8.5%		750,000		734,522		—		*
	Beautiful Beanfields, Inc.		Senior Secured	6.0%		275,000		255,324		127,662		*
	Ceres Imaging, Inc.		Senior Secured	12.0%		2,843,184		2,781,445		2,781,445		*
	BloomTech Inc.		Senior Secured	11.3%		267,698		267,698		267,698		5/1/2026
	Coffee.ai Inc.		Senior Secured	11.0%		1,101,447		1,033,864		1,033,864		5/1/2027
	Brave Care Technologies, Inc.		Senior Secured	12.0%		738,617		724,173		649,416		9/1/2024
	Content Adjacent, Inc.		Senior Secured	12.0%		1,370,177		1,275,059		927,667		*
	Bryte, Inc.		Senior Secured	10.0%		1,680,936		1,640,717		1,640,717		9/1/2025
	CornerUp, Inc.		Senior Secured	15.0%		392,046		359,248		211,951		*
	Creoate Limited ** ^		Senior Secured	14.0%		136,025		134,790		134,790		3/1/2026
	Creoate Limited ** ^		Senior Secured	15.5%		444,128		437,777		437,777		2/1/2027
	Creoate Limited ** ^		Senior Secured	11.8%		327,018		319,831		319,831		12/1/2025
	Creoate Limited Subtotal ** ^					907,171		892,398		892,398
	Digital. Thing(s), Inc.		Senior Secured	12.0%		328,844		293,172		293,172		10/1/2025
	Eguana Technologies, Inc. ** ^		Senior Secured	12.0%		3,107,383		2,762,835		2,389,088		*
	Fanimal, Inc.		Senior Secured	11.8%		578,498		534,576		25,853		*
	Heading Health Inc.		Senior Secured	12.5%		1,208,548		955,616		253,305		*
	Higher Ground Education, Inc.		Senior Secured	12.5%		325,522		324,460		324,460		2/1/2025
	Higher Ground Education, Inc.		Senior Secured	12.5%		1,339,384		1,329,730		1,329,730		6/1/2025
	Higher Ground Education, Inc. Subtotal					1,664,906		1,654,190		1,654,190
	Hint, Inc.		Senior Secured	12.0%		1,527,606		1,479,004		1,479,004		5/1/2025
	Holo, Inc.		Senior Secured	13.5%		242,433		89,505		89,505		*
	Hyphen Technologies, Inc.		Senior Secured	11.5%		1,608,875		1,576,699		1,576,699		3/1/2026
	Intuition Robotics, Inc. ** ^		Senior Secured	12.0%		1,006,125		991,613		991,613		11/1/2025
	Invert Robotics Group, Ltd.		Senior Secured	13.0%		286,146		261,015		261,015		5/1/2025
	Joy Memories, Inc		Senior Secured	12.0%		834,464		771,276		771,276		6/1/2027
	Kibeam Learning, Inc.		Senior Secured	11.5%		231,496		228,325		228,325		6/1/2025
	LendTable Inc.		Senior Secured	14.1%		2,414,807		2,364,069		1,623,465		*
	Logistech Solutions Pte. Ltd. ** ^		Senior Secured	11.5%		217,628		201,948		201,948		12/1/2025
	Logistech Solutions Pte. Ltd. ** ^		Senior Secured	12.8%		764,101		755,548		755,548		10/1/2026
	Logistech Solutions Pte. Ltd. Subtotal ** ^					981,729		957,496		957,496
	Mavenform, Inc.		Senior Secured	11.1%		1,453,642		1,445,530		1,145,128		10/1/2025
	Merlin Labs, Inc.		Senior Secured	11.0%		565,162		560,264		560,264		6/1/2025
	Noteleaf, Inc.		Senior Secured	18.0%		2,277,124		1,836,011		—		*
	Ocho Holdings Co.		Senior Secured	11.3%	44.1%	317,157		317,157		317,157		12/1/2024
	Plant Prefab, Inc.		Senior Secured	11.6%		2,887,000		2,286,773		2,067,861		*
	PlantBaby, Inc.		Senior Secured	12.0%		32,637		32,416		32,416		7/1/2025
	PlantBaby, Inc.		Senior Secured	14.3%		76,300		74,791		74,791		5/1/2026
	PlantBaby, Inc.		Senior Secured	12.0%		47,093		46,250		46,250		5/1/2025
	PlantBaby, Inc.		Senior Secured	13.8%		59,550		56,119		56,119		1/1/2026

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date
	Candy Club Holdings, Inc.		Senior Secured	12.0%		6,166,737		5,802,074		1,550,346		*
	PlantBaby, Inc.		Senior Secured	12.0%		45,953		45,528		45,528		10/1/2025
	Ceres Imaging, Inc.		Senior Secured	12.0%		1,127,835		1,088,832		1,088,832		4/1/2025
	PlantBaby, Inc. Subtotal					261,533		255,104		255,104
	Ceres Imaging, Inc.		Senior Secured	12.0%		1,630,476		1,602,801		1,602,801		4/1/2026
	Platform Science, Inc.		Senior Secured	12.5%		2,530,661		2,451,050		2,451,050		2/1/2026
	Ceres Imaging, Inc. Subtotal					2,758,311		2,691,633		2,691,633
	Platform Science, Inc.		Senior Secured	12.5%		2,697,095		2,676,222		2,676,222		3/1/2026
	Content Adjacent, Inc.		Senior Secured	12.0%		1,370,177		1,246,061		1,246,061		10/1/2027
	Platform Science, Inc. Subtotal					5,227,756		5,127,272		5,127,272
	Copia Global Inc. ** ^		Senior Secured	12.0%		7,699,044		7,542,825		7,542,825		1/1/2027
	Reali Inc.		Senior Secured	12.5%		11,275,525		8,533,922		23,751		*
	CornerUp, Inc.		Senior Secured	15.0%		229,002		196,822		196,822		3/1/2026
	Rise Gardens, Inc.		Senior Secured	11.8%		1,380,944		1,201,703		616,757		*
	CornerUp, Inc.		Senior Secured	15.0%		236,122		232,070		232,070		4/1/2026
	Romaine Empire, Inc.		Senior Secured	13.5%		8,887,530		8,764,571		8,764,571		12/1/2027
	CornerUp, Inc. Subtotal					465,124		428,892		428,892
	SMS OPCO LLC		Senior Secured	8.0%		29,942		11,192		—		*
	Creoate Limited ** ^		Senior Secured	11.8%		617,298		592,002		592,002		12/1/2025
	Supplant, Inc. ** ^		Senior Secured	16.0%		415,527		410,093		410,093		12/1/2026
	Creoate Limited ** ^		Senior Secured	15.5%		500,000		488,425		488,425		2/1/2027
	Supplant, Inc. ** ^		Senior Secured	13.0%		1,341,684		1,306,881		1,306,881		7/1/2026
	Creoate Limited ** ^		Senior Secured	14.0%		228,750		225,211		225,211		3/1/2026
	Supplant, Inc. Subtotal ** ^					1,757,211		1,716,974		1,716,974
	Creoate Limited Subtotal ** ^					1,346,048		1,305,638		1,305,638
	Sustainable Living Partners, LLC		Senior Secured	12.5%		13,967,808		13,094,889		10,926,993		*
	Daybase, Inc.		Senior Secured	11.0%		2,018,671		1,798,943		—		*
	The Farm Project, PBC.		Senior Secured	15.0%		2,272,202		2,252,211		1,916,072		6/1/2026
	EasyKnock, Inc.		Senior Secured	11.5%		1,902,781		1,763,129		1,763,129		10/1/2025
	TheSquareFoot, Inc.		Senior Secured	18.0%		628,478		325,058		—		*
	EasyKnock, Inc.		Senior Secured	11.5%		2,056,477		2,016,015		2,016,015		12/1/2025
	Titan Health & Security Technologies, Inc.		Senior Secured	12.0%		445,279		439,569		439,569		8/1/2025
	EasyKnock, Inc.		Senior Secured	11.5%		2,427,481		2,369,344		2,369,344		5/1/2026
	Umbra Lab, Inc.		Senior Secured	13.5%		2,878,167		2,828,922		2,828,922		4/1/2026
	EasyKnock, Inc. Subtotal					6,386,739		6,148,488		6,148,488
	Velo Holdings Limited		Senior Secured	12.0%		2,471,720		1,065,823		1,065,823		*
	Eguana Technologies, Inc. ** ^		Senior Secured	12.0%		1,410,524		1,339,264		1,339,264		4/1/2025
	Virtuix Holdings, Inc.		Senior Secured	12.3%		166,629		165,055		165,055		9/1/2025
	Eguana Technologies, Inc. ** ^		Senior Secured	12.0%		1,729,692		1,696,603		1,696,603		8/1/2025
	Wheels Labs, Inc. **		Senior Secured	12.0%		700,000		700,000		145,328		*
	Eguana Technologies, Inc. Subtotal ** ^					3,140,216		3,035,867		3,035,867
	Zeno Technologies, Inc.		Senior Secured	10.0%		251,129		233,996		233,996		*
	Fanimal, Inc.		Senior Secured	11.8%		189,126		169,116		169,116		2/1/2026
	Zimeno Inc.		Senior Secured	11.5%		2,933,530		2,867,300		2,867,300		1/1/2026
	Fanimal, Inc.		Senior Secured	11.8%		250,000		244,279		244,279		3/1/2027
	Zimeno Inc.		Senior Secured	11.5%		4,757,352		4,704,217		4,704,217		10/1/2026
	Fanimal, Inc.		Senior Secured	11.8%		330,628		324,581		324,581		7/1/2026
	Zimeno Inc. Subtotal					7,690,882		7,571,517		7,571,517
	Fanimal, Inc.		Senior Secured	11.8%		375,000		364,987		364,987		7/1/2027
Other Technology Total		56.6%				$	99,406,613	$	90,543,555	$	67,570,223
	Fanimal, Inc. Subtotal					1,144,754		1,102,963		1,102,963
Security
	Hadrian Automation, Inc.		Senior Secured	11.5%		1,366,697		1,342,175		1,342,175		2/1/2025
	Axiado Corporation		Senior Secured	10.5%		$	885,386	$	864,939	$	864,939	10/1/2025
	Heading Health Inc.		Senior Secured	13.2%		1,065,032		981,214		793,209		*
	Axiado Corporation		Senior Secured	10.5%		885,386		885,383		885,383		10/1/2025
	Higher Ground Education, Inc.		Senior Secured	12.5%		2,143,133		2,109,187		2,109,187		2/1/2025
	Axiado Corporation Subtotal					1,770,772		1,750,322		1,750,322
	Higher Ground Education, Inc.		Senior Secured	12.5%		3,780,792		3,708,955		3,708,955		6/1/2025
	Popily, Inc.		Senior Secured	12.5%		1,998,517		1,559,440		34,704		*
	Higher Ground Education, Inc. Subtotal					5,923,925		5,818,142		5,818,142
Security Total		1.5%				$	3,769,289	$	3,309,762	$	1,785,026
	Hint, Inc.		Senior Secured	12.0%		4,898,181		4,458,792		4,458,792		5/1/2025
Software
	Holo, Inc.		Senior Secured	13.5%		826,350		769,711		769,711		12/1/2025
	Abacum Inc. ** ^		Senior Secured	13.5%		$	1,148,769	$	1,103,285	$	1,103,285	10/1/2026
	Holo, Inc.		Senior Secured	15.5%		486,194		472,810		472,810		5/1/2026
	Bizly, Inc.		Senior Secured	12.5%		1,636,014		1,594,976		1,594,976		3/1/2027
	Holo, Inc. Subtotal					1,312,544		1,242,521		1,242,521
	BlueCart, Inc.		Senior Secured	14.1%		1,124,923		1,001,277		1,001,277		12/1/2026
	Hyphen Technologies, Inc.		Senior Secured	11.5%		2,737,343		2,644,141		2,644,141		3/1/2026
	Canopy Technology Corp.		Senior Secured	15.0%		547,212		541,475		541,475		3/1/2026
	Hyphen Technologies, Inc.		Senior Secured	12.0%		644,888		635,125		635,125		7/1/2024
	Canopy Technology Corp.		Senior Secured	13.5%		610,420		595,815		595,815		11/1/2025
	Hyphen Technologies, Inc. Subtotal					3,382,231		3,279,266		3,279,266
	Canopy Technology Corp. Subtotal					1,157,632		1,137,290		1,137,290
	Intuition Robotics, Inc. ** ^		Senior Secured	12.0%		1,982,991		1,927,316		1,927,316		11/1/2025
	Chowbus, Inc.		Senior Secured	12.0%		527,766		518,629		518,629		3/1/2025
	Invert Robotics Group, Ltd. ** ^		Senior Secured	13.0%		935,240		900,588		900,588		1/1/2025
	Common Sun, Inc		Senior Secured	11.0%		364,513		364,510		364,510		1/1/2027
	Joy Memories, Inc		Senior Secured	12.0%		1,235,303		1,158,922		1,158,922		12/1/2025
	Common Sun, Inc		Senior Secured	11.0%		854,040		829,969		829,969		7/1/2026
	Kibeam Learning, Inc.		Senior Secured	11.5%		656,577		633,002		633,002		6/1/2025
	Common Sun, Inc Subtotal					1,218,553		1,194,479		1,194,479
	Lacuna Technologies, Inc.		Senior Secured	12.0%		3,432,568		3,240,601		—		*
	Eskalera, Inc.		Senior Secured	12.0%		1,128,083		1,103,259		792,024		10/1/2026
	LendTable Inc.		Senior Secured	13.5%		1,828,989		1,751,544		1,751,544		3/1/2026
	Form Remodel, Inc.		Senior Secured	11.0%		216,860		209,140		209,140		12/1/2025
	LendTable Inc.		Senior Secured	14.8%		1,500,000		1,469,096		1,469,096		9/1/2026
	Form Remodel, Inc.		Senior Secured	11.0%		316,562		313,999		313,999		6/1/2026
	LendTable Inc. Subtotal					3,328,989		3,220,640		3,220,640
	Form Remodel, Inc.		Senior Secured	11.0%		250,709		249,109		249,109		2/1/2026
	Literati, Inc.		Senior Secured	11.3%		6,548,474		6,397,107		6,397,107		3/1/2026
	Form Remodel, Inc.		Senior Secured	11.0%		348,469		345,326		345,326		8/1/2026
	Logistech Solutions Pte. Ltd. ** ^		Senior Secured	12.8%		1,000,000		981,817		981,817		10/1/2026
	Form Remodel, Inc. Subtotal					1,132,600		1,117,574		1,117,574
	FutureProof Technologies, Inc.		Senior Secured	13.5%		640,496		617,606		617,606		6/1/2026
	Grokker, Inc.		Senior Secured	11.5%		243,895		240,305		240,305		4/1/2026

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date
	Logistech Solutions Pte. Ltd. ** ^		Senior Secured	11.5%		411,295		357,702		357,702		12/1/2025
	Grokker, Inc.		Senior Secured	11.5%		96,037		95,610		95,610		3/1/2025
	Logistech Solutions Pte. Ltd. Subtotal ** ^					1,411,295		1,339,519		1,339,519
	Grokker, Inc. Subtotal					339,932		335,915		335,915
	Mavenform, Inc.		Senior Secured	11.0%		375,896		372,103		372,103		10/1/2025
	HaystacksAI, Inc.		Senior Secured	12.3%		809,810		784,109		546,129		*
	Mavenform, Inc.		Senior Secured	11.5%		221,127		218,898		218,898		6/1/2024
	Hoken Holdings Inc.		Senior Secured	13.0%		379,142		359,408		165,361		5/1/2026
	Mavenform, Inc.		Senior Secured	11.5%		313,405		310,943		310,943		6/1/2025
	Ketch Kloud, Inc.		Senior Secured	13.0%		6,521,957		6,319,245		6,319,245		4/1/2027
	Mavenform, Inc.		Senior Secured	11.0%		986,918		966,038		966,038		7/1/2025
	Ratio Technologies, Inc.		Senior Secured	11.0%		128,333		112,710		112,710		1/1/2027
	Mavenform, Inc. Subtotal					1,897,346		1,867,982		1,867,982
	Ratio Technologies, Inc.		Senior Secured	11.0%		848,283		839,947		839,947		1/1/2027
	Merlin Labs, Inc.		Senior Secured	11.0%		1,606,760		1,570,011		1,570,011		6/1/2025
	Ratio Technologies, Inc.		Senior Secured	11.0%		306,717		303,661		303,661		1/1/2027
	MinoMonsters, Inc. ** ^		Senior Secured	11.5%		904,417		894,738		894,738		10/1/2024
	Ratio Technologies, Inc. Subtotal					1,283,333		1,256,318		1,256,318
	Momentus Space LLC **		Senior Secured	12.0%		2,292,963		2,285,030		2,285,030		2/1/2024
	Safe Securities Inc.		Senior Secured	11.5%		481,779		478,328		478,328		4/1/2026
	Natomas Labs, Inc.		Senior Secured	13.3%		4,407,183		4,167,612		4,167,612		9/1/2025
	Safe Securities Inc.		Senior Secured	11.5%		1,680,219		1,661,759		1,661,759		9/1/2025
	Noteleaf, Inc.		Senior Secured	18.0%		2,277,124		1,836,011		—		*
	Safe Securities Inc. Subtotal					2,161,998		2,140,087		2,140,087
	Ocho Holdings Co.		Senior Secured	11.3%		482,259		499,616		499,616		12/1/2024
	SF Insuretech, Inc.		Senior Secured	13.5%		786,275		786,275		786,275		11/1/2026
	OnePointOne, Inc.		Senior Secured	12.0%		151,028		150,032		150,032		2/1/2024
	SF Insuretech, Inc.		Senior Secured	13.5%		725,598		725,598		725,598		9/1/2026
	OnePointOne, Inc.		Senior Secured	12.0%		151,109		150,780		150,780		2/1/2024
	SF Insuretech, Inc.		Senior Secured	13.5%		1,200,388		1,113,723		1,113,723		5/1/2026
	OnePointOne, Inc. Subtotal					302,137		300,812		300,812
	SF Insuretech, Inc. Subtotal					2,712,261		2,625,596		2,625,596
	Phase Four, Inc.		Senior Secured	11.5%		645,144		631,219		631,219		12/1/2024
	Swiftly Systems, Inc.		Senior Secured	11.5%		80,788		80,588		80,588		1/1/2025
	Phase Four, Inc.		Senior Secured	11.5%		690,634		682,050		682,050		8/1/2025
	Terragon, Inc. ** ^		Senior Secured	12.0%		74,798		76,108		76,108		*
	Phase Four, Inc. Subtotal					1,335,778		1,313,269		1,313,269
	Traction Apps, Inc. ** ^		Senior Secured	12.0%		669,230		687,621		420,442		*
	Plant Prefab, Inc.		Senior Secured	11.0%		789,927		784,016		784,016		11/1/2024
	UCM Digital Health, Inc.		Senior Secured	12.5%		1,325,856		1,159,785		1,159,785		5/1/2027
	Plant Prefab, Inc.		Senior Secured	12.4%		1,236,363		1,174,111		1,174,111		12/1/2025
	Vesta Housing, Inc.		Senior Secured	11.8%		748,772		722,566		722,566		6/1/2026
	Plant Prefab, Inc.		Senior Secured	11.0%		873,346		858,280		858,280		8/1/2024
	Vesta Housing, Inc.		Senior Secured	11.8%		748,772		739,470		739,470		6/1/2026
	Plant Prefab, Inc. Subtotal					2,899,636		2,816,407		2,816,407
	Vesta Housing, Inc. Subtotal					1,497,544		1,462,036		1,462,036
	PlantBaby, Inc.		Senior Secured	13.8%		107,087		96,231		96,231		1/1/2026
Software Total		21.5%				$	27,571,485	$	26,675,191	$	25,664,750
	PlantBaby, Inc.		Senior Secured	12.0%		95,285		93,485		93,485		10/1/2025
Technology Services
	PlantBaby, Inc.		Senior Secured	12.0%		150,836		143,047		143,047		5/1/2025
	Klar Holdings Limited ** ^		Senior Secured	11.8%		$	1,463,620	$	1,438,665	$	1,438,665	8/1/2025
	PlantBaby, Inc.		Senior Secured	14.3%		121,495		117,614		117,614		5/1/2026
	Loansnap Holdings Inc. **		Senior Secured	10.3%		3,982,300		3,782,386		1,907,838		*
	PlantBaby, Inc.		Senior Secured	12.0%		83,466		82,084		82,084		7/1/2025
Technology Services Total		2.8%				$	5,445,920	$	5,221,051	$	3,346,503
	PlantBaby, Inc. Subtotal					558,169		532,461		532,461
Wireless
	Platform Science, Inc.		Senior Secured	12.5%		4,421,154		4,179,690		4,179,690		2/1/2026
	Juvo Mobile, Inc. **		Senior Secured	12.0%		$	1,002,031	$	975,385	$	975,385	7/1/2026
	Platform Science, Inc.		Senior Secured	12.5%		4,567,377		4,506,939		4,506,939		3/1/2026
	Juvo Mobile, Inc. **		Senior Secured	15.5%		338,922		334,592		334,592		7/1/2026
	Platform Science, Inc. Subtotal					8,988,531		8,686,629		8,686,629
	Juvo Mobile, Inc. Subtotal **					1,340,953		1,309,977		1,309,977
	Privoro Holdings, Inc.		Senior Secured	12.0%		275,766		273,403		273,403		4/1/2024
Wireless Total		1.1%				$	1,340,953	$	1,309,977	$	1,309,977
	Reali Inc.		Senior Secured	12.5%		11,275,525		8,533,922		23,751		*
	Grand Total	126.6%				$	212,550,855	$	194,533,292	$	151,064,673
	Rise Gardens, Inc.		Senior Secured	11.8%		500,000		491,113		343,184		10/1/2026
	Rise Gardens, Inc.		Senior Secured	11.8%		792,662		769,831		537,948		11/1/2025
	Rise Gardens, Inc. Subtotal					1,292,662		1,260,944		881,132
	Romaine Empire, Inc.		Senior Secured	13.5%		8,887,530		8,586,100		8,586,100		12/1/2027
	Setex Technologies, Inc.		Senior Secured	12.3%		367,247		356,513		356,513		8/1/2024
	SISU Aesthetics Clinic, Inc. ** ^		Senior Secured	13.5%		943,438		912,621		912,621		4/1/2026
	SISU Aesthetics Clinic, Inc. ** ^		Senior Secured	14.0%		728,903		723,510		723,510		5/1/2026
	SISU Aesthetics Clinic, Inc. Subtotal ** ^					1,672,341		1,636,131		1,636,131
	SMS OPCO LLC		Senior Secured	8.0%		29,942		11,192		—		*
	Supplant, Inc. ** ^		Senior Secured	16.0%		500,000		489,453		489,453		12/1/2026
	Supplant, Inc. ** ^		Senior Secured	13.0%		2,000,000		1,917,423		1,917,423		7/1/2026
	Supplant, Inc. Subtotal ** ^					2,500,000		2,406,876		2,406,876
	Sustainable Living Partners, LLC		Senior Secured	12.5%		13,689,730		12,816,811		12,816,811		*
	The Farm Project, PBC.		Senior Secured	12.0%		2,617,147		2,575,221		2,575,221		1/1/2025
	The Safe and Fair Food Company LLC		Senior Secured	12.3%		758,271		731,681		731,681		9/1/2024
	TheSquareFoot, Inc.		Senior Secured	18.0%		628,478		325,058		—		*


	Ticker Symbol	Percent of Net Assets	Number of Shares	Cost		Fair Value
Cash Equivalents
First American Government Obligations Fund - Class Z	FGZXX	3.8%	4,583,701	$	4,583,701	$	4,583,701
Total Cash Equivalents		3.8%	4,583,701	$	4,583,701	$	4,583,701

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Cost		Fair Value (d)		Final Maturity Date
	Titan Health & Security Technologies, Inc.		Senior Secured	12.0%		1,048,969		1,018,428		1,018,428		8/1/2025
	TLNT Inc.		Senior Secured	15.8%		312,500		304,453		190,530		2/1/2027
	TLNT Inc.		Senior Secured	14.3%		353,987		325,391		203,633		4/1/2026
	TLNT Inc.		Senior Secured	15.3%		312,500		305,936		191,458		8/1/2026
	TLNT Inc.		Senior Secured	14.8%		118,039		115,912		72,539		4/1/2026
	TLNT Inc. Subtotal					1,097,026		1,051,692		658,160
	Umbra Lab, Inc.		Senior Secured	13.5%		4,717,188		4,583,466		4,583,466		4/1/2026
	Umbra Lab, Inc.		Senior Secured	12.0%		1,110,816		1,101,946		1,101,946		6/1/2024
	Umbra Lab, Inc.		Senior Secured	12.0%		1,110,412		1,102,605		1,102,605		6/1/2024
	Umbra Lab, Inc. Subtotal					6,938,416		6,788,017		6,788,017
	Velo Holdings Limited		Senior Secured	12.0%		2,471,720		1,362,429		1,362,429		*
	Virtuix Holdings, Inc.		Senior Secured	12.3%		365,971		358,553		358,553		9/1/2025
	Wellth, Inc.		Senior Secured	12.0%		705,341		676,303		676,303		4/1/2025
	Wellth, Inc.		Senior Secured	12.0%		423,265		416,804		416,804		4/1/2025
	Wellth, Inc. Subtotal					1,128,606		1,093,107		1,093,107
	Wheels Labs, Inc. **		Senior Secured	12.0%		700,000		700,000		498,994		*
	World Wrapps II, Inc.		Senior Secured	12.0%		111,028		105,072		105,072		6/1/2024
	World Wrapps II, Inc.		Senior Secured	12.0%		111,036		111,036		111,036		6/1/2024
	World Wrapps II, Inc.		Senior Secured	12.0%		111,166		111,166		111,166		6/1/2024
	World Wrapps II, Inc. Subtotal					333,230		327,274		327,274
	Zeno Technologies, Inc.		Senior Secured	10.0%		165,526		165,525		165,525		7/1/2025
	Zeno Technologies, Inc.		Senior Secured	10.0%		165,526		155,757		155,757		7/1/2025
	Zeno Technologies, Inc. Subtotal					331,052		321,282		321,282
	Zimeno Inc.		Senior Secured	11.5%		5,331,391		5,114,486		5,114,486		1/1/2026
	Zimeno Inc.		Senior Secured	11.5%		6,250,000		6,136,157		6,136,157		10/1/2026
	Zimeno Inc. Subtotal					11,581,391		11,250,643		11,250,643
Other Technology Total		75.8%				$	178,296,191	$	167,462,148	$	142,995,711
Security
	Axiado Corporation		Senior Secured	10.5%		$	1,849,112	$	1,762,565	$	1,762,565	10/1/2025
	Axiado Corporation		Senior Secured	10.5%		1,849,112		1,849,098		1,849,098		10/1/2025
	Axiado Corporation Subtotal					3,698,224		3,611,663		3,611,663
	Lassen Peak, Inc.		Senior Secured	11.0%		109,199		107,258		107,258		8/1/2024
	Popily, Inc.		Senior Secured	12.5%		1,998,517		1,559,440		50,722		*
Security Total		2.0%				$	5,805,940	$	5,278,361	$	3,769,643
Software
	Abacum Inc. ** ^		Senior Secured	13.5%		$	1,500,000	$	1,404,738	$	1,404,738	10/1/2026
	Afero, Inc.		Senior Secured	12.3%		95,118		94,408		94,408		1/1/2024
	BackboneAI Inc.		Senior Secured	12.3%		134,312		133,684		130,791		8/1/2024
	Bizly, Inc.		Senior Secured	12.5%		1,636,661		1,600,527		1,600,527		12/1/2025
	BlueCart, Inc.		Senior Secured	14.8%		221,804		216,774		216,774		2/1/2026
	BlueCart, Inc.		Senior Secured	12.5%		1,326,346		1,263,830		1,263,830		2/1/2026
	BlueCart, Inc. Subtotal					1,548,150		1,480,604		1,480,604
	Canopy Technology Corp.		Senior Secured	13.5%		1,194,573		1,139,432		1,139,432		11/1/2025
	Canopy Technology Corp.		Senior Secured	15.0%		916,006		899,683		899,683		3/1/2026
	Canopy Technology Corp. Subtotal					2,110,579		2,039,115		2,039,115
	Chowbus, Inc.		Senior Secured	12.0%		2,625,783		2,449,576		2,449,576		3/1/2025
	Common Sun, Inc		Senior Secured	11.0%		500,000		499,995		499,995		1/1/2027
	Common Sun, Inc		Senior Secured	11.0%		1,320,637		1,262,731		1,262,731		7/1/2026
	Common Sun, Inc Subtotal					1,820,637		1,762,726		1,762,726
	Eskalera, Inc.		Senior Secured	12.0%		1,481,557		1,428,773		1,428,773		10/1/2026
	Form Remodel, Inc.		Senior Secured	11.0%		410,822		383,743		383,743		12/1/2025
	Form Remodel, Inc.		Senior Secured	11.0%		441,105		436,137		436,137		2/1/2026

*As of December 31, 2024, loans with a cost basis of $95.5 million and a fair value of $53.8 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.

42**Indicates assets that the Fund deems “non-qualifying assets.” As of December 31, 2024, 13.2% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund's investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Cost		Fair Value (d)		Final Maturity Date
	Form Remodel, Inc.		Senior Secured	11.0%		500,000		493,526		493,526		6/1/2026
	Form Remodel, Inc.		Senior Secured	11.0%		500,000		492,701		492,701		8/1/2026
	Form Remodel, Inc. Subtotal					1,851,927		1,806,107		1,806,107
	FutureProof Technologies, Inc.		Senior Secured	13.5%		1,000,000		943,769		943,769		6/1/2026
	Grokker, Inc.		Senior Secured	11.5%		453,850		445,992		445,992		3/1/2025
	Grokker, Inc.		Senior Secured	11.5%		403,473		393,586		393,586		4/1/2026
	Grokker, Inc. Subtotal					857,323		839,578		839,578
	HaystacksAI, Inc.		Senior Secured	11.0%		426,099		426,099		426,099		1/1/2026
	HaystacksAI, Inc.		Senior Secured	11.0%		426,099		404,188		404,188		1/1/2026
	HaystacksAI, Inc. Subtotal					852,198		830,287		830,287
	Hoken Holdings Inc.		Senior Secured	13.0%		607,201		556,766		556,766		5/1/2026
	Journey Builders, Inc.		Senior Secured	12.5%		942,299		901,246		901,246		8/1/2026
	Ketch Kloud, Inc.		Senior Secured	13.0%		7,000,000		6,739,524		6,739,524		10/1/2026
	Ocurate, Inc.		Senior Secured	11.5%		380,556		367,489		367,489		10/1/2025
	Ocurate, Inc.		Senior Secured	11.5%		380,556		376,162		376,162		10/1/2025
	Ocurate, Inc. Subtotal					761,112		743,651		743,651
	Overalls, Inc.		Senior Secured	13.5%		471,719		442,548		442,548		4/1/2026
	Overalls, Inc.		Senior Secured	15.5%		236,209		236,209		236,209		4/1/2026
	Overalls, Inc. Subtotal					707,928		678,757		678,757
	Parkoursc, Inc.		Senior Secured	12.0%		226,953		226,084		226,084		9/1/2024
	Ratio Technologies, Inc.		Senior Secured	11.0%		430,449		424,310		424,310		1/1/2027
	Ratio Technologies, Inc.		Senior Secured	11.0%		180,104		149,795		149,795		1/1/2027
	Ratio Technologies, Inc.		Senior Secured	11.0%		1,190,488		1,173,736		1,173,736		1/1/2027
	Ratio Technologies, Inc. Subtotal					1,801,041		1,747,841		1,747,841
	Safe Securities Inc.		Senior Secured	11.5%		797,813		788,287		788,287		4/1/2026
	Safe Securities Inc.		Senior Secured	11.5%		3,707,507		3,620,387		3,620,387		9/1/2025
	Safe Securities Inc. Subtotal					4,505,320		4,408,674		4,408,674
	SF Insuretech, Inc.		Senior Secured	13.5%		988,750		988,750		988,750		11/1/2026
	SF Insuretech, Inc.		Senior Secured	13.5%		1,920,296		1,701,661		1,701,661		5/1/2026
	SF Insuretech, Inc.		Senior Secured	11.8%		878,326		866,253		866,253		8/1/2024
	SF Insuretech, Inc.		Senior Secured	13.5%		988,431		988,431		988,431		9/1/2026
	SF Insuretech, Inc. Subtotal					4,775,803		4,545,095		4,545,095
	Swiftly Systems, Inc.		Senior Secured	11.5%		992,459		975,741		975,741		1/1/2025
	Swiftly Systems, Inc.		Senior Secured	11.5%		1,548,309		1,475,261		1,475,261		10/1/2024
	Swiftly Systems, Inc. Subtotal					2,540,768		2,451,002		2,451,002
	Terragon, Inc. ** ^		Senior Secured	12.0%		93,038		87,637		87,637		5/1/2024
	Traction Apps, Inc. ** ^		Senior Secured	12.0%		676,801		650,923		650,923		6/1/2026
	Truthset, Inc.		Senior Secured	12.5%		316,907		291,452		291,452		9/1/2024
	UCM Digital Health, Inc.		Senior Secured	12.5%		1,482,990		1,399,404		1,399,404		4/1/2026
	Vesta Housing, Inc.		Senior Secured	11.8%		1,178,533		1,155,197		1,155,197		6/1/2026
	Vesta Housing, Inc.		Senior Secured	11.8%		1,178,533		1,113,411		1,113,411		6/1/2026
	Vesta Housing, Inc. Subtotal					2,357,066		2,268,608		2,268,608
	WorkRails, Inc.		Senior Secured	12.0%		455,117		369,727		68,278		*
	Workspot, Inc.		Senior Secured	12.0%		112,755		112,008		112,008		3/1/2024
Software Total		23.7%				$	46,877,344	$	44,992,291	$	44,687,949
Technology Services
	iLearningEngines Inc.		Senior Secured	11.5%		$	927,277	$	910,395	$	910,395	1/1/2025
	iLearningEngines Inc.		Senior Secured	11.5%		2,109,706		2,063,191		2,063,191		1/1/2026
	iLearningEngines Inc.		Senior Secured	11.5%		904,731		600,569		600,569		10/1/2024
	iLearningEngines Inc.		Senior Secured	11.5%		1,407,609		1,360,828		1,360,828		4/1/2025
	iLearningEngines Inc.		Senior Secured	11.5%		1,770,172		1,733,026		1,733,026		6/1/2024
	iLearningEngines Inc.		Senior Secured	11.5%		1,727,221		1,695,265		1,695,265		8/1/2025
	iLearningEngines Inc. Subtotal					8,846,716		8,363,274		8,363,274

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Cost		Fair Value (d)		Final Maturity Date
	Klar Holdings Limited ** ^		Senior Secured	12.0%		555,388		547,459		547,459		6/1/2024
	Klar Holdings Limited ** ^		Senior Secured	12.0%	3.0%	798,776		794,348		794,348		8/1/2024
	Klar Holdings Limited ** ^		Senior Secured	11.8%		3,455,849		3,323,072		3,323,072		8/1/2025
	Klar Holdings Limited Subtotal ** ^					4,810,013		4,664,879		4,664,879
	Loansnap Holdings Inc. **		Senior Secured	10.3%		3,982,300		3,782,386		2,537,800		*
Technology Services Total		8.2%				$	17,639,029	$	16,810,539	$	15,565,953
Wireless
	AirVine Scientific, Inc.		Senior Secured	10.8%		$	137,457	$	136,703	$	136,703	6/1/2024
	AirVine Scientific, Inc.		Senior Secured	10.8%		137,388		135,628		135,628		6/1/2024
	AirVine Scientific, Inc. Subtotal					274,845		272,331		272,331
	Juvo Mobile, Inc. **		Senior Secured	15.5%		500,000		489,833		489,833		7/1/2026
	Juvo Mobile, Inc. **		Senior Secured	12.0%		1,500,000		1,436,390		1,436,390		7/1/2026
	Juvo Mobile, Inc. Subtotal **					2,000,000		1,926,223		1,926,223
	MeshPlusPlus, Inc.		Senior Secured	12.5%		84,976		84,148		84,148		3/1/2024
	MeshPlusPlus, Inc.		Senior Secured	12.5%		55,783		55,474		55,474		6/1/2024
	MeshPlusPlus, Inc. Subtotal					140,759		139,622		139,622
Wireless Total		1.2%				$	2,415,604	$	2,338,176	$	2,338,176
	Grand Total	160.5%				$	374,151,262	$	350,627,997	$	302,804,781

	Ticker Symbol	Percent of Net Assets	Cost		Fair Value
Cash Equivalents
First American Government Obligations Fund - Class Z	FGZXX	11.1%	$	21,017,408	$	21,017,408
Total Cash Equivalents		11.1%	$	21,017,408	$	21,017,408

* As of December 31, 2023, loans with a cost basis of $77.7 million and a fair value of $32.9 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.

**Indicates assets that the Fund deems “non-qualifying assets.” As of December 31, 2023, 13.3% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund's investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.

(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are generally the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Schedule of Investments based on a ~~hypothetical~~most advantageous market and the estimates may include the use of significant unobservable inputs.

As of December 31, ~~2023~~2024, all loans were made to non-affiliates.

See notes to financial statements.

44(Intentionally left blank)

VENTURE LENDING & LEASING IX, INC.

Schedule of Investments

As of December 31, ~~2022~~2023

Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date
Biotechnology
	Calysta, Inc.		Senior Secured	11.8%		$	64,~~356~~034,~~409~~272	$	63,~~061~~915,~~521~~776	$	63,~~061~~915,~~521~~776	6/1/2025
	Driver Bioengineering, Inc.		Senior Secured	11.0%		55,584		54,428		54,428		4/1/2023
	Genomic Prediction, Inc.		Senior Secured	11.0%		462,427		450,632		450,632		1/1/2025
	Driver Bioengineering, Inc.		Senior Secured	11.0%		192,798		191,887		191,887		6/1/2023
	GLO Pharma, Inc.		Senior Secured	10.5%		855,052		842,954		842,954		12/1/2024
	Driver Bioengineering, Inc. Subtotal					248,382		246,315		246,315
	GLO Pharma, Inc.		Senior Secured	10.5%		1,281,930		1,270,942		1,270,942		12/1/2024
	Genomic Prediction, Inc.		Senior Secured	11.0%		843,236		804,598		804,598		1/1/2025
	GLO Pharma, Inc. Subtotal					2,136,982		2,113,896		2,113,896
	GLO Pharma, Inc.		Senior Secured	10.5%		1,625,228		1,582,163		1,582,163		12/1/2024
	Ukko Inc.		Senior Secured	11.5%		3,398,473		3,253,318		3,253,318		5/1/2026
	GLO Pharma, Inc.		Senior Secured	10.5%		2,436,610		2,397,362		2,397,362		12/1/2024
Biotechnology Total		5.2%				$	10,032,154	$	9,733,622	$	9,733,622
	GLO Pharma, Inc. Subtotal					4,061,838		3,979,525		3,979,525
	Quartzy, Inc.		Senior Secured	12.0%		202,740		196,508		196,508		8/1/2023
	Quartzy, Inc.		Senior Secured	12.0%		618,402		612,373		612,373		5/1/2024
	Quartzy, Inc.		Senior Secured	12.0%		684,617		677,177		677,177		7/1/2024
	Quartzy, Inc.		Senior Secured	11.0%		1,237,478		895,384		895,384		2/1/2026
	Quartzy, Inc.		Senior Secured	11.0%		1,237,779		1,166,087		1,166,087		5/1/2026
	Quartzy, Inc.		Senior Secured	11.0%		1,238,126		1,175,663		1,175,663		8/1/2026
	Quartzy, Inc.		Senior Secured	11.0%		1,238,420		1,171,479		1,171,479		10/1/2026
	Quartzy, Inc. Subtotal					6,457,562		5,894,671		5,894,671
	Ukko Inc. ** ^		Senior Secured	11.5%		3,500,000		3,255,446		3,255,446		5/1/2026
Biotechnology Total		7.6%				$	21,467,427	$	20,242,076	$	20,242,076
Computers & Storage
	Canary Connect, Inc.		Senior Secured	12.0%		$	4225,~~250,186~~469	$	4224,~~154,761~~872	$	4224,~~154,761~~872	3/1/2024
	Canary Connect, Inc.		Senior Secured	1112.80%		14901,~~831,521~~528		14896,~~240,717~~305		14896,~~240,717~~305		3/1/~~2026~~2024
	Canary Connect, Inc.		Senior Secured	1211.8%		~~283~~13,~~712~~521,618		~~282~~13,~~621~~193,287		~~282~~13,~~621~~193,287		3/1/~~2023~~2026
	Canary Connect, Inc.		Senior Secured	12.0%		1,062,957		1,051,985		1,051,985		3/1/2024
	Canary Connect, Inc. Subtotal					14,648,615		14,314,464		14,314,464
	Canary Connect, Inc. Subtotal					20,428,376		19,730,084		19,730,084
	Proto, Inc.		Senior Secured	12.5%		1,049,740		1,001,515		1,001,515		10/1/2025
	Proto, Inc.		Senior Secured	12.58%		1,~~375~~050,~~000~~540		1,~~273~~050,~~897~~539		1,~~273~~050,~~897~~539		10/1/2025
	Proto, Inc.		Senior Secured	12.8%		1,375,000		1,374,999		1,374,999		10/1/2025
	Proto, Inc. Subtotal					2,100,280		2,052,054		2,052,054
	Proto, Inc. Subtotal					2,750,000		2,648,896		2,648,896
Computers & Storage Total		8.7%				$	16,748,895	$	16,366,518	$	16,366,518
Computers & Storage Total		8.3%				$	23,178,376	$	22,378,980	$	22,378,980
Enterprise Networking
	Diamanti, Inc.		Senior Secured	11.0%		$	5,~~932~~404,~~984~~212	$	43,~~584~~687,~~616~~334	$	3,~~549~~687,~~308~~334	*
Enterprise Networking Total		12.30%				$	5,~~932~~404,~~984~~212	$	43,~~584~~687,~~616~~334	$	3,~~549~~687,~~308~~334
Internet
	10club Pte Ltd. ** ^		Senior Secured	12.0%		$	15,~~343~~264,~~394~~876	$	14,~~015~~762,~~257~~966	$	12,~~015~~801,~~257~~583	811/1/2025
	10club Pte Ltd. ** ^		Senior Secured	12.0%		4,346,160		4,253,288		4,253,288		11/1/2025
	Ainsly, Inc. ** ^		Senior Secured	12.5%		133,826		133,821		133,821		7/1/2025
	10club Pte Ltd. Subtotal ** ^					5,689,554		5,268,545		5,268,545
	Ainsly, Inc. ** ^		Senior Secured	12.5%		200,739		153,231		153,231		7/1/2025
	Ainsly, Inc. ** ^		Senior Secured	12.5%		300,000		196,815		196,815		7/1/2025
	Ainsly, Inc. Subtotal ** ^					334,565		287,052		287,052
	Ainsly, Inc. ** ^		Senior Secured	12.5%		82,401		79,368		79,368		9/1/2023
	D2C Store, Inc.		Senior Secured	10.0%		1,905,572		1,572,688		1,572,688		*
	Ainsly, Inc. ** ^		Senior Secured	12.5%		200,000		199,989		199,989		7/1/2025
	Good Counsel, LLC		Senior Secured	12.3%		2,707,456		2,431,880		2,431,880		4/1/2026
	Ainsly, Inc. Subtotal ** ^					582,401		476,172		476,172
	iZENEtech, Inc. ** ^		Senior Secured	12.3%		3,001,339		2,997,442		2,790,190		*
	D2C Store, Inc.		Senior Secured	10.0%		2,500,000		2,227,117		2,227,117		*
	Kings Mountain I LLC		Senior Secured	11.5%		94,770		76,620		71,768		*
	Good Counsel, LLC		Senior Secured	12.3%		2,967,909		2,846,304		2,846,304		10/1/2025
	Miami Labs, Inc.		Senior Secured	13.3%		7,500,000		7,162,069		7,162,069		5/1/2026
	iZENEtech, Inc. ** ^		Senior Secured	12.3%		3,135,994		3,045,707		3,045,707		9/1/2024
	OneLocal, Inc. ** ^		Senior Secured	12.0%		1,245,475		1,201,210		1,201,210		1/1/2025
	Osix Corporation		Senior Secured	12.3%		3,679,812		3,369,724		3,369,724		*
	Pixalate, Inc.		Senior Secured	12.5%		3,389,495		3,271,244		3,271,244		4/1/2025
	Quantcast Corp.		Senior Secured	12.0%		12,500,000		11,779,146		11,779,146		7/1/2026
	RenoFi, Inc.		Senior Secured	11.5%		988,490		929,802		929,802		7/1/2025
	RenoFi, Inc.		Senior Secured	11.5%		1,082,499		1,070,622		1,070,622		9/1/2025
	RenoFi, Inc. Subtotal					2,070,989		2,000,424		2,000,424
	Residently USA, LLC ** ^		Senior Secured	12.0%		422,364		389,326		389,326		4/1/2026
	RetailerX, Inc.		Senior Secured	11.3%		5,769,455		5,446,191		5,446,191		7/1/2026
	Serface Care, Inc.		Senior Secured	12.3%		597,411		344,785		—		*
	Stay Alfred, Inc.		Senior Secured	18.0%		4,921,822		3,408,326		—		*
	Usual Beverage Co.		Senior Secured	12.0%		1,699,532		1,629,519		284,813		*
	Verishop, Inc.		Senior Secured	12.6%		1,145,286		1,139,192		1,139,192		12/1/2024
	Vinvesto, Inc.		Senior Secured	15.0%		243,054		243,054		243,054		5/1/2026
	Vinvesto, Inc.		Senior Secured	14.8%		243,033		223,116		223,116		5/1/2026
	Vinvesto, Inc. Subtotal					486,087		466,170		466,170
Internet Total		24.6%				$	58,736,306	$	53,735,974	$	46,464,670


Industry	Borrower	Percent of Net Assets (a)	Collateral	Interest Rate (b)	End of Term Payment (c)	Principal		Amortized Cost		Fair Value (d)		Final Maturity Date

Medical Devices
	Anutra Medical, Inc.		Senior Secured	18.0%		$	398,742	$	346,750	$	—	*
	CytoVale, Inc.		Senior Secured	12.0%		1,217,661		1,205,201		1,205,201		1/1/2025
	Medrobotics Corporation, Inc.		Senior Secured	18.0%		10,000,000		8,932,603		—		*
	Norbert Health, Inc.		Senior Secured	12.3%		222,648		217,849		217,849		6/1/2024
	Siren Care, Inc.		Senior Secured	13.5%		606,861		604,374		604,374		1/1/2025
Medical Devices Total		1.1%				$	12,445,912	$	11,306,777	$	2,027,424

Other Healthcare
	Elysium Health, Inc.		Senior Secured	12.0%		$	3,204,172	$	3,083,630	$	3,083,630	2/1/2025
	GoForward, Inc.		Senior Secured	11.5%		690,974		688,087		688,087		6/1/2024
	Grayce, Inc.		Senior Secured	11.8%		215,439		213,798		213,798		12/1/2024
	Grayce, Inc.		Senior Secured	14.0%		664,671		631,909		631,909		2/1/2026
	Grayce, Inc.		Senior Secured	11.8%		327,838		322,236		322,236		9/1/2024
	Grayce, Inc. Subtotal					1,207,948		1,167,943		1,167,943
	Hello Heart Inc.		Senior Secured	11.0%		440,421		434,449		434,449		6/1/2024
	Hello Heart Inc.		Senior Secured	11.0%		1,250,622		1,242,667		1,242,667		6/1/2025
	Hello Heart Inc. Subtotal					1,691,043		1,677,116		1,677,116
	Honeybee Health, Inc.		Senior Secured	11.0%		1,503,502		1,438,883		1,438,883		9/1/2025
	Julie Products Inc.		Senior Secured	15.3%		375,000		366,817		366,817		4/1/2026
	Julie Products Inc.		Senior Secured	15.8%		375,000		366,153		366,153		6/1/2026
	Julie Products Inc.		Senior Secured	13.0%		802,628		764,447		764,447		9/1/2025
	Julie Products Inc. Subtotal					1,552,628		1,497,417		1,497,417
	KBS, Inc.		Senior Secured	14.0%		250,000		229,967		229,967		6/1/2026
	Minded, Inc.		Senior Secured	11.2%		2,224,305		2,008,841		—		*
	Open Inc.		Senior Secured	14.8%		457,878		451,414		451,414		3/1/2026
	Open Inc.		Senior Secured	13.5%		457,247		436,107		436,107		3/1/2026
	Open Inc. Subtotal					915,125		887,521		887,521
	Oula Health, Inc.		Senior Secured	12.0%		56,647		56,322		56,322		2/1/2024
	Oula Health, Inc.		Senior Secured	12.0%		90,275		89,868		89,868		7/1/2024
	Oula Health, Inc. Subtotal					146,922		146,190		146,190
	PrecisionOS Technology Inc. ** ^		Senior Secured	12.0%		667,730		643,612		643,612		7/1/2025
	Therapydia, Inc.		Senior Secured	12.0%		1,777,402		1,753,942		1,753,942		2/1/2027
	Tia, Inc.		Senior Secured	11.8%		371,042		364,011		364,011		5/1/2024
	Tia, Inc.		Senior Secured	11.8%		818,984		815,087		815,087		9/1/2024
	Tia, Inc. Subtotal					1,190,026		1,179,098		1,179,098
	Vessel Health, Inc.		Senior Secured	12.0%		711,734		588,211		553,968		1/1/2026
	Yes Health, Inc.		Senior Secured	12.0%		1,773,262		1,705,392		—		*
	Yuva Biosciences, Inc.		Senior Secured	13.3%		242,902		220,407		220,407		5/1/2026
Other Healthcare Total		8.0%				$	19,749,675	$	18,916,257	$	15,167,781

Other Technology
	8i Corporation		Senior Secured	12.0%		$	390,777	$	386,909	$	243,768	10/1/2025
	Aclima, Inc.		Senior Secured	12.0%		321,219		298,126		298,126		*
	Airspeed, Inc.		Senior Secured	11.0%		532,573		505,660		505,660		1/1/2026
	Airspeed, Inc.		Senior Secured	11.0%		625,000		625,000		625,000		7/1/2026
	Airspeed, Inc. Subtotal					1,157,573		1,130,660		1,130,660
	Azumo, Inc.		Senior Secured	12.8%		1,282,604		1,203,696		1,203,696		1/1/2026
	Bankroll Club, LLC		Senior Secured	12.9%		4,262,576		3,955,801		970,983		*
	Beautiful Beanfields, Inc.		Senior Secured	6.0%		275,000		255,324		127,662		*
	BloomTech Inc.		Senior Secured	11.3%		267,698		267,698		267,698		5/1/2026
	Brave Care Technologies, Inc.		Senior Secured	12.0%		738,617		724,173		649,416		9/1/2024
	Bryte, Inc.		Senior Secured	10.0%		1,680,936		1,640,717		1,640,717		9/1/2025
	Candy Club Holdings, Inc.		Senior Secured	12.0%		6,166,737		5,802,074		1,550,346		*

Industry

Borrower

Percent of Net Assets (a)

Collateral

Interest Rate (b)

End of Term Payment (c)

Principal

Amortized Cost

Fair Value (d)

Final Maturity Date

Ceres Imaging, Inc.

Senior Secured

12.0%

1,127,835

1,088,832

4/1/2025

Ceres Imaging, Inc.

Senior Secured

12.0%

Filing Compare · Venture Lending & Leasing IX, Inc.